<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Fragile X Syndrome " Version="20190226" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">Fragile X syndrome (FXS) is a monogenetic disorder cause by a mutation in the FMR1 gene and the most common form of inherited intellectual disability and autism spectrum disorder (ASD). Patients with FXS show a range of typical physical features such as macro-orchidism in males, a long and narrow face, large and protruding ears and hyperextensible joints. Common comorbidities of FXS are neuropsychiatric disorders such as hyperactivity, depression and anxiety. 
The mutation of FMR1 in FXS disrupts production of the FMR1 gene product, the fragile mental retardation protein (FMRP). The main function of FMRP is to locally act as a translational repressor for target mRNAs and thereby regulate de novo protein synthesis and ultimately synaptic plasticity. FMRP, together with the mTOR pathway and the ERK pathway regulates expression of target mRNAsn mediated by stimulation of Group I metabotropic glutamate receptors (mGluR) and thereby regulate  Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) internalisation and thus long term depression (LTD).  LTD is a form of synaptic plasticity which is involved in learning and memory. Lack of FMRP leads to exaggerated mGluR dependant LTD, which accounts for most of FXS pathogenesis. </Comment>
  <Graphics BoardWidth="5231.347826086948" BoardHeight="2968.2470780738595"/>
  <DataNode TextLabel="glutamate" GraphId="a2fd0" Type="Metabolite">
    <Graphics CenterX="745.3333333333333" CenterY="343.93548387096746" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:14321"/>
  </DataNode>
  <DataNode TextLabel="KCND2" GraphId="a3c40" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2699.9999999999973" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000184408"/>
  </DataNode>
  <DataNode TextLabel="MMP9" GraphId="a9604" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2737.9999999999973" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000100985"/>
  </DataNode>
  <DataNode TextLabel="KCNC1" GraphId="ac5ae" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2663.9999999999973" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000129159"/>
  </DataNode>
  <DataNode TextLabel="CYFIP2" GraphId="ad39d" Type="GeneProduct">
    <Graphics CenterX="1603.6666666666763" CenterY="2583.9999999999973" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000055163"/>
  </DataNode>
  <DataNode TextLabel="GABRD" GraphId="aefd4" Type="GeneProduct">
    <Graphics CenterX="1137.1904761904793" CenterY="2408.6666666666592" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000187730"/>
  </DataNode>
  <DataNode TextLabel="GRM5" GraphId="b0473" Type="GeneProduct">
    <Graphics CenterX="1605.75" CenterY="2445.7500000000014" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000168959"/>
  </DataNode>
  <DataNode TextLabel="CNR1" GraphId="c324d" Type="GeneProduct">
    <Graphics CenterX="377.0" CenterY="740.935483870968" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000118432"/>
  </DataNode>
  <DataNode TextLabel="SRC" GraphId="daa4e" Type="GeneProduct">
    <Graphics CenterX="1556.0" CenterY="964.0" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000197122"/>
  </DataNode>
  <DataNode TextLabel="DUSP3" GraphId="db077" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2545.0" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000108861"/>
  </DataNode>
  <DataNode TextLabel="HOMER1" GraphId="ece9e" Type="GeneProduct">
    <Comment>The short splice variant of Homer, Homer1a, competes with Homer 1 for the binding site on mGluR. In FXS mouse model, Homer1a has been shown to associate more with mGluR than Homer1, thereby it disrupts mGluR signalling and causes constitutive, agonist-independent activity of Group I mGluR. </Comment>
    <BiopaxRef>fd2</BiopaxRef>
    <Graphics CenterX="602.0" CenterY="505.0" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="ff3300"/>
    <Xref Database="Ensembl" ID="ENSG00000152413"/>
  </DataNode>
  <DataNode TextLabel="FYN" GraphId="f0fb0" Type="GeneProduct">
    <Comment>Tyrosine-protein kinase Fyn (FYN) is a member of the Src family of tyrosine kinases which is involved in the regulation of brain function. </Comment>
    <BiopaxRef>a79</BiopaxRef>
    <Graphics CenterX="3112.014492753615" CenterY="314.6021505376343" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000010810"/>
  </DataNode>
  <DataNode TextLabel="GRIN2A" GraphId="f5ca1" Type="GeneProduct">
    <Graphics CenterX="1605.75" CenterY="2369.7500000000014" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000183454"/>
  </DataNode>
  <DataNode TextLabel="EEF1A1" GraphId="f6832" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2541.3333333333317" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000156508"/>
  </DataNode>
  <DataNode TextLabel="GRIN2A" GraphId="f71d3" Type="GeneProduct">
    <Graphics CenterX="1446.6666666666665" CenterY="2370.0000000000014" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000183454"/>
  </DataNode>
  <DataNode TextLabel="HCN1" GraphId="f8758" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2623.9999999999973" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000164588"/>
  </DataNode>
  <DataNode TextLabel="EPS8L1" GraphId="fcd81" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2778.9999999999977" Width="90.0" Height="25.0" ZOrder="32768" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000131037"/>
  </DataNode>
  <DataNode TextLabel="BDNF-TrkB Signalling" GraphId="fda63" Type="Pathway">
    <Graphics CenterX="1561.3750000000027" CenterY="469.08333333333326" Width="146.08333333333283" Height="25.0" ZOrder="32768" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="None" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP3676"/>
  </DataNode>
  <DataNode TextLabel="ABAT" GraphId="d7a44" Type="GeneProduct">
    <Comment>4-aminobutyrate aminotransferase (ABAT) is involved in GABA catabolism. </Comment>
    <BiopaxRef>dda</BiopaxRef>
    <Graphics CenterX="1137.1904761904793" CenterY="2371.6231589409845" Width="90.0" Height="25.0" ZOrder="32770" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000183044"/>
  </DataNode>
  <DataNode TextLabel="PI3K-Akt-mTOR &#10;Pathway&#10;" GraphId="b7759" Type="Pathway">
    <Comment>Activation of mTOR pathway is required for mGlur-LTD. mTOR activation is believed to sustain the increase in overall rate of mRNA translation at the synapse. </Comment>
    <BiopaxRef>f8b</BiopaxRef>
    <Graphics CenterX="556.1884057971014" CenterY="586.0151940158951" Width="150.66666666666652" Height="38.33333333333326" ZOrder="32772" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="None" Color="14961e"/>
    <Xref Database="WikiPathways" ID="WP4172"/>
  </DataNode>
  <DataNode TextLabel="CAMKIV-CREB Pathway" GraphId="b8d60" Type="Pathway">
    <Graphics CenterX="2315.4203507489883" CenterY="363.2653158037401" Width="176.6526610644255" Height="25.105042016806692" ZOrder="32774" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="None" Color="14961e"/>
    <Xref Database="" ID=""/>
  </DataNode>
  <DataNode TextLabel="glutamate" GraphId="fe5c4" Type="Metabolite">
    <Graphics CenterX="3288.5144927536203" CenterY="366.77862112586894" Width="83.66666666666833" Height="25.0" ZOrder="32776" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:14321"/>
  </DataNode>
  <DataNode TextLabel="BDNF" GraphId="cf9d9" Type="GeneProduct">
    <Graphics CenterX="1437.5098039215682" CenterY="496.023719165085" Width="90.0" Height="25.0" ZOrder="32778" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000176697"/>
  </DataNode>
  <DataNode TextLabel="AP2A1" GraphId="e95af" Type="GeneProduct" GroupRef="e75aa">
    <Graphics CenterX="4530.347826086948" CenterY="955.9354838709687" Width="90.0" Height="25.0" ZOrder="32780" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000196961"/>
  </DataNode>
  <DataNode TextLabel="PLCB1" GraphId="d36bc" Type="GeneProduct">
    <Graphics CenterX="2321.7971014492714" CenterY="411.2688172043004" Width="90.0" Height="25.0" ZOrder="32784" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000182621"/>
  </DataNode>
  <DataNode TextLabel="GAD1" GraphId="a824e" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2486.289825607657" Width="90.0" Height="25.0" ZOrder="32786" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000128683"/>
  </DataNode>
  <DataNode TextLabel="cAMP" GraphId="fd5c1" Type="Metabolite">
    <Graphics CenterX="2411.9673913043453" CenterY="1375.6854838709687" Width="90.0" Height="25.0" ZOrder="32788" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:17489"/>
  </DataNode>
  <DataNode TextLabel="CLTCL1" GraphId="bd259" Type="GeneProduct" GroupRef="e4320">
    <Graphics CenterX="4499.014492753626" CenterY="1324.6021505376355" Width="90.0" Height="25.0" ZOrder="32790" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000070371"/>
  </DataNode>
  <DataNode TextLabel="PPP3CA" GraphId="b531b" Type="GeneProduct">
    <Comment>Calcineurin</Comment>
    <Graphics CenterX="3874.347826086945" CenterY="418.6021505376352" Width="90.0" Height="25.0" ZOrder="32792" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000138814"/>
  </DataNode>
  <DataNode TextLabel="GRIP2" GraphId="f03e0" Type="GeneProduct" GroupRef="f8b08">
    <Comment>Glutamate receptor-interacting protein 2 (GRIP2) also called AMPAR binding protein (ABP) interacts with GRIP1 to regulate AMPAR trafficking</Comment>
    <Graphics CenterX="4426.347826086948" CenterY="511.93548387096746" Width="90.0" Height="25.0" ZOrder="32794" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000144596"/>
  </DataNode>
  <DataNode TextLabel="CREB1" GraphId="d3036" Type="GeneProduct">
    <Graphics CenterX="2519.2480818414397" CenterY="1666.602150537631" Width="90.0" Height="25.0" ZOrder="32796" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000118260"/>
  </DataNode>
  <DataNode TextLabel="DLG4" GraphId="b4869" Type="GeneProduct">
    <Graphics CenterX="4542.097826086949" CenterY="457.68548387096746" Width="90.0" Height="25.0" ZOrder="32798" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000132535"/>
  </DataNode>
  <DataNode TextLabel="DLG4" GraphId="b0e44" Type="GeneProduct">
    <Comment>postsynaptic density protein 95 (PSD-95 also known as SAP-90, encoded by the gene DLG4) is a PSD scaffolding protein, located at synapses, which is involved in the modulation of AMPAR ineternalization, stabilization of dendritic spines and synaptic strength. Translation of PSD-95 is negatively regulated by FMRP and miR-125a and positively regulated by mGluR activation. PSD-95 anchors synaptic proteins at the membrane and thus plays a cruicial role in synaptic plasticity and NMDAR-dependant LTP. In that sense, PSD-95 has a binary role, it serves as a structural scaffold which anchors AMPARs at the synapse. It also acts as a signalling scaffold required for LTD. </Comment>
    <BiopaxRef>de1</BiopaxRef>
    <BiopaxRef>f91</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2403.4508900334326" Width="90.0" Height="25.0" ZOrder="32800" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000132535"/>
  </DataNode>
  <DataNode TextLabel="SLC6A1" GraphId="a14d7" Type="GeneProduct">
    <Comment>Sodium- and chloride-dependent GABA transporter 1 (SLC6A1 or GAT-1)  has a function in GABA reuptake in the cortex, cerebellum and the whole forebrain. GAT-1 ends GABA action by removing GABA from the synaptic cleft and restoring it to presynaptic terminals.</Comment>
    <BiopaxRef>e3a</BiopaxRef>
    <Graphics CenterX="1137.1904761904793" CenterY="2330.956492274324" Width="90.0" Height="25.0" ZOrder="32802" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000157103"/>
  </DataNode>
  <DataNode TextLabel="PRKCA" GraphId="a5ba0" Type="GeneProduct">
    <Graphics CenterX="3961.347826086948" CenterY="803.9354838709675" Width="90.0" Height="25.0" ZOrder="32806" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000154229"/>
  </DataNode>
  <DataNode TextLabel="GAD1" GraphId="eec3b" Type="GeneProduct">
    <Comment>Glutamate decarboxylase 1 (GAD1) encoded an enzyme (glutamic acid decarboxylase) that has a role in Î³-aminobutyric acid (GABA) synthesis. The enzyme catalyzes the production of GABA from L-glutamic acid. </Comment>
    <BiopaxRef>dc9</BiopaxRef>
    <Graphics CenterX="1137.1904761904793" CenterY="2486.2898256076514" Width="90.0" Height="25.0" ZOrder="32808" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000128683"/>
  </DataNode>
  <DataNode TextLabel="PRKACA" GraphId="f560d" Type="GeneProduct" GroupRef="ceedf">
    <Graphics CenterX="2233.3768115941994" CenterY="1471.9354838709687" Width="90.0" Height="25.0" ZOrder="32812" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000072062"/>
  </DataNode>
  <DataNode TextLabel="MEK-ERK-Mnk1 Pathway" GraphId="c93d5" Type="Pathway">
    <Comment>Activation of ERK pathway is required for mGlur-LTD. ERK activation is thought to control the activation of specific mRNAs such as the LTD proteins. </Comment>
    <BiopaxRef>f8b</BiopaxRef>
    <Graphics CenterX="2010.949275362319" CenterY="694.3521505376365" Width="185.00000000000023" Height="21.833333333333314" ZOrder="32814" FontWeight="Bold" FontSize="12" Valign="Middle" ShapeType="None" Color="14961e"/>
    <Xref Database="KEGG Pathway" ID="map04010"/>
  </DataNode>
  <DataNode TextLabel="EIF4G1" GraphId="f0ce6" Type="GeneProduct" GroupRef="acd3f">
    <Graphics CenterX="1142.0000000000005" CenterY="2043.2688172043015" Width="90.0" Height="25.0" ZOrder="32816" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000114867"/>
  </DataNode>
  <DataNode TextLabel="ALDH5A1" GraphId="e91f9" Type="GeneProduct">
    <Comment>aldehyde dehydrogenase 5 family member A1 (ALDHA1) and encodes encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenaseis that is involved in the catalysis of GABA.</Comment>
    <BiopaxRef>def</BiopaxRef>
    <Graphics CenterX="1137.1904761904793" CenterY="2448.9564922743166" Width="90.0" Height="25.0" ZOrder="32820" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000112294"/>
  </DataNode>
  <DataNode TextLabel="Î³-aminobutyric acid" GraphId="fb109" Type="Metabolite">
    <Comment>Î³-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system. </Comment>
    <BiopaxRef>f8c</BiopaxRef>
    <Graphics CenterX="377.0" CenterY="815.2443074003775" Width="168.75" Height="25.0" ZOrder="32822" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:16865"/>
  </DataNode>
  <DataNode TextLabel="SHC1" GraphId="e3d66" Type="GeneProduct">
    <Graphics CenterX="1551.333333333334" CenterY="800.018817204302" Width="90.0" Height="25.0" ZOrder="32824" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000160691"/>
  </DataNode>
  <DataNode TextLabel="GRIA1" GraphId="cb3ca" Type="Rna">
    <Graphics CenterX="1446.6666666666665" CenterY="2262.2211981566866" Width="90.0" Height="25.0" ZOrder="32826" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000155511"/>
  </DataNode>
  <DataNode TextLabel="CLTC" GraphId="cff0b" Type="GeneProduct" GroupRef="e4320">
    <Graphics CenterX="4499.014492753626" CenterY="1300.6021505376352" Width="90.0" Height="25.0" ZOrder="32828" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000141367"/>
  </DataNode>
  <DataNode TextLabel="AP2B1" GraphId="b60a8" Type="GeneProduct" GroupRef="e75aa">
    <Graphics CenterX="4530.347826086948" CenterY="979.9354838709687" Width="90.0" Height="25.0" ZOrder="32830" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000006125"/>
  </DataNode>
  <DataNode TextLabel="CPT1A" GraphId="db8ff" Type="Rna">
    <Graphics CenterX="1942.6666666666665" CenterY="2642.1259600614476" Width="90.0" Height="25.0" ZOrder="32832" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000110090"/>
  </DataNode>
  <DataNode TextLabel="PRKACA" GraphId="cef38" Type="GeneProduct" GroupRef="ceedf">
    <Comment>Exact subunits which make up PKA in thus pathway could not be found. PKA is made up of 2 regulary subunits and 2 catalytic subunits. Because no information on the composition of subunits in this case could have been found, subunits A have been used for regulatory and catalytic parts of PKA. </Comment>
    <Graphics CenterX="2322.0434782608663" CenterY="1471.9354838709687" Width="90.0" Height="25.0" ZOrder="32834" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000072062"/>
  </DataNode>
  <DataNode TextLabel="PIP2" GraphId="dfc5c" Type="Metabolite">
    <Graphics CenterX="2708.3768115942007" CenterY="709.2688172043021" Width="90.0" Height="25.0" ZOrder="32838" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:18348"/>
  </DataNode>
  <DataNode TextLabel="PTPN5" GraphId="cd7a0" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2257.2155959157867" Width="90.0" Height="25.0" ZOrder="32840" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000110786"/>
  </DataNode>
  <DataNode TextLabel="GRB2" GraphId="a364c" Type="GeneProduct">
    <Graphics CenterX="1551.333333333334" CenterY="850.268817204302" Width="90.0" Height="25.0" ZOrder="32842" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000177885"/>
  </DataNode>
  <DataNode TextLabel="CLTB" GraphId="e5ee5" Type="GeneProduct" GroupRef="e4320">
    <Graphics CenterX="4409.681159420285" CenterY="1324.6021505376357" Width="90.0" Height="25.0" ZOrder="32844" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000175416"/>
  </DataNode>
  <DataNode TextLabel="GPHN" GraphId="e8fca" Type="GeneProduct">
    <Comment>Gephyrin is involved in GABA receptor clustering in the cortex. Gephyrin is a neuronal assembly protein that anchors inhibitory neurotransmitter receptors, such as GABA receptors, to the postsynaptic cytoskeleton. </Comment>
    <BiopaxRef>e30</BiopaxRef>
    <Graphics CenterX="1137.1904761904793" CenterY="2286.956492274326" Width="90.0" Height="25.0" ZOrder="32846" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000171723"/>
  </DataNode>
  <DataNode TextLabel="GRIP1" GraphId="b3e2b" Type="GeneProduct" GroupRef="f8b08">
    <Comment>   </Comment>
    <Graphics CenterX="4426.097826086949" CenterY="536.3521505376334" Width="90.0" Height="25.0" ZOrder="32850" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155974"/>
  </DataNode>
  <DataNode TextLabel="DLG4" GraphId="b6e01" Type="GeneProduct">
    <Graphics CenterX="2990.3768115942003" CenterY="768.6021505376345" Width="90.0" Height="25.0" ZOrder="32852" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000132535"/>
  </DataNode>
  <DataNode TextLabel="GRIA2" GraphId="c405a" Type="GeneProduct" GroupRef="b28cc">
    <Graphics CenterX="5072.264492753616" CenterY="592.6854838709673" Width="90.0" Height="25.0" ZOrder="32854" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000120251"/>
  </DataNode>
  <DataNode TextLabel="APP" GraphId="f9760" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2505.0783410138242" Width="90.0" Height="25.0" ZOrder="32856" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000142192"/>
  </DataNode>
  <DataNode TextLabel="miR-125b&#10;" GraphId="e2bb4" Type="Rna" GroupRef="bb884">
    <Graphics CenterX="493.74999999999903" CenterY="2362.6021505376343" Width="90.0" Height="25.0" ZOrder="32858" FontSize="12" Valign="Middle" Color="660066"/>
    <Xref Database="miRBase mature sequence" ID="MIMAT0042091"/>
  </DataNode>
  <DataNode TextLabel="CAMK4" GraphId="f9f8c" Type="GeneProduct">
    <Comment>CAMK4 or CAMKIV</Comment>
    <Graphics CenterX="2707.463768115939" CenterY="1426.6021505376366" Width="90.0" Height="25.0" ZOrder="32860" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000152495"/>
  </DataNode>
  <DataNode TextLabel="CREB1" GraphId="bf607" Type="GeneProduct">
    <Graphics CenterX="2250.0127877237846" CenterY="1666.9354838709703" Width="90.0" Height="25.0" ZOrder="32862" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000118260"/>
  </DataNode>
  <DataNode TextLabel="PTPN11" GraphId="b64db" Type="GeneProduct">
    <Graphics CenterX="1551.333333333334" CenterY="825.268817204302" Width="90.0" Height="25.0" ZOrder="32868" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000179295"/>
  </DataNode>
  <DataNode TextLabel="GRIA1" GraphId="fdf19" Type="GeneProduct" GroupRef="b28cc">
    <Graphics CenterX="5072.014492753616" CenterY="567.9354838709677" Width="90.0" Height="25.0" ZOrder="32870" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155511"/>
  </DataNode>
  <DataNode TextLabel="AP2S1" GraphId="b236e" Type="GeneProduct" GroupRef="e75aa">
    <Graphics CenterX="4530.347826086948" CenterY="1027.9354838709687" Width="90.0" Height="25.0" ZOrder="32872" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000042753"/>
  </DataNode>
  <DataNode TextLabel="AGO2" GraphId="c16d9" Type="GeneProduct" GroupRef="bb884">
    <Graphics CenterX="493.74999999999926" CenterY="2307.2688172042945" Width="90.0" Height="25.0" ZOrder="32874" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000123908"/>
  </DataNode>
  <DataNode TextLabel="AKAP5" GraphId="e9258" Type="GeneProduct">
    <Comment>A-kinase anchor protein 5 (AKAP5) anchors protein kinase A (PKA) at the PSD by directly interacting with PSD-95. This interaction is important for NMDAR-dependant AMPAR endocytosis and LTD. </Comment>
    <BiopaxRef>b64</BiopaxRef>
    <Graphics CenterX="4542.347826086948" CenterY="293.9354838709676" Width="90.0" Height="25.0" ZOrder="32876" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000179841"/>
  </DataNode>
  <DataNode TextLabel="GABRG2" GraphId="ccf74" Type="GeneProduct">
    <Comment>GABA rceeptor subunit Î³</Comment>
    <Graphics CenterX="1137.1904761904793" CenterY="2610.373158941006" Width="90.0" Height="25.0" ZOrder="32880" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000113327"/>
  </DataNode>
  <DataNode TextLabel="CAMK1" GraphId="a4e3c" Type="GeneProduct">
    <Graphics CenterX="2584.5217391304336" CenterY="1241.9354838709687" Width="78.95652173913277" Height="25.0" ZOrder="32884" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000134072"/>
  </DataNode>
  <DataNode TextLabel="ARHGAP32" GraphId="b5824" Type="GeneProduct">
    <Comment>Rho GTPase activating protein 32 (ARHGAP32) is a neuron-associated GAP that may regulate dendritic spine morphology and strength through modulation of Rho GTPase activity. </Comment>
    <BiopaxRef>e12</BiopaxRef>
    <Graphics CenterX="491.333333333333" CenterY="2580.6021505376357" Width="90.0" Height="25.0" ZOrder="32886" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000134909"/>
  </DataNode>
  <DataNode TextLabel="GAB1" GraphId="b023c" Type="GeneProduct">
    <Graphics CenterX="1397.3333333333344" CenterY="705.935483870968" Width="90.0" Height="25.0" ZOrder="32888" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000109458"/>
  </DataNode>
  <DataNode TextLabel="GABRA1" GraphId="f0e0d" Type="GeneProduct">
    <Comment>GABA receptor subunit Î±</Comment>
    <Graphics CenterX="1137.1904761904793" CenterY="2528.623158941005" Width="90.0" Height="25.0" ZOrder="32890" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000022355"/>
  </DataNode>
  <DataNode TextLabel="PTPN5" GraphId="dc475" Type="GeneProduct">
    <Comment>Tyrosine-protein phosphatase non-receptor type 5 (STEP) is involves to regulate AMPAR trafficking and negatively regulates AMPAR surface expression thereby contributing to mGluR-LTD. STEP promotes LTD by stimulating synaptic weakening by dephosphorylation of ERK1/2 and subunits of NDMA and AMPA receptors. STEP has been shown to promote NMDA internalization. </Comment>
    <BiopaxRef>f94</BiopaxRef>
    <BiopaxRef>cf2</BiopaxRef>
    <Graphics CenterX="2106.1408860663387" CenterY="2257.9655959157867" Width="90.0" Height="25.0" ZOrder="32892" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000110786"/>
  </DataNode>
  <DataNode TextLabel="Dynamin-1" GraphId="c5ce3" Type="Protein">
    <Graphics CenterX="4294.097826086948" CenterY="913.6854838709687" Width="90.0" Height="25.0" ZOrder="32894" FontSize="12" Valign="Middle"/>
    <Xref Database="Uniprot-TrEMBL" ID="A0A0D9SFB1"/>
  </DataNode>
  <DataNode TextLabel="DICER1" GraphId="b3e88" Type="GeneProduct">
    <Comment>DICER, is an endonuclease, which cleaves double stranded RNA (dsRNA) into short single stranded RNA called miRNA and tehreby faciliates the activation of RISC</Comment>
    <BiopaxRef>ce2</BiopaxRef>
    <Graphics CenterX="469.33333333333326" CenterY="1823.9354838709687" Width="90.0" Height="25.0" ZOrder="32896" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100697"/>
  </DataNode>
  <DataNode TextLabel="AP2M1" GraphId="cbb2a" Type="GeneProduct" GroupRef="e75aa">
    <Graphics CenterX="4530.347826086948" CenterY="1003.9354838709687" Width="90.0" Height="25.0" ZOrder="32898" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000161203"/>
  </DataNode>
  <DataNode TextLabel="PICK1" GraphId="c3764" Type="GeneProduct">
    <Comment>Protein Interacting with Kinase C 1 (PICK1)  </Comment>
    <Graphics CenterX="4005.347826086948" CenterY="688.9354838709678" Width="90.0" Height="25.0" ZOrder="32900" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100151"/>
  </DataNode>
  <DataNode TextLabel="DAG1" GraphId="c3f9f" Type="GeneProduct">
    <Graphics CenterX="2539.2173913043453" CenterY="1037.6021505376355" Width="90.0" Height="25.0" ZOrder="32902" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000173402"/>
  </DataNode>
  <DataNode TextLabel="GRIN2B" GraphId="b91f7" Type="GeneProduct">
    <Comment>N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDAR) are ionotropic receptors activated by glutamate. NMDAR activation allows Ca2+ influx leading to NMDAR-dependant LTP and LTD. NMDA receptors contribute to dendritic structure and thus, can have impact on neuronal firing. </Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <BiopaxRef>b4e</BiopaxRef>
    <Graphics CenterX="3387.014492753623" CenterY="467.2688172043006" Width="90.0" Height="25.0" ZOrder="32904" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000273079"/>
  </DataNode>
  <DataNode TextLabel="GABRB2" GraphId="f0c60" Type="GeneProduct">
    <Comment>GABA receptor subunit Î²</Comment>
    <Graphics CenterX="1137.1904761904793" CenterY="2570.623158941005" Width="90.0" Height="25.0" ZOrder="32906" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000145864"/>
  </DataNode>
  <DataNode TextLabel="endocannabinoids" GraphId="d7fc2" Type="Metabolite">
    <Comment/>
    <Graphics CenterX="377.0" CenterY="657.7443074003777" Width="127.0" Height="22.5" ZOrder="32910" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:67197"/>
  </DataNode>
  <DataNode TextLabel="NTRK2" GraphId="e58ce" Type="GeneProduct">
    <Graphics CenterX="1548.6666666666672" CenterY="554.602150537634" Width="90.0" Height="25.0" ZOrder="32912" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000148053"/>
  </DataNode>
  <DataNode TextLabel="SLC16A1" GraphId="d055a" Type="Rna">
    <Graphics CenterX="1942.6666666666665" CenterY="2676.1259600614467" Width="90.0" Height="25.0" ZOrder="32914" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000155380"/>
  </DataNode>
  <DataNode TextLabel="CLTA" GraphId="e0616" Type="GeneProduct" GroupRef="e4320">
    <Graphics CenterX="4409.681159420285" CenterY="1301.018817204302" Width="90.0" Height="25.0" ZOrder="32916" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000122705"/>
  </DataNode>
  <DataNode TextLabel="GRIA2" GraphId="f5337" Type="Rna">
    <Graphics CenterX="1446.6666666666665" CenterY="2300.8878648233535" Width="90.0" Height="25.0" ZOrder="32918" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000120251"/>
  </DataNode>
  <DataNode TextLabel="SYNGAP1" GraphId="a7faf" Type="GeneProduct">
    <Graphics CenterX="2989.3768115941944" CenterY="865.602150537635" Width="90.0" Height="25.0" ZOrder="32920" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000197283"/>
  </DataNode>
  <DataNode TextLabel="ITPR1" GraphId="b70e9" Type="GeneProduct">
    <Graphics CenterX="2809.376811594201" CenterY="1040.268817204302" Width="90.0" Height="25.0" ZOrder="32922" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000150995"/>
  </DataNode>
  <DataNode TextLabel="PPP1CA" GraphId="b56c5" Type="GeneProduct">
    <Comment>PP1 had 4 isomforms, however, in this pathway, only one (gene PPP1CA) has been used since literature did not specify which isoform is involved in this specific case. </Comment>
    <BiopaxRef>d04</BiopaxRef>
    <Graphics CenterX="3874.3478260869497" CenterY="389.6021505376341" Width="90.0" Height="25.0" ZOrder="32924" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000172531"/>
  </DataNode>
  <DataNode TextLabel="PLCG1" GraphId="cd617" Type="GeneProduct">
    <Graphics CenterX="2321.7971014492714" CenterY="442.6021505376343" Width="90.0" Height="25.0" ZOrder="32926" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000124181"/>
  </DataNode>
  <DataNode TextLabel="CAMK2B" GraphId="df13f" Type="GeneProduct">
    <Comment>CAMKII catalyzes the phosphorylation of AMPAR an</Comment>
    <Graphics CenterX="4061.014492753617" CenterY="913.9354838709694" Width="90.0" Height="25.0" ZOrder="32928" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000058404"/>
  </DataNode>
  <DataNode TextLabel="SHANK1" GraphId="e5fba" Type="GeneProduct">
    <Graphics CenterX="1941.9999999999966" CenterY="2470.411674347159" Width="90.0" Height="25.0" ZOrder="32930" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000161681"/>
  </DataNode>
  <DataNode TextLabel="DLG4" GraphId="a8467" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2403.1175567000996" Width="90.0" Height="25.0" ZOrder="32932" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000132535"/>
  </DataNode>
  <DataNode TextLabel="DLGAP3" GraphId="fe57b" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2434.411674347158" Width="90.0" Height="25.0" ZOrder="32934" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000116544"/>
  </DataNode>
  <DataNode TextLabel="MAP2K2" GraphId="a4e5a" Type="GeneProduct">
    <Graphics CenterX="1747.1304347826087" CenterY="1329.660121552128" Width="90.0" Height="25.0" ZOrder="32936" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000126934"/>
  </DataNode>
  <DataNode TextLabel="FMR1" GraphId="a3823" Type="GeneProduct">
    <Comment>FMR1 gene product, called fragile mental retardation protein (FMRP) is a major regulator of mGluR-dependant protein synthesis and synaptic plasticity in hippocampus and cerebellum. It functions as a translational regulator of certain target mRNAs, is involved in denrite and axon developent as well as in learning and memory. </Comment>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics CenterX="984.0000000000011" CenterY="1412.6854838709673" Width="90.0" Height="25.0" ZOrder="32938" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000102081"/>
  </DataNode>
  <DataNode TextLabel="MAP1B" GraphId="c2bc4" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2332.117556700096" Width="90.0" Height="25.0" ZOrder="32940" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000131711"/>
  </DataNode>
  <DataNode TextLabel="ARC" GraphId="a8263" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2296.7450076804885" Width="90.0" Height="25.0" ZOrder="32942" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000198576"/>
  </DataNode>
  <DataNode TextLabel="MKNK1" GraphId="e1da2" Type="GeneProduct">
    <Graphics CenterX="1904.4637681159404" CenterY="1722.268817204302" Width="90.0" Height="25.0" ZOrder="32944" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000079277"/>
  </DataNode>
  <DataNode TextLabel="RPS6KB1" GraphId="f9577" Type="GeneProduct">
    <Graphics CenterX="1411.3333333333348" CenterY="1389.9354838709662" Width="90.0" Height="25.0" ZOrder="32946" FillColor="Transparent" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108443"/>
  </DataNode>
  <DataNode TextLabel="MAP1B" GraphId="b4ed7" Type="GeneProduct">
    <Comment>Microtubule-associated protein 1B (MAP1B) is involved in mcirotubule assembly and neurogenesis. MAP1b is involved in the regulation of the morphology of dendritic spines in glutamatergic synapses. Furthermore, MAP1b is a negative regulator of AMPAR surface expression thereby contributing to mGluR-LTD. </Comment>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2332.7842233667607" Width="90.0" Height="25.0" ZOrder="32948" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000131711"/>
  </DataNode>
  <DataNode TextLabel="MAPK1" GraphId="f401e" Type="GeneProduct">
    <Graphics CenterX="1734.1304347826074" CenterY="1506.602150537635" Width="90.0" Height="25.0" ZOrder="32950" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100030"/>
  </DataNode>
  <DataNode TextLabel="KRAS" GraphId="b2983" Type="GeneProduct">
    <Graphics CenterX="1999.8804347826072" CenterY="732.6854838709687" Width="90.0" Height="25.0" ZOrder="32952" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000133703"/>
  </DataNode>
  <DataNode TextLabel="CYFIP1" GraphId="bfc13" Type="GeneProduct">
    <Comment>CYFIP1 interacts with FMRP and with translation initiation factor eIF4E</Comment>
    <BiopaxRef>e9d</BiopaxRef>
    <Graphics CenterX="1131.75" CenterY="1823.9354838709676" Width="90.0" Height="25.0" ZOrder="32954" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000273749"/>
  </DataNode>
  <DataNode TextLabel="AKT1S1" GraphId="ddce6" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1069.9999999999998" CenterY="1259.6021505376357" Width="90.0" Height="25.0" ZOrder="32956" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000204673"/>
  </DataNode>
  <DataNode TextLabel="ARC" GraphId="c167f" Type="GeneProduct">
    <Comment>Activity-regulated cytoskeleton-associated protein (ARC) is a key regulator of synaptic plasticity. It is required for protein synthesis-dependent LTP and LTD as well as  for the formation of long-term memory. ARC regulates synaptic plasticity by promoting endocytosis of AMPA receptors AMPAR and thus, LTD. </Comment>
    <BiopaxRef>dfe</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2297.1616743471545" Width="90.0" Height="25.0" ZOrder="32958" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000198576"/>
  </DataNode>
  <DataNode TextLabel="MAP2K1" GraphId="d78b2" Type="GeneProduct">
    <Graphics CenterX="1747.1304347826083" CenterY="1300.660121552128" Width="90.0" Height="25.0" ZOrder="32960" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000169032"/>
  </DataNode>
  <DataNode TextLabel="CAMK2A" GraphId="f473b" Type="Rna">
    <Graphics CenterX="1941.9999999999966" CenterY="2367.784223366764" Width="90.0" Height="25.0" ZOrder="32962" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000070808"/>
  </DataNode>
  <DataNode TextLabel="SOS1" GraphId="b6067" Type="GeneProduct">
    <Comment>SOS, a guanine-associated echange factor (GEF), activates Ras by inducing the exchange of GTDP by GTP. This positively regulates Ras signalling.</Comment>
    <BiopaxRef>ac2</BiopaxRef>
    <Graphics CenterX="1772.5471014492728" CenterY="826.6854838709687" Width="90.0" Height="25.0" ZOrder="32964" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000115904"/>
  </DataNode>
  <DataNode TextLabel="PPP2R5B" GraphId="c4c61" Type="GeneProduct">
    <Graphics CenterX="733.0" CenterY="1418.2688172043022" Width="90.0" Height="25.0" ZOrder="32966" FillColor="Transparent" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000068971"/>
  </DataNode>
  <DataNode TextLabel="EIF4EBP2" GraphId="eee9f" Type="GeneProduct">
    <Graphics CenterX="1344.1477591036405" CenterY="1821.262514683294" Width="90.0" Height="25.0" ZOrder="32968" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000148730"/>
  </DataNode>
  <DataNode TextLabel="RAF1" GraphId="de858" Type="GeneProduct">
    <Graphics CenterX="1766.8949275362295" CenterY="1167.6854838709687" Width="90.0" Height="25.0" ZOrder="32970" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000132155"/>
  </DataNode>
  <DataNode TextLabel="NF1" GraphId="a5d72" Type="GeneProduct">
    <Comment>NF1 functions as a guanine exchange factors (GEF), stimulating the conversion of GTP-bound RAS into GDP-bound RAS and tehreby negatively regulating the MEK-ERK-Mnk1 pathway.</Comment>
    <BiopaxRef>db1</BiopaxRef>
    <Graphics CenterX="2185.1304347826076" CenterY="860.268817204302" Width="90.0" Height="25.0" ZOrder="32972" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000196712"/>
  </DataNode>
  <DataNode TextLabel="EIF4E" GraphId="b1db8" Type="GeneProduct" GroupRef="acd3f">
    <Graphics CenterX="1142.0000000000002" CenterY="2018.5188172043026" Width="90.0" Height="25.0" ZOrder="32974" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000151247"/>
  </DataNode>
  <DataNode TextLabel="CAMK2A" GraphId="ee5c2" Type="GeneProduct">
    <Comment>calcium/calmodulin dependent protein kinase II alpha (CAMKIIÎ±) is expressed at synapses where its translation is negatively regulated by FMRP. CAMKIIÎ± is a key determinant for AMPAR internalization and thus LTD. The protein kinase mediates AMPAR internalization through phosphorylation of AMPAR subunits. CAMKIIÎ± is involved in synaptic plasticity, neurotransmitter release and LTP. </Comment>
    <BiopaxRef>afd</BiopaxRef>
    <BiopaxRef>c33</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2368.4508900334295" Width="90.0" Height="25.0" ZOrder="32976" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000070808"/>
  </DataNode>
  <DataNode TextLabel="FMR1" GraphId="b1f46" Type="GeneProduct">
    <Graphics CenterX="983.75" CenterY="1563.3220384928177" Width="90.0" Height="25.0" ZOrder="32978" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000102081"/>
  </DataNode>
  <DataNode TextLabel="DEPTOR" GraphId="e9825" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1159.9999999999995" CenterY="1259.6021505376357" Width="90.0" Height="25.0" ZOrder="32980" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155792"/>
  </DataNode>
  <DataNode TextLabel="TELO2" GraphId="cdae6" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1069.7499999999998" CenterY="1309.1021505376357" Width="90.0" Height="25.0" ZOrder="32982" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100726"/>
  </DataNode>
  <DataNode TextLabel="RPTOR" GraphId="c5110" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1023.2499999999998" CenterY="1284.3521505376357" Width="90.0" Height="25.0" ZOrder="32984" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000141564"/>
  </DataNode>
  <DataNode TextLabel="MLST8" GraphId="f97de" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1203.499999999999" CenterY="1284.4771505376357" Width="90.0" Height="25.0" ZOrder="32986" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000167965"/>
  </DataNode>
  <DataNode TextLabel="MTOR" GraphId="b8297" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1113.5" CenterY="1284.3521505376357" Width="90.0" Height="25.0" ZOrder="32988" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000198793"/>
  </DataNode>
  <DataNode TextLabel="PIK3CB" GraphId="b3ff7" Type="GeneProduct">
    <Graphics CenterX="708.2500000000002" CenterY="869.4354838709687" Width="90.0" Height="25.0" ZOrder="32990" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000051382"/>
  </DataNode>
  <DataNode TextLabel="TTI1" GraphId="e9636" Type="GeneProduct" GroupRef="a806b">
    <Graphics CenterX="1159.7499999999995" CenterY="1309.1021505376357" Width="90.0" Height="25.0" ZOrder="32992" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000101407"/>
  </DataNode>
  <DataNode TextLabel="GRM5" GraphId="d0cd1" Type="GeneProduct">
    <Graphics CenterX="967.5" CenterY="447.93548387096746" Width="90.0" Height="25.0" ZOrder="32994" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000168959"/>
  </DataNode>
  <DataNode TextLabel="RHEB" GraphId="f3077" Type="GeneProduct">
    <Graphics CenterX="1039.6666666666677" CenterY="1140.2688172043022" Width="90.0" Height="25.0" ZOrder="32996" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000106615"/>
  </DataNode>
  <DataNode TextLabel="HOMER1" GraphId="ac4db" Type="GeneProduct">
    <Comment>Long homer variant</Comment>
    <Graphics CenterX="632.163043478261" CenterY="648.7398316970543" Width="90.0" Height="25.0" ZOrder="32998" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000152413"/>
  </DataNode>
  <DataNode TextLabel="GRM1" GraphId="b5ca7" Type="GeneProduct">
    <Graphics CenterX="967.0" CenterY="417.93548387096746" Width="90.0" Height="25.0" ZOrder="33000" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000152822"/>
  </DataNode>
  <DataNode TextLabel="PDK1" GraphId="ddab0" Type="GeneProduct">
    <Graphics CenterX="898.6666666666669" CenterY="913.6021505376352" Width="90.0" Height="25.0" ZOrder="33002" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000152256"/>
  </DataNode>
  <DataNode TextLabel="AGAP2" GraphId="c9e48" Type="GeneProduct">
    <Graphics CenterX="589.5833333333337" CenterY="761.2688172043015" Width="90.0" Height="25.0" ZOrder="33004" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000135439"/>
  </DataNode>
  <DataNode TextLabel="PIP2" GraphId="cd6ac" Type="Metabolite">
    <Graphics CenterX="896.6666666666669" CenterY="759.602150537635" Width="90.0" Height="25.0" ZOrder="33006" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:18348"/>
  </DataNode>
  <DataNode TextLabel="PTEN" GraphId="b8ad4" Type="GeneProduct">
    <Graphics CenterX="1107.666666666668" CenterY="814.9354838709687" Width="90.0" Height="25.0" ZOrder="33008" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000171862"/>
  </DataNode>
  <DataNode TextLabel="TSC1" GraphId="e9609" Type="GeneProduct" GroupRef="bc2f4">
    <Graphics CenterX="1132.6666666666679" CenterY="951.018817204302" Width="90.0" Height="25.0" ZOrder="33010" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000165699"/>
  </DataNode>
  <DataNode TextLabel="AKT1" GraphId="aaa9b" Type="GeneProduct">
    <Graphics CenterX="898.6666666666669" CenterY="975.2688172043022" Width="90.0" Height="25.0" ZOrder="33012" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000142208"/>
  </DataNode>
  <DataNode TextLabel="PIP3" GraphId="c42c7" Type="Metabolite">
    <Graphics CenterX="898.6666666666667" CenterY="857.2688172043024" Width="90.0" Height="25.0" ZOrder="33014" FontSize="12" Valign="Middle" Color="0000ff"/>
    <Xref Database="ChEBI" ID="CHEBI:16618"/>
  </DataNode>
  <DataNode TextLabel="TSC2" GraphId="f7bf9" Type="GeneProduct" GroupRef="bc2f4">
    <Graphics CenterX="1132.6666666666679" CenterY="976.0188172043021" Width="90.0" Height="25.0" ZOrder="33016" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000103197"/>
  </DataNode>
  <DataNode TextLabel="TBC1D7" GraphId="fb6ee" Type="GeneProduct" GroupRef="bc2f4">
    <Graphics CenterX="1132.6666666666679" CenterY="1001.0188172043021" Width="90.0" Height="25.0" ZOrder="33018" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000145979"/>
  </DataNode>
  <DataNode TextLabel="RHEB" GraphId="d6ade" Type="GeneProduct">
    <Graphics CenterX="1205.666666666667" CenterY="1139.6021505376352" Width="90.0" Height="25.0" ZOrder="33024" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000106615"/>
  </DataNode>
  <DataNode TextLabel="KRAS" GraphId="ba06e" Type="GeneProduct">
    <Graphics CenterX="2000.8804347826072" CenterY="946.018817204302" Width="90.0" Height="25.0" ZOrder="33034" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000133703"/>
  </DataNode>
  <DataNode TextLabel="DLGAP3" GraphId="bb595" Type="GeneProduct">
    <Comment>SAP90/PSD-95-associated protein 3 (SAPAP3) plays a role in the organization of synapses and neuronal cell signaling and is negatively regulated by FMRP. SAPAP3 is a postsynaptic scaffolding protein which is associated with PSD-95 and localized in dendrites. SAPAP3 plays an improtant role in maturation of synapses</Comment>
    <BiopaxRef>d39</BiopaxRef>
    <BiopaxRef>d51</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2434.411674347157" Width="90.0" Height="25.0" ZOrder="33070" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000116544"/>
  </DataNode>
  <DataNode TextLabel="SHANK1" GraphId="ceef6" Type="GeneProduct">
    <Comment>Shank,  an adapter protein in the PSD of excitatory synapses, is necessary for the structural and functional integrity of dendritic spines and synaptic junction.</Comment>
    <BiopaxRef>ee2</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2471.0783410138247" Width="90.0" Height="25.0" ZOrder="33076" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000161681"/>
  </DataNode>
  <DataNode TextLabel="GRIN2B" GraphId="eba48" Type="GeneProduct">
    <Graphics CenterX="1446.6666666666665" CenterY="2334.697388632877" Width="90.0" Height="25.0" ZOrder="33078" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000273079"/>
  </DataNode>
  <DataNode TextLabel="GRIN2B" GraphId="f052f" Type="GeneProduct">
    <Comment>Glutamate receptor ionotropic, NMDA 2B (GluN2B) is a subunit of the NMDAR receptor which is negatively regulated by FMRP. </Comment>
    <BiopaxRef>c0d</BiopaxRef>
    <Graphics CenterX="1605.75" CenterY="2334.6973886328765" Width="90.0" Height="25.0" ZOrder="33080" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000273079"/>
  </DataNode>
  <DataNode TextLabel="GABRA1" GraphId="c8c69" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2527.623158941005" Width="90.0" Height="25.0" ZOrder="33084" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000022355"/>
  </DataNode>
  <DataNode TextLabel="GABRB2" GraphId="d08d6" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2567.623158941005" Width="90.0" Height="25.0" ZOrder="33086" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000145864"/>
  </DataNode>
  <DataNode TextLabel="GABRG2" GraphId="bc2be" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2608.623158941006" Width="90.0" Height="25.0" ZOrder="33088" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000113327"/>
  </DataNode>
  <DataNode TextLabel="GPHN" GraphId="a327a" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2286.956492274326" Width="90.0" Height="25.0" ZOrder="33090" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000171723"/>
  </DataNode>
  <DataNode TextLabel="SLC6A1" GraphId="fd84a" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2329.6231589409913" Width="90.0" Height="25.0" ZOrder="33092" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000157103"/>
  </DataNode>
  <DataNode TextLabel="ABAT" GraphId="a279d" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2370.289825607655" Width="90.0" Height="25.0" ZOrder="33094" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000183044"/>
  </DataNode>
  <DataNode TextLabel="ALDH5A1" GraphId="c82be" Type="Rna">
    <Graphics CenterX="981.0476190476204" CenterY="2449.2898256076624" Width="90.0" Height="25.0" ZOrder="33096" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000112294"/>
  </DataNode>
  <DataNode TextLabel="ALDH3A2" GraphId="d27f0" Type="Rna">
    <Graphics CenterX="1942.6666666666665" CenterY="2710.1259600614467" Width="90.0" Height="25.0" ZOrder="33116" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000072210"/>
  </DataNode>
  <DataNode TextLabel="ABCD3" GraphId="fc054" Type="Rna">
    <Graphics CenterX="1942.6666666666665" CenterY="2744.1259600614467" Width="90.0" Height="25.0" ZOrder="33118" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000117528"/>
  </DataNode>
  <DataNode TextLabel="TECR" GraphId="d9f72" Type="Rna">
    <Graphics CenterX="1942.6666666666665" CenterY="2779.1259600614467" Width="90.0" Height="25.0" ZOrder="33120" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000099797"/>
  </DataNode>
  <DataNode TextLabel="CPT1A" GraphId="df0e6" Type="GeneProduct">
    <Comment>CPT1A encodes the hepatic enzyme carnitine palmitoyltransferase 1A. The enzyme is responsible for fatty acid oxidation within the mitochondria, it connects carnitine to long-chain fatty acids thereby enabling the crossing of the fatty acid into the inner membrane of mitochondria. FMRP negatively regulates CPT1A and thus lipid metabolism. </Comment>
    <BiopaxRef>f34</BiopaxRef>
    <BiopaxRef>b22</BiopaxRef>
    <Graphics CenterX="2101.75" CenterY="2642.1259600614476" Width="90.0" Height="25.0" ZOrder="33122" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000110090"/>
  </DataNode>
  <DataNode TextLabel="SLC16A1" GraphId="cd09d" Type="GeneProduct">
    <Comment>Monocarboxylate transporter 1 (MCT1) is a proton coupled monocarboxylate transporter which function is to catalyse the rapid transport of many monocarboxylates across the plasma membrane.</Comment>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics CenterX="2101.75" CenterY="2676.1259600614467" Width="90.0" Height="25.0" ZOrder="33132" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155380"/>
  </DataNode>
  <DataNode TextLabel="ALDH3A2" GraphId="a70a9" Type="GeneProduct">
    <Comment>Fatty aldehyde dehydrogenase (ALDH3A2) catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. ALDH3A2 has shown to be essential for the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation.</Comment>
    <BiopaxRef>eb2</BiopaxRef>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics CenterX="2101.75" CenterY="2710.1259600614467" Width="90.0" Height="25.0" ZOrder="33134" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000072210"/>
  </DataNode>
  <DataNode TextLabel="ABCD3" GraphId="e3430" Type="GeneProduct">
    <Comment>ABCD3, a peroxisomal membrane protein, is involved in the  transport of branched chain acyl-CoA into peroxisomes. ABCD3 is a fatty acid (FA) transporter protein. </Comment>
    <BiopaxRef>e4c</BiopaxRef>
    <Graphics CenterX="2101.75" CenterY="2745.1259600614467" Width="90.0" Height="25.0" ZOrder="33136" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000117528"/>
  </DataNode>
  <DataNode TextLabel="TECR" GraphId="a0794" Type="GeneProduct">
    <Comment>Very-long-chain enoyl-CoA reductase (TECR) is responsible to catalyze the last of the four reactions of the long-chain fatty acids elongation cycle. </Comment>
    <BiopaxRef>edd</BiopaxRef>
    <Graphics CenterX="2101.75" CenterY="2780.1259600614467" Width="90.0" Height="25.0" ZOrder="33138" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000099797"/>
  </DataNode>
  <DataNode TextLabel="PRKAR1A" GraphId="eebfb" Type="GeneProduct" GroupRef="ceedf">
    <Graphics CenterX="2232.0434782608663" CenterY="1496.9354838709687" Width="90.0" Height="25.0" ZOrder="33142" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108946"/>
  </DataNode>
  <DataNode TextLabel="PRKAR1A" GraphId="a45ab" Type="GeneProduct" GroupRef="ceedf">
    <Graphics CenterX="2322.0434782608663" CenterY="1496.9354838709687" Width="90.0" Height="25.0" ZOrder="33144" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108946"/>
  </DataNode>
  <DataNode TextLabel="FMR1" GraphId="acdc1" Type="GeneProduct">
    <Graphics CenterX="1231.333333333333" CenterY="1413.0188172043013" Width="90.0" Height="25.0" ZOrder="33148" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000102081"/>
  </DataNode>
  <DataNode TextLabel="GRIA1" GraphId="fe447" Type="GeneProduct" GroupRef="fbce9">
    <Graphics CenterX="4881.504688832053" CenterY="2015.2688172043108" Width="90.0" Height="25.0" ZOrder="33152" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155511"/>
  </DataNode>
  <DataNode TextLabel="GRIA2" GraphId="e48af" Type="GeneProduct" GroupRef="fbce9">
    <Graphics CenterX="4881.7546888320485" CenterY="2040.0188172043106" Width="90.0" Height="25.0" ZOrder="33154" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000120251"/>
  </DataNode>
  <DataNode TextLabel="GRIA2" GraphId="a13bb" Type="GeneProduct" GroupRef="abd19">
    <Graphics CenterX="4677.597826086952" CenterY="592.6854838709676" Width="90.0" Height="25.0" ZOrder="33160" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000120251"/>
  </DataNode>
  <DataNode TextLabel="GRIA1" GraphId="e9e88" Type="GeneProduct" GroupRef="abd19">
    <Comment>Î±-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR) are ionotropic glutamate transmembrane receptors that mediate the majority of fast excitatory transmission in the central nervous system (CNS). </Comment>
    <BiopaxRef>b64</BiopaxRef>
    <Graphics CenterX="4677.347826086952" CenterY="567.9354838709678" Width="90.0" Height="25.0" ZOrder="33162" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155511"/>
  </DataNode>
  <DataNode TextLabel="GRIA1" GraphId="ea469" Type="GeneProduct">
    <Comment>AMPAR subunit GuA1</Comment>
    <Graphics CenterX="1605.75" CenterY="2261.5545314900205" Width="90.0" Height="25.0" ZOrder="33168" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000155511"/>
  </DataNode>
  <DataNode TextLabel="GRIA2" GraphId="c5c19" Type="GeneProduct">
    <Comment>AMPAR subunit GluA2</Comment>
    <Graphics CenterX="1605.75" CenterY="2299.8878648233526" Width="90.0" Height="25.0" ZOrder="33170" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000120251"/>
  </DataNode>
  <DataNode TextLabel="miR-132&#10;" GraphId="df321" Type="Rna" GroupRef="bb884">
    <Graphics CenterX="493.74999999999903" CenterY="2387.268817204297" Width="90.0" Height="25.0" ZOrder="33172" FontSize="12" Valign="Middle" Color="660066"/>
    <Xref Database="miRBase mature sequence" ID="MIMAT0004594"/>
  </DataNode>
  <DataNode TextLabel="miR-196a&#10;&#10;" GraphId="af977" Type="Rna" GroupRef="bb884">
    <Graphics CenterX="493.74999999999903" CenterY="2338.602150537632" Width="90.0" Height="25.0" ZOrder="33174" FontSize="12" Valign="Middle" Color="660066"/>
    <Xref Database="miRBase mature sequence" ID="MIMAT0000226"/>
  </DataNode>
  <DataNode TextLabel="SH3GL1" GraphId="c757d" Type="GeneProduct">
    <Comment>Endophoilin 2</Comment>
    <Graphics CenterX="3702.7644927536167" CenterY="1631.7688172043008" Width="90.0" Height="25.0" ZOrder="33176" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000141985"/>
  </DataNode>
  <DataNode TextLabel="DNM2" GraphId="b1b97" Type="GeneProduct">
    <Comment>Dynamin is a large GTPase modulating release of endosomes from the membrane by pinching off and fissioning the membrane. 
</Comment>
    <BiopaxRef>b65</BiopaxRef>
    <Graphics CenterX="3702.7644927536167" CenterY="1665.0188172043008" Width="90.0" Height="25.0" ZOrder="33178" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000079805"/>
  </DataNode>
  <DataNode TextLabel="EIF4A1" GraphId="a0ff1" Type="GeneProduct" GroupRef="acd3f">
    <Graphics CenterX="1142.0000000000002" CenterY="2067.935483870968" Width="90.0" Height="25.0" ZOrder="33206" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000161960"/>
  </DataNode>
  <DataNode TextLabel="TARBP2" GraphId="e0005" Type="GeneProduct" GroupRef="bb884">
    <Graphics CenterX="494.41666666666555" CenterY="2282.6021505376298" Width="90.0" Height="25.0" ZOrder="33208" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000139546"/>
  </DataNode>
  <DataNode TextLabel="EIF4EBP2" GraphId="dcf1f" Type="GeneProduct">
    <Comment>Phosphorylated 4E-BP cannot bind to eIF4E anymore, this means that its inhibitory effect on translation is repressed</Comment>
    <BiopaxRef>eb4</BiopaxRef>
    <Graphics CenterX="1345.4810924369735" CenterY="1613.262514683296" Width="90.0" Height="25.0" ZOrder="33210" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000148730"/>
  </DataNode>
  <DataNode TextLabel="MECP2" GraphId="a10ba" Type="GeneProduct">
    <Comment>Methyl-CpG-binding protein 2 (MECP2) is a nuclear protein that is capable of binding to methylated DNA. It is essential for nerve cell functionality. </Comment>
    <BiopaxRef>d33</BiopaxRef>
    <Graphics CenterX="490.66666666666646" CenterY="2614.6021505376357" Width="90.0" Height="25.0" ZOrder="33212" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000169057"/>
  </DataNode>
  <DataNode TextLabel="EPHA4" GraphId="c6308" Type="GeneProduct">
    <Comment>Ephrin type-A receptor 4 (EPHA4) is a receptor tyrosine kinase binding tp ephrin ligands. EPHA4 is has a function in the development of the nervous system. </Comment>
    <BiopaxRef>a10</BiopaxRef>
    <Graphics CenterX="667.9999999999993" CenterY="2579.93548387097" Width="90.0" Height="25.0" ZOrder="33214" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000116106"/>
  </DataNode>
  <DataNode TextLabel="GRIN2A" GraphId="e7257" Type="GeneProduct">
    <Comment>NMDA receptor subunit 2 A</Comment>
    <Graphics CenterX="667.9999999999991" CenterY="2613.9354838709705" Width="90.0" Height="25.0" ZOrder="33216" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000183454"/>
  </DataNode>
  <DataNode TextLabel="CDKN2A" GraphId="c72d1" Type="GeneProduct">
    <Comment>Cyclin-dependent kinase inhibitor 2A (CDKC2A) 
</Comment>
    <Graphics CenterX="667.9999999999993" CenterY="2647.935483870968" Width="90.0" Height="25.0" ZOrder="33218" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000147889"/>
  </DataNode>
  <DataNode TextLabel="HOXB8" GraphId="eb0d1" Type="GeneProduct">
    <Graphics CenterX="324.00000000000006" CenterY="2597.9354838709705" Width="90.0" Height="25.0" ZOrder="33220" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000120068"/>
  </DataNode>
  <DataNode TextLabel="MAP2K2" GraphId="e4f56" Type="GeneProduct">
    <Graphics CenterX="2170.797101449276" CenterY="1326.3267882187947" Width="90.0" Height="25.0" ZOrder="33222" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000126934"/>
  </DataNode>
  <DataNode TextLabel="MAP2K1" GraphId="e9306" Type="GeneProduct">
    <Graphics CenterX="2170.797101449276" CenterY="1297.3267882187947" Width="90.0" Height="25.0" ZOrder="33224" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000169032"/>
  </DataNode>
  <DataNode TextLabel="MAPK1" GraphId="df3b8" Type="GeneProduct">
    <Graphics CenterX="1904.1304347826074" CenterY="1505.602150537635" Width="90.0" Height="25.0" ZOrder="33228" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100030"/>
  </DataNode>
  <DataNode TextLabel="MKNK1" GraphId="d478a" Type="GeneProduct">
    <Graphics CenterX="1733.4637681159404" CenterY="1722.268817204302" Width="90.0" Height="25.0" ZOrder="33230" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000079277"/>
  </DataNode>
  <DataNode TextLabel="BRAF" GraphId="fa17c" Type="GeneProduct">
    <Graphics CenterX="2001.8804347826072" CenterY="1167.6854838709687" Width="90.0" Height="25.0" ZOrder="33232" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000157764"/>
  </DataNode>
  <DataNode TextLabel="ARAF" GraphId="c49ef" Type="GeneProduct">
    <Graphics CenterX="2225.880434782607" CenterY="1167.6854838709687" Width="90.0" Height="25.0" ZOrder="33234" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000078061"/>
  </DataNode>
  <DataNode TextLabel="SH3GL3" GraphId="bc1dd" Type="GeneProduct">
    <Comment>Endopilin 3</Comment>
    <Graphics CenterX="3702.0978260869506" CenterY="1600.4354838709692" Width="90.0" Height="25.0" ZOrder="33248" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000140600"/>
  </DataNode>
  <DataNode TextLabel="PRKACA" GraphId="ea7cc" Type="GeneProduct" GroupRef="a4a6b">
    <Comment>Exact subunits which make up PKA in thus pathway could not be found. PKA is made up of 2 regulary subunits and 2 catalytic subunits. Because no information on the composition of subunits in this case could have been found, subunits A have been used for regulatory and catalytic parts of PKA.</Comment>
    <Graphics CenterX="4259.347826086955" CenterY="279.9354838709676" Width="90.0" Height="25.0" ZOrder="33314" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000072062"/>
  </DataNode>
  <DataNode TextLabel="PRKACA" GraphId="d983e" Type="GeneProduct" GroupRef="a4a6b">
    <Graphics CenterX="4169.347826086956" CenterY="279.9354838709676" Width="90.0" Height="25.0" ZOrder="33316" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000072062"/>
  </DataNode>
  <DataNode TextLabel="PRKAR1A" GraphId="f07fd" Type="GeneProduct" GroupRef="a4a6b">
    <Graphics CenterX="4169.347826086956" CenterY="304.9354838709676" Width="90.0" Height="25.0" ZOrder="33318" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108946"/>
  </DataNode>
  <DataNode TextLabel="PRKAR1A" GraphId="a3e27" Type="GeneProduct" GroupRef="a4a6b">
    <Graphics CenterX="4259.347826086955" CenterY="304.9354838709676" Width="90.0" Height="25.0" ZOrder="33320" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108946"/>
  </DataNode>
  <DataNode TextLabel="APP" GraphId="d8731" Type="GeneProduct">
    <Comment>Amyloid-beta precursor protein (APP), large membrane-spanning glycoprotein, is implicated in neurogenesis and synapse formation. It is mainly expressed in synapses. APP is suspected to contribute to altered mGluR-LTD. </Comment>
    <Comment>Type your comment here</Comment>
    <BiopaxRef>fb0</BiopaxRef>
    <BiopaxRef>d7c</BiopaxRef>
    <Graphics CenterX="2104.1408860663387" CenterY="2505.7450076804917" Width="90.0" Height="25.0" ZOrder="33322" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000142192"/>
  </DataNode>
  <DataNode TextLabel="GRIN2B" GraphId="f003b" Type="GeneProduct">
    <Comment>N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDAR) are ionotropic receptors activated by glutamate. NMDAR activation allows Ca2+ influx leading to NMDAR-dependant LTP and LTD</Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics CenterX="2947.2173913043503" CenterY="469.2688172043015" Width="90.0" Height="25.0" ZOrder="33370" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000273079"/>
  </DataNode>
  <DataNode TextLabel="AP2A1" GraphId="ffb13" Type="GeneProduct" GroupRef="adc57">
    <Graphics CenterX="3601.014492753613" CenterY="711.935483870968" Width="90.0" Height="25.0" ZOrder="33377" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000196961"/>
  </DataNode>
  <DataNode TextLabel="AP2B1" GraphId="ff0b9" Type="GeneProduct" GroupRef="adc57">
    <Graphics CenterX="3601.014492753613" CenterY="735.9354838709683" Width="90.0" Height="25.0" ZOrder="33378" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000006125"/>
  </DataNode>
  <DataNode TextLabel="AP2S1" GraphId="d8b47" Type="GeneProduct" GroupRef="adc57">
    <Graphics CenterX="3601.014492753613" CenterY="783.9354838709683" Width="90.0" Height="25.0" ZOrder="33379" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000042753"/>
  </DataNode>
  <DataNode TextLabel="AP2M1" GraphId="d0500" Type="GeneProduct" GroupRef="adc57">
    <Graphics CenterX="3601.014492753613" CenterY="759.9354838709683" Width="90.0" Height="25.0" ZOrder="33380" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000161203"/>
  </DataNode>
  <DataNode TextLabel="CLTCL1" GraphId="a68e0" Type="GeneProduct" GroupRef="eeb7e">
    <Graphics CenterX="3648.347826086956" CenterY="1057.2688172043015" Width="90.0" Height="25.0" ZOrder="33383" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000070371"/>
  </DataNode>
  <DataNode TextLabel="CLTC" GraphId="f4fe5" Type="GeneProduct" GroupRef="eeb7e">
    <Comment>Clathrin mediates the endocytosis of NMDAR by binding to AP-2</Comment>
    <BiopaxRef>e42</BiopaxRef>
    <Graphics CenterX="3648.347826086956" CenterY="1033.2688172043013" Width="90.0" Height="25.0" ZOrder="33384" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000141367"/>
  </DataNode>
  <DataNode TextLabel="CLTB" GraphId="c642e" Type="GeneProduct" GroupRef="eeb7e">
    <Graphics CenterX="3559.014492753616" CenterY="1057.2688172043017" Width="90.0" Height="25.0" ZOrder="33385" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000175416"/>
  </DataNode>
  <DataNode TextLabel="CLTA" GraphId="beb9b" Type="GeneProduct" GroupRef="eeb7e">
    <Graphics CenterX="3559.014492753616" CenterY="1033.685483870968" Width="90.0" Height="25.0" ZOrder="33386" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000122705"/>
  </DataNode>
  <DataNode TextLabel="GRIN2B" GraphId="f3f5d" Type="GeneProduct">
    <Comment>N-methyl-D-aspartate (NMDA)-type glutamate receptors (NMDAR) are ionotropic receptors activated by glutamate. NMDAR activation allows Ca2+ influx leading to NMDAR-dependant LTP and LTD</Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics CenterX="3409.0144927536226" CenterY="1253.268817204302" Width="90.0" Height="25.0" ZOrder="33387" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000273079"/>
  </DataNode>
  <DataNode TextLabel="PTEN" GraphId="ef958" Type="GeneProduct">
    <Comment>PTEN is enhanced by FMRP and negatively regulates GABA A receptor subunits, this way PTEN has a protective role in reducing GABA A deficiency-indiced incidence of seizures</Comment>
    <BiopaxRef>d7d</BiopaxRef>
    <Graphics CenterX="1605.0000000000095" CenterY="2817.60215053763" Width="90.0" Height="25.0" ZOrder="33407" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000171862"/>
  </DataNode>
  <DataNode TextLabel="PTEN" GraphId="ebc84" Type="Rna">
    <Comment>PTEN is enhanced by FMRP and negatively regulates GABA A receptor subunits, this way PTEN has a protective role in reducing GABA A deficiency-indiced incidence of seizures</Comment>
    <BiopaxRef>d7d</BiopaxRef>
    <Graphics CenterX="1443.0" CenterY="2816.268817204298" Width="90.0" Height="25.0" ZOrder="33408" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000171862"/>
  </DataNode>
  <DataNode TextLabel="GRIN1" GraphId="e2467" Type="GeneProduct">
    <Graphics CenterX="1446.6666666666665" CenterY="2406.0000000000014" Width="90.0" Height="25.0" ZOrder="33415" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000176884"/>
  </DataNode>
  <DataNode TextLabel="GRIN1" GraphId="c13a6" Type="GeneProduct">
    <Graphics CenterX="1605.75" CenterY="2405.7500000000014" Width="90.0" Height="25.0" ZOrder="33416" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000176884"/>
  </DataNode>
  <DataNode TextLabel="DUSP3" GraphId="d9192" Type="GeneProduct">
    <Comment>Also referred to as VHR, a ERK specific phosphatase</Comment>
    <BiopaxRef>f3d</BiopaxRef>
    <Graphics CenterX="1603.6666666666763" CenterY="2545.0" Width="90.0" Height="25.0" ZOrder="33418" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108861"/>
  </DataNode>
  <DataNode TextLabel="EEF1A1" GraphId="ef97c" Type="GeneProduct">
    <Comment>Eukarytic translation elongation factor (EF1Î±) </Comment>
    <Graphics CenterX="2104.1408860663387" CenterY="2540.6666666666647" Width="90.0" Height="25.0" ZOrder="33423" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000156508"/>
  </DataNode>
  <DataNode TextLabel="CYFIP2" GraphId="e2b5d" Type="Rna">
    <Graphics CenterX="1444.0" CenterY="2582.7499999999973" Width="90.0" Height="22.5" ZOrder="33424" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000055163"/>
  </DataNode>
  <DataNode TextLabel="GABRD" GraphId="c68df" Type="Protein">
    <Graphics CenterX="981.0476190476204" CenterY="2408.666666666656" Width="90.0" Height="25.0" ZOrder="33425" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000187730"/>
  </DataNode>
  <DataNode TextLabel="GRM5" GraphId="d5fb5" Type="Rna">
    <Graphics CenterX="1446.6666666666665" CenterY="2445.7500000000014" Width="90.0" Height="25.0" ZOrder="33427" FontSize="12" Valign="Middle" Color="666666"/>
    <Xref Database="Ensembl" ID="ENSG00000168959"/>
  </DataNode>
  <DataNode TextLabel="HCN1" GraphId="a8697" Type="GeneProduct">
    <Comment>Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (HCN1)</Comment>
    <Graphics CenterX="1603.6666666666763" CenterY="2623.9999999999973" Width="90.0" Height="25.0" ZOrder="33429" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000164588"/>
  </DataNode>
  <DataNode TextLabel="KCNC1" GraphId="f9182" Type="GeneProduct">
    <Graphics CenterX="1603.6666666666763" CenterY="2663.9999999999973" Width="90.0" Height="25.0" ZOrder="33431" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000129159"/>
  </DataNode>
  <DataNode TextLabel="KCND2" GraphId="b9df8" Type="GeneProduct">
    <Graphics CenterX="1603.6666666666763" CenterY="2701.9999999999973" Width="90.0" Height="25.0" ZOrder="33433" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000184408"/>
  </DataNode>
  <DataNode TextLabel="MMP9" GraphId="c875c" Type="GeneProduct">
    <Graphics CenterX="1603.6666666666763" CenterY="2737.9999999999973" Width="90.0" Height="25.0" ZOrder="33435" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000100985"/>
  </DataNode>
  <DataNode TextLabel="PRKCA" GraphId="a3b2c" Type="GeneProduct">
    <Comment>Protein Kinase C</Comment>
    <Comment>mGluR activation leads to activation of the PLC pathway which induces release of Ca2+ and PKC. PKC will phohsphorylate and activate RAF1 and tehereby activate RAF1 and thus the ERK pathway</Comment>
    <Graphics CenterX="2223.1304347825917" CenterY="1038.6021505376334" Width="90.0" Height="25.0" ZOrder="33439" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000154229"/>
  </DataNode>
  <DataNode TextLabel="RAP1GAP" GraphId="ae6d6" Type="GeneProduct">
    <Comment>RAP1 is phsohprylated and activated by PKA and in turn stimulates the activation of B-Raf, thus leading to the activation of the ERK pathway</Comment>
    <BiopaxRef>d20</BiopaxRef>
    <BiopaxRef>aae</BiopaxRef>
    <Graphics CenterX="2379.797101449269" CenterY="1098.9275362318867" Width="90.0" Height="25.0" ZOrder="33445" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000076864"/>
  </DataNode>
  <DataNode TextLabel="EPS8L1" GraphId="d9562" Type="GeneProduct">
    <Comment>Epidermal growth factor receptor pathway substrate 8-related protein 1  (EPS8L1) is an FMRP target and important for teh remodelling of actin in response to EGF stimulation.  EPS8L1 gene product EPS8 is needed for  normal spine morphology, synaptic plasticity, and memory formation. EPS8 has been shown to be downregulated in autism, since it's a binding partner of FMRP, it is likely that it is also downregulated in FXS. </Comment>
    <BiopaxRef>a26</BiopaxRef>
    <Graphics CenterX="1603.6666666666763" CenterY="2779.9999999999977" Width="90.0" Height="25.0" ZOrder="33448" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000131037"/>
  </DataNode>
  <DataNode TextLabel="SHANK1" GraphId="e5dcd" Type="GeneProduct">
    <Comment>Shank,  an adapter protein in the PSD of excitatory synapses, is necessary for the structural and functional integrity of dendritic spines and synaptic junction.</Comment>
    <BiopaxRef>ee2</BiopaxRef>
    <Graphics CenterX="1124.1408860663387" CenterY="517.0783410138247" Width="90.0" Height="25.0" ZOrder="33450" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000161681"/>
  </DataNode>
  <DataNode TextLabel="PTPN5" GraphId="ae436" Type="GeneProduct">
    <Comment>Tyrosine-protein phosphatase non-receptor type 5 (STEP) is involves to regulate AMPAR trafficking and negatively regulates AMPAR surface expression thereby contributing to mGluR-LTD. STEP promotes LTD by stimulating synaptic weakening by dephosphorylation of ERK1/2 and subunits of NDMA and AMPA receptors. STEP has been shown to promote NMDA internalization.</Comment>
    <BiopaxRef>f94</BiopaxRef>
    <BiopaxRef>cf2</BiopaxRef>
    <Graphics CenterX="3088.1408860663387" CenterY="591.9655959157867" Width="90.0" Height="25.0" ZOrder="33451" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000110786"/>
  </DataNode>
  <DataNode TextLabel="MAP1B" GraphId="a0910" Type="GeneProduct">
    <Comment>Microtubule-associated protein 1B (MAP1B) is involved in mcirotubule assembly and neurogenesis. MAP1b is involved in the regulation of the morphology of dendritic spines in glutamatergic synapses. Furthermore, MAP1b is a negative regulator of AMPAR surface expression thereby contributing to mGluR-LTD.</Comment>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics CenterX="4397.640886066339" CenterY="678.7842233667607" Width="90.0" Height="25.0" ZOrder="33452" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000131711"/>
  </DataNode>
  <DataNode TextLabel="PTPN5" GraphId="dd010" Type="GeneProduct">
    <Comment>Tyrosine-protein phosphatase non-receptor type 5 (STEP) is involves to regulate AMPAR trafficking and negatively regulates AMPAR surface expression thereby contributing to mGluR-LTD. STEP promotes LTD by stimulating synaptic weakening by dephosphorylation of ERK1/2 and subunits of NDMA and AMPA receptors. STEP has been shown to promote NMDA internalization.</Comment>
    <BiopaxRef>f94</BiopaxRef>
    <BiopaxRef>cf2</BiopaxRef>
    <Graphics CenterX="5022.1408860663405" CenterY="451.96559591578693" Width="90.0" Height="25.0" ZOrder="33454" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000110786"/>
  </DataNode>
  <DataNode TextLabel="DUSP3" GraphId="a2785" Type="GeneProduct">
    <Comment>Also referred to as VHR, a ERK specific phosphatase</Comment>
    <BiopaxRef>f3d</BiopaxRef>
    <Graphics CenterX="1905.6666666666763" CenterY="1442.0" Width="90.0" Height="25.0" ZOrder="33455" FontSize="12" Valign="Middle"/>
    <Xref Database="Ensembl" ID="ENSG00000108861"/>
  </DataNode>
  <Interaction GraphId="c2993">
    <Graphics ZOrder="-34" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2294.6378648233535" GraphRef="f5337" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2293.6378648233526" GraphRef="c5c19" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id1531d62a">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="3342.014492753623" Y="461.0188172043006" GraphRef="b91f7" RelX="-1.0" RelY="-0.5"/>
      <Point X="2992.2173913043503" Y="463.0188172043015" GraphRef="f003b" RelX="1.0" RelY="-0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="e377b"/>
      <Anchor Position="0.6518425906595564" Shape="None" GraphId="bb67c"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id1bbdc298">
    <Comment>Shank, a major scaffolding protein in the PSD, binds to the EVH1 domain of the  Homer  protein, together they form a mesh-like structure and are involved the recruitment of proteins at the synapse and are required for structural integrity of dendritic spines. </Comment>
    <BiopaxRef>a61</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1124.1408860663387" Y="529.5783410138247" GraphRef="e5dcd" RelX="0.0" RelY="1.0"/>
      <Point X="889.4019647722998" Y="596.0"/>
      <Point X="654.663043478261" Y="636.2398316970543" GraphRef="ac4db" RelX="0.5" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id2215b39c">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2657.7499999999973" GraphRef="ac5ae" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2657.7499999999973" GraphRef="f9182" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id236ab5f0">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="4542.347826086948" Y="306.4354838709676" GraphRef="e9258" RelX="0.0" RelY="1.0"/>
      <Point X="4542.097826086949" Y="445.18548387096746" GraphRef="b4869" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id2808ee1c">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2617.7499999999973" GraphRef="f8758" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2617.7499999999973" GraphRef="a8697" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id2f51b03a">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2535.0833333333317" GraphRef="f6832" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2534.4166666666647" GraphRef="ef97c" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3056638c">
    <Comment>mGluR mediated mobilization of endocannabinoids activates cannabinoid receptor 1(CNR1) on the presynaptic cholecystokinin interneuron terminal located in the hippocampus. This in turn suppresses GABA release. </Comment>
    <BiopaxRef>fa0</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="377.0" Y="668.9943074003777" GraphRef="d7fc2" RelX="0.0" RelY="1.0"/>
      <Point X="377.0" Y="728.435483870968" GraphRef="c324d" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id31f1255b">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2772.7499999999977" GraphRef="fcd81" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2773.7499999999977" GraphRef="d9562" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id34a4b4d3">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1199.0000000000005" Y="2067.8313172043017" GraphRef="aeb05" RelX="1.0" RelY="0.5"/>
      <Point X="1285.3333333333333" Y="2211.561491935484"/>
      <Point X="1372.8333333333321" Y="2355.2916666666665" GraphRef="c7dbe" RelX="-1.0" RelY="-0.5" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id351ecd42">
    <Comment>STEP catalyses the dephosphorylation of NMDA receptor 2B (NR2B or GRIN2B) at the site Y1472. As a consequence, AP-2 can associate with NMDA and mediate clathrin-dependant endocytosis of NMDAR and thus promote NMDA-mediated LTD.</Comment>
    <BiopaxRef>e42</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0" Color="336600">
      <Point X="3088.1408860663387" Y="579.4655959157867" GraphRef="ae436" RelX="0.0" RelY="-1.0"/>
      <Point X="3160.4218923085273" Y="534.0"/>
      <Point X="3232.7028985507154" Y="474.14381720430094" GraphRef="e71ff" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id387cfe42">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1950.6666666666763" Y="1435.75" GraphRef="a2785" RelX="1.0" RelY="-0.5"/>
      <Point X="2047.332273515701" Y="1328.7301536336606" GraphRef="e678d" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3c9d8b3f">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2538.75" GraphRef="db077" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2538.75" GraphRef="d9192" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3dbc8f1d">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="1107.9999999999807" Y="318.9166666666674" GraphRef="a510b" RelX="-1.0" RelY="0.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id40bb43f7">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0" Color="0033cc">
      <Point X="1170.5000000000005" Y="2092.435483870968" GraphRef="aeb05" RelX="0.5" RelY="1.0"/>
      <Point X="1781.0833333333323" Y="2191.5" GraphRef="c7dbe" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4362bcda">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="647.0" Y="505.0" GraphRef="ece9e" RelX="1.0" RelY="0.0"/>
      <Point X="915.5" Y="448.81048387096746" GraphRef="a264b" RelX="-1.0" RelY="0.5" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id437824b0">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1605.0000000000095" Y="2830.10215053763" GraphRef="ef958" RelX="0.0" RelY="1.0"/>
      <Point X="1365.1041666666752" Y="2850.0"/>
      <Point X="1125.2083333333405" Y="2628.666666666674" GraphRef="b921f" RelX="0.5" RelY="1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id465a2e47">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2277.0434782608663" Y="1447.4354838709687" GraphRef="b129c" RelX="0.0" RelY="-1.0"/>
      <Point X="2328.4202898550675" Y="1238.0"/>
      <Point X="2379.797101449269" Y="1111.4275362318867" GraphRef="ae6d6" RelX="0.0" RelY="1.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.8743676489414249" Shape="None" GraphId="df7ed"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4899cbb3">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="4515.681159420346" Y="2118.935483870968" GraphRef="b23f7" RelX="0.0" RelY="-1.0"/>
      <Point X="4573.67391304347" Y="2021.9354838709687" GraphRef="bb8b9" RelX="0.0" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4a33aa60">
    <Comment>The MAP3K trier transmits the signal downstream through phosphorylation and activation of the MAPKKs (Mitogen-activated protein kinase kinase) MEK 1 and MEK 2 (MEK 1/2)</Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2001.8804347826072" Y="1180.1854838709687" GraphRef="fa17c" RelX="0.0" RelY="1.0"/>
      <Point X="2003.305142788078" Y="1296.7960838387794" GraphRef="ffd68" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4c78ca44">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="815.7473118279563" Y="290.8548387096771" GraphRef="aab06" RelX="1.0" RelY="0.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id586ad924">
    <Comment>mGluR activation leads to activation of the PLC IP3 pathway to release Ca2+ and activate PKC alpha which phohphorylates AMPAR subunit GluA2 at Ser880 and induces endocytosis of AMPAR</Comment>
    <BiopaxRef>a1e</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2456.9673913043453" Y="1369.4354838709687" GraphRef="fd5c1" RelX="1.0" RelY="-0.5"/>
      <Point X="3938.847826086948" Y="816.4354838709675" GraphRef="a5ba0" RelX="-0.5" RelY="1.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5af54689">
    <Comment>Scr is activated through mGluR and can activate the ERK pathway through RAF1</Comment>
    <BiopaxRef>b75</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1556.0" Y="976.5" GraphRef="daa4e" RelX="0.0" RelY="1.0"/>
      <Point X="1721.8949275362295" Y="1167.6854838709687" GraphRef="de858" RelX="-1.0" RelY="0.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.4" Shape="None" GraphId="a4486"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6a13e51e">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2693.7499999999973" GraphRef="a3c40" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2695.7499999999973" GraphRef="b9df8" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6d06b23c">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="3603.6811594202863" Y="1008.7688172043013" GraphRef="b7b69" RelX="0.0" RelY="-1.0"/>
      <Point X="3601.014492753613" Y="808.4354838709683" GraphRef="cb9d3" RelX="0.0" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6ee6222b">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="961.25" Y="1575.8220384928177" GraphRef="b1f46" RelX="-0.5" RelY="1.0"/>
      <Point X="806.0000000000005" Y="1806.0000000000002" GraphRef="b3674" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id71a70594">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2992.2173913043503" Y="475.5188172043015" GraphRef="f003b" RelX="1.0" RelY="0.5"/>
      <Point X="3342.014492753623" Y="473.5188172043006" GraphRef="b91f7" RelX="-1.0" RelY="0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.6874999999999719" Shape="None" GraphId="e71ff"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id741c4125">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2379.797101449269" Y="1166.550183929097" GraphRef="df7ed" RelX="0.0" RelY="0.0"/>
      <Point X="2398.432609792787" Y="1164.6963534361857" GraphRef="ff791" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7aea312d">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="2390.793478260867" Y="1029.4930256609528" GraphRef="b768c" RelX="0.0" RelY="1.0"/>
      <Point X="2390.0" Y="1038.6021505376334" GraphRef="b15ca" RelX="0.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7b8ae55a">
    <Comment/>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2494.2173913043453" Y="1037.6021505376355" GraphRef="c3f9f" RelX="-1.0" RelY="0.0"/>
      <Point X="2556.5507246376783" Y="1038.1021505376343"/>
      <Point X="2268.1304347825917" Y="1038.6021505376334" GraphRef="a3b2c" RelX="1.0" RelY="0.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.13832199546484786" Shape="None"/>
      <Anchor Position="0.6535371430925424" Shape="None" GraphId="b15ca"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id8804fd08">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2577.1249999999973" GraphRef="e2b5d" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2577.7499999999973" GraphRef="ad39d" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id95ae74a">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="0033cc">
      <Point X="983.75" Y="1575.8220384928177" GraphRef="b1f46" RelX="0.0" RelY="1.0"/>
      <Point X="985.3333333333312" Y="2225.3333333333335" GraphRef="ea186" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9aa2e278">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0" Color="336600">
      <Point X="3409.514492753623" Y="479.7688172043006" GraphRef="b91f7" RelX="0.5" RelY="1.0"/>
      <Point X="3409.0144927536226" Y="1240.768817204302" GraphRef="f3f5d" RelX="0.0" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9b470ae">
    <Comment>CAMKIV phosphorylates CREB and thereby regulates the trascription of FMRP. </Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2707.463768115939" Y="1439.1021505376366" GraphRef="f9f8c" RelX="0.0" RelY="1.0"/>
      <Point X="2555.008866155158" Y="1554.0"/>
      <Point X="2402.553964194378" Y="1666.7354838709666" GraphRef="c411f" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9bf5cfb6">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2334.797101449269" Y="1098.9275362318867" GraphRef="ae6d6" RelX="-1.0" RelY="0.0"/>
      <Point X="2024.3804347826072" Y="1155.1854838709687" GraphRef="fa17c" RelX="0.5" RelY="-1.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9eb991ce">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1817.5471014492728" Y="826.6854838709687" GraphRef="b6067" RelX="1.0" RelY="0.0"/>
      <Point X="1841.0" Y="823.6021505376353"/>
      <Point X="1977.7804347826072" Y="820.518817204302" GraphRef="f5ce1" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida08013c5">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff0000">
      <Point X="1005.3333333333278" Y="2680.6021505376357" GraphRef="b7d58" RelX="0.0" RelY="1.0"/>
      <Point X="1105.2807971014474" Y="2903.2470780738595" GraphRef="fc0e9" RelX="-0.5" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida6e1d01b">
    <Comment>Fyn catalyses the phosphorylation of NMDA receptor 2B at the site Y1472. Phosphorylation of the NMDA receptor will result in dissociation from AP-2 and thus inhibit clathrin-mediated endocytosis and thus LTD. </Comment>
    <BiopaxRef>e42</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="3112.014492753615" Y="327.1021505376343" GraphRef="f0fb0" RelX="0.0" RelY="1.0"/>
      <Point X="3114.0018439397254" Y="462.3225023856203" GraphRef="bb67c" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida758ab4c">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="1019.5" Y="448.81048387096746" GraphRef="a264b" RelX="1.0" RelY="0.5"/>
      <Point X="1280.0" Y="706.4052419354837"/>
      <Point X="1511.0" Y="964.0" GraphRef="daa4e" RelX="-1.0" RelY="0.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idaf1cb650">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="493.7499999999991" Y="2399.768817204297" GraphRef="df321" RelX="0.0" RelY="1.0"/>
      <Point X="495.0833333333318" Y="2560.102150537635" GraphRef="a15ec" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb409510d">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2363.7500000000014" GraphRef="f71d3" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2363.5000000000014" GraphRef="f5ca1" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb7a11521">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="806.0000000000005" Y="1850.5000000000002" GraphRef="b3674" RelX="0.0" RelY="1.0"/>
      <Point X="1191.4791666666663" Y="2144.0"/>
      <Point X="1576.9583333333321" Y="2191.5" GraphRef="c7dbe" RelX="-0.5" RelY="-1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb809dedc">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1488.0" Y="2810.018817204298" GraphRef="ebc84" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.0000000000095" Y="2811.35215053763" GraphRef="ef958" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idbd71d149">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1855.8804347826147" Y="978.6871221719682" GraphRef="f5e1e" RelX="0.0" RelY="-1.0"/>
      <Point X="1855.991143317196" Y="1006.1021505376334" GraphRef="a8bc7" RelX="0.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc6d0b35d">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1556.0" Y="1119.3321645628794" GraphRef="a4486" RelX="0.0" RelY="0.0"/>
      <Point X="1534.9876585671714" Y="1115.3537888386359" GraphRef="f4d08" RelX="0.0" RelY="-1.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idcd72f7ba">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2439.5000000000014" GraphRef="d5fb5" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2439.5000000000014" GraphRef="b0473" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idcfdaba90">
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0" Color="669900">
      <Point X="3386.5144927536226" Y="1240.768817204302" GraphRef="f3f5d" RelX="-0.5" RelY="-1.0"/>
      <Point X="3387.014492753623" Y="479.7688172043006" GraphRef="b91f7" RelX="0.0" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idcfe979b6">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1330.0000000000005" Y="642.4898316970543" GraphRef="e5d5c" RelX="0.0" RelY="0.0"/>
      <Point X="1332.4166666666665" Y="626.1838455699728" GraphRef="d8a83" RelX="0.0" RelY="1.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd37db456">
    <Comment>mGluR activation leads to activation of the PLC pathway which induces release of Ca2+ and PKC. PKC will phohsphorylate and activate RAF1 and tehereby activate RAF1 and thus the ERK pathway</Comment>
    <BiopaxRef>e46</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2245.6304347825917" Y="1026.1021505376334" GraphRef="a3b2c" RelX="0.5" RelY="-1.0"/>
      <Point X="1744.3949275362295" Y="1155.1854838709687" GraphRef="de858" RelX="-0.5" RelY="-1.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.6111111111111484" Shape="None" GraphId="a8bc7"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd4ab41e5">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="2434.4673913043453" Y="1363.1854838709687" GraphRef="fd5c1" RelX="0.5" RelY="-1.0"/>
      <Point X="2535.0" Y="1308.25" GraphRef="bdfcb" RelX="-1.0" RelY="0.0" ArrowHead="mim-conversion"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd7387c6c">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="4997.014492753618" Y="663.4354838709683" GraphRef="d0e6c" RelX="0.0" RelY="1.0"/>
      <Point X="4996.8478260869515" Y="741.4354838709714" GraphRef="b5f0c" RelX="0.0" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd84c0ffa">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2402.416666666656" GraphRef="c68df" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2402.4166666666592" GraphRef="aefd4" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd9de0d8f">
    <Comment>AP2 binds to tyrosine-based internalization motif (YELK) which contains the Y1472 site which results in clathrin mediated endocytosis of NR2B (GRIN2B)</Comment>
    <BiopaxRef>e42</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0" Color="336600">
      <Point X="3544.014492753613" Y="717.685483870968" GraphRef="cb9d3" RelX="-1.0" RelY="-0.5"/>
      <Point X="3432.014492753623" Y="473.5188172043006" GraphRef="b91f7" RelX="1.0" RelY="0.5" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idece8178a">
    <Graphics ConnectorType="Elbow" ZOrder="12288" LineThickness="1.0">
      <Point X="2149.1408860663387" Y="2368.4508900334295" GraphRef="ee5c2" RelX="1.0" RelY="0.0"/>
      <Point X="4258.0" Y="1505.470360865242"/>
      <Point X="677.163043478261" Y="642.4898316970543" GraphRef="ac4db" RelX="1.0" RelY="-0.5" ArrowHead="mim-modification"/>
      <Anchor Position="0.9119650564766462" Shape="None" GraphId="e5d5c"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf72dbc9c">
    <Graphics ZOrder="12288" LineThickness="1.0">
      <Point X="1489.0" Y="2731.7499999999973" GraphRef="a9604" RelX="1.0" RelY="-0.5"/>
      <Point X="1558.6666666666763" Y="2731.7499999999973" GraphRef="c875c" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3a11b4ec">
    <Graphics ConnectorType="Elbow" ZOrder="12290" LineThickness="1.0">
      <Point X="3432.014492753623" Y="461.0188172043006" GraphRef="b91f7" RelX="1.0" RelY="-0.5"/>
      <Point X="3807.3061594202845" Y="968.1021505376359" GraphRef="a88d2" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idaff31120">
    <Comment>Activated, GTP bound Ras, recruits RAF1, BRAF and ARAF, the MAP3K (MAP kinase kinase kinase) trier of the cascade, and stimulates their protein kinase activity </Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12292" LineThickness="1.0">
      <Point X="2000.8804347826072" Y="958.518817204302" GraphRef="ba06e" RelX="0.0" RelY="1.0"/>
      <Point X="2001.8804347826072" Y="1155.1854838709687" GraphRef="fa17c" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc358245">
    <Graphics ConnectorType="Elbow" ZOrder="12294" LineThickness="1.0">
      <Point X="3288.5144927536203" Y="379.27862112586894" GraphRef="fe5c4" RelX="0.0" RelY="1.0"/>
      <Point X="3326.5144927536217" Y="414.0"/>
      <Point X="3364.514492753623" Y="454.7688172043006" GraphRef="b91f7" RelX="-0.5" RelY="-1.0" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id94cd1b3">
    <Graphics ConnectorType="Elbow" ZOrder="12296" LineThickness="1.0">
      <Point X="2106.1408860663387" Y="2245.4655959157867" GraphRef="dc475" RelX="0.0" RelY="-1.0"/>
      <Point X="2076.7365797910197" Y="2097.826086956522"/>
      <Point X="2047.332273515701" Y="1328.7301536336606" GraphRef="e678d" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5cc5e16f">
    <Graphics ZOrder="12298" LineThickness="1.0">
      <Point X="2250.0127877237846" Y="1654.4354838709703" GraphRef="bf607" RelX="0.0" RelY="-1.0"/>
      <Point X="2251.547101449273" Y="1635.4909856313384" GraphRef="f3f22" RelX="0.0" RelY="1.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6bb0441c">
    <Graphics ConnectorType="Elbow" ZOrder="12302" LineThickness="1.0">
      <Point X="2708.3768115942007" Y="721.7688172043021" GraphRef="dfc5c" RelX="0.0" RelY="1.0"/>
      <Point X="2623.797101449273" Y="968.0"/>
      <Point X="2539.2173913043453" Y="1025.1021505376355" GraphRef="c3f9f" RelX="0.0" RelY="-1.0" ArrowHead="mim-cleavage"/>
      <Anchor Position="0.1285545023696682" Shape="None" GraphId="cffe0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id76a67dc3">
    <Graphics ZOrder="12304" LineThickness="1.0">
      <Point X="5015.014492753616" Y="561.8729838709677" GraphRef="d33a7" RelX="-1.0" RelY="-0.5"/>
      <Point X="4734.597826086952" Y="561.8729838709678" GraphRef="a7c50" RelX="1.0" RelY="-0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4451333931630993" Shape="None" GraphId="abbee"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3c77e076">
    <Graphics ZOrder="12306" LineThickness="1.0">
      <Point X="1343.2065962571799" Y="1284.3521505376357" GraphRef="ec363" RelX="0.0" RelY="0.0"/>
      <Point X="1342.75" Y="1276.10251872346" GraphRef="e358b" RelX="0.0" RelY="1.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc06a5bd5">
    <Comment>CaMKII interacts with with AMPAR subunit GluA2 and catalyzes the phosphorylation of AMPAR, promoting receptor insertion into the synaptic membrane and LTP. </Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12308" LineThickness="1.0" Color="ffcc00">
      <Point X="4106.014492753617" Y="913.9354838709694" GraphRef="df13f" RelX="1.0" RelY="0.0"/>
      <Point X="4126.014492753617" Y="862.9677419354847"/>
      <Point X="4467.526513095733" Y="812.0"/>
      <Point X="4809.03853343785" Y="580.3104838709677" GraphRef="e3910" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id30e5479">
    <Comment/>
    <BiopaxRef>b23</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12310" LineThickness="1.0">
      <Point X="469.33333333333326" Y="1836.4354838709687" GraphRef="b3e88" RelX="0.0" RelY="1.0"/>
      <Point X="429.49999999999955" Y="2298.2271505376298" GraphRef="b8279" RelX="-1.0" RelY="-0.5" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7dd14ab9">
    <Comment>MEK 1/2 subsequently phosphorylate and activate ERK 1 and 2 (ERK1/2) at their Thr and Tyr residues within the Thr-Glu-Tyr domain of the activation loop</Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12312" LineThickness="1.0">
      <Point X="2170.213768115943" Y="1344.3267882187947" GraphRef="ffca3" RelX="0.0" RelY="1.0"/>
      <Point X="1987.672101449275" Y="1394.0"/>
      <Point X="1811.1304347826074" Y="1506.202150537635" GraphRef="b24ff" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="iddf325579">
    <Comment>PI3K catalyzes the phosphorylation of PIP2 into PIP3</Comment>
    <BiopaxRef>f3c</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12314" LineThickness="1.0">
      <Point X="753.2500000000002" Y="863.1854838709687" GraphRef="b3ff7" RelX="1.0" RelY="-0.5"/>
      <Point X="875.0428134556577" Y="803.9354838709685" GraphRef="ab27c" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6ebf7936">
    <Comment>AMPAR receptors can be recycled and re-inserted into the membrane</Comment>
    <Graphics ZOrder="12318" LineStyle="Broken" LineThickness="1.0" Color="ffcc00">
      <Point X="5118.347826086948" Y="2075.01881720431" GraphRef="ff607" RelX="1.0" RelY="0.0"/>
      <Point X="5100.701992753616" Y="617.1854838709673" GraphRef="d33a7" RelX="0.5" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id836536be">
    <BiopaxRef>a20</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12320" LineThickness="1.0">
      <Point X="448.7499999999991" Y="2338.602150537632" GraphRef="af977" RelX="-1.0" RelY="0.0"/>
      <Point X="332.6666666666648" Y="2571.9354838709696" GraphRef="b805b" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc4ceabf5">
    <Comment>PSD-95 (postsynaptic density protein 95) is is recruited and interacts with the NR2 subuni of the NMDA receptor upon NDMAR activation. </Comment>
    <BiopaxRef>a19</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12322" LineThickness="1.0">
      <Point X="3364.514492753623" Y="479.7688172043006" GraphRef="b91f7" RelX="-0.5" RelY="1.0"/>
      <Point X="2990.3768115942003" Y="756.1021505376345" GraphRef="b6e01" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7ceedc8c">
    <Graphics ZOrder="12326" LineThickness="1.0">
      <Point X="1344.1477591036405" Y="1808.762514683294" GraphRef="eee9f" RelX="0.0" RelY="-1.0"/>
      <Point X="1345.4810924369735" Y="1625.762514683296" GraphRef="dcf1f" RelX="0.0" RelY="1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.5261329038381142" Shape="None" GraphId="fce0a"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id89b24162">
    <Graphics ConnectorType="Elbow" ZOrder="12328" LineThickness="1.0">
      <Point X="2708.3768115942007" Y="721.7688172043021" GraphRef="dfc5c" RelX="0.0" RelY="1.0"/>
      <Point X="2758.876811594201" Y="968.0"/>
      <Point X="2809.376811594201" Y="1027.768817204302" GraphRef="b70e9" RelX="0.0" RelY="-1.0" ArrowHead="mim-cleavage"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id36968a16">
    <Comment>Phosphorylated CREB initiates CREB-dependant transcription of the FMR1 gene, thereby CREB upregulates FMRP (FMR1 gene product)</Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12330" LineThickness="1.0">
      <Point X="2205.0127877237846" Y="1666.9354838709703" GraphRef="bf607" RelX="-1.0" RelY="0.0"/>
      <Point X="1231.333333333333" Y="1425.5188172043013" GraphRef="acdc1" RelX="0.0" RelY="1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9e830c04">
    <Graphics ZOrder="12332" LineThickness="1.0">
      <Point X="1987.6666666666665" Y="2635.8759600614476" GraphRef="db8ff" RelX="1.0" RelY="-0.5"/>
      <Point X="2056.75" Y="2635.8759600614476" GraphRef="df0e6" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5ba77a9e">
    <Comment>Glutamate Receptor Interacting Protein (GRIP) interacts with AMPAR binding protein (ABP or GRIP2) to anchor AMPARs at synaptic and intracelluar membranes, thereby inhibiting AMPAR internalization.</Comment>
    <BiopaxRef>ba9</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12334" LineThickness="1.0">
      <Point X="4483.347826086949" Y="542.4979838709669" GraphRef="d2136" RelX="1.0" RelY="0.5"/>
      <Point X="4620.347826086952" Y="598.7479838709676" GraphRef="a7c50" RelX="-1.0" RelY="0.5" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idafb07498">
    <Comment>PIP3 recruits PDK1 and Akt to the membrane</Comment>
    <BiopaxRef>f3c</BiopaxRef>
    <Graphics ZOrder="12336" LineThickness="1.0">
      <Point X="898.6666666666667" Y="869.7688172043024" GraphRef="c42c7" RelX="0.0" RelY="1.0"/>
      <Point X="898.6666666666669" Y="901.1021505376352" GraphRef="ddab0" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd85cc5a8">
    <Comment>ARC interacts with dynamin and isoforms of endophilin (isoform 2 and 3 only) to stimulate AMPAR internalization and thus negatively regulate AMPAR surface expression. Rapid mGluR-mediated synthesis of ARC is required for to maintain decrease in surafce AMPAR  and thereby maintaining LTD. </Comment>
    <BiopaxRef>b65</BiopaxRef>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12338" LineThickness="1.0">
      <Point X="2149.1408860663387" Y="2297.1616743471545" GraphRef="c167f" RelX="1.0" RelY="0.0"/>
      <Point X="3572.4288342714804" Y="1965.548579109061"/>
      <Point X="3646.34782608695" Y="1633.9354838709676" GraphRef="b2f66" RelX="-1.0" RelY="0.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id33e3a006">
    <Comment>Calcineurin/Dynamin 1 complex stimulates clathrin-mediated endocytosis of AMPAR</Comment>
    <BiopaxRef>aa6</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12340" LineThickness="1.0">
      <Point X="4316.597826086948" Y="926.1854838709687" GraphRef="c5ce3" RelX="0.5" RelY="1.0"/>
      <Point X="4352.681159420286" Y="1312.6021505376355" GraphRef="e42e2" RelX="-1.0" RelY="0.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id9daeda7b">
    <Graphics ZOrder="12342" LineThickness="1.0">
      <Point X="2474.2480818414397" Y="1666.602150537631" GraphRef="d3036" RelX="-1.0" RelY="0.0"/>
      <Point X="2295.0127877237846" Y="1666.9354838709703" GraphRef="bf607" RelX="1.0" RelY="0.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="c411f"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id86164a0c">
    <Graphics ZOrder="12344" LineThickness="1.0">
      <Point X="733.0" Y="1305.6676135688315" GraphRef="b09b1" RelX="0.0" RelY="0.0"/>
      <Point X="709.2903786820991" Y="1305.6021505376357" GraphRef="d7fe4" RelX="1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idea863590">
    <Comment>ARC, dynamin and endophilin bind in an cooperative assembly that stimulates AMPAR endocytosis. </Comment>
    <Graphics ConnectorType="Elbow" ZOrder="12348" LineThickness="1.0">
      <Point X="3702.34782608695" Y="1581.2688172043008" GraphRef="b2f66" RelX="0.0" RelY="-1.0"/>
      <Point X="4675.0993175464455" Y="1571.7178610567435" GraphRef="c98be" RelX="0.0" RelY="0.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc076bf35">
    <Graphics ConnectorType="Elbow" ZOrder="12350" LineThickness="1.0">
      <Point X="538.7499999999991" Y="2362.6021505376343" GraphRef="e2bb4" RelX="1.0" RelY="0.0"/>
      <Point X="672.0833333333328" Y="2554.102150537636" GraphRef="af92b" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ide3b4171b">
    <Comment>The MAP3K trier transmits the signal downstream through phosphorylation and activation of the MAPKKs (Mitogen-activated protein kinase kinase) MEK 1 and MEK 2 (MEK 1/2)</Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12352" LineThickness="1.0">
      <Point X="2225.880434782607" Y="1180.1854838709687" GraphRef="c49ef" RelX="0.0" RelY="1.0"/>
      <Point X="2003.305142788078" Y="1296.7960838387794" GraphRef="ffd68" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb57cdc19">
    <Comment>Modest activation of NMDAR leads to repeated occurance of a small Ca2+ influx which leads to the activation of NMDA dependant protein phosphatases, protein phosphatase 1 and Calcineurin</Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics ZOrder="12354" LineThickness="1.0">
      <Point X="3849.5561594202845" Y="968.1021505376359" GraphRef="a88d2" RelX="0.5" RelY="-1.0"/>
      <Point X="3849.3061594202854" Y="438.60215053763534" GraphRef="e2fa1" RelX="-0.5" RelY="1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd5f4cb6e">
    <Comment>In turn, activated ERK 1/2 phosphorylates MAPKAPK (MAP Kinase Activated Protein Kinase) components such as MNK1 </Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12356" LineThickness="1.0">
      <Point X="1904.1304347826074" Y="1518.102150537635" GraphRef="df3b8" RelX="0.0" RelY="1.0"/>
      <Point X="1810.8637681159405" Y="1722.268817204302" GraphRef="e4cf7" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id8c5753f6">
    <Comment>Maximal influx of Ca2+ through strong activation NMDAR  activates PICK1 (Protein Interacting with C Kinase - 1)</Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12358" LineThickness="1.0">
      <Point X="3849.5561594202845" Y="990.2688172043024" GraphRef="a88d2" RelX="0.5" RelY="1.0"/>
      <Point X="4061.0144927536167" Y="926.4354838709694" GraphRef="df13f" RelX="0.0" RelY="1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idfd8371c7">
    <Comment>Elevated cAMP levels lead to the activation of cAMP dependant protein kinase (PKA) </Comment>
    <BiopaxRef>c3b</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12360" LineThickness="1.0">
      <Point X="2411.9673913043453" Y="1388.1854838709687" GraphRef="fd5c1" RelX="0.0" RelY="1.0"/>
      <Point X="2379.0434782608663" Y="1484.4354838709687" GraphRef="b129c" RelX="1.0" RelY="0.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4387c677">
    <Graphics ZOrder="12362" LineThickness="1.0">
      <Point X="1300.4810924369735" Y="1613.262514683296" GraphRef="dcf1f" RelX="-1.0" RelY="0.0"/>
      <Point X="1284.867821646425" Y="1614.2688172043065" GraphRef="ab17f" RelX="1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idbb01aae5">
    <Comment>Activation of TrkB recruits and activates Shc and adaptor protein Gbr2. PI3K is activated via Gbr2 through Gab1. </Comment>
    <BiopaxRef>d83</BiopaxRef>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12364" LineThickness="1.0">
      <Point X="1500.833333333334" Y="824.6854838709687" GraphRef="c4403" RelX="-1.0" RelY="0.0"/>
      <Point X="1374.8333333333344" Y="718.435483870968" GraphRef="b023c" RelX="-0.5" RelY="1.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id2cb6fa60">
    <Comment>Activation of PLC (phospholipase C) through mGluR or TrkB leads to hydrolysis of membrane bound PIP2 (phosphatidylinositol 4,5-bisphosphate) to generate IP3 and DAG. </Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12366" LineThickness="1.0">
      <Point X="2320.46376811594" Y="461.9354838709676" GraphRef="c6afc" RelX="0.0" RelY="1.0"/>
      <Point X="2475.7536231884037" Y="743.9354838709681"/>
      <Point X="2631.0434782608672" Y="763.2226859452867"/>
      <Point X="2708.3768115942007" Y="782.5098880196053" GraphRef="cffe0" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf3e218d7">
    <Comment>The MAP3K trier transmits the signal downstream through phosphorylation and activation of the MAPKKs (Mitogen-activated protein kinase kinase) MEK 1 and MEK 2 (MEK 1/2)</Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12368" LineThickness="1.0">
      <Point X="1766.8949275362295" Y="1180.1854838709687" GraphRef="de858" RelX="0.0" RelY="1.0"/>
      <Point X="2003.305142788078" Y="1296.7960838387794" GraphRef="ffd68" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7225c00d">
    <Comment>PDK1 phosphorylates and activates Akt </Comment>
    <BiopaxRef>f3c</BiopaxRef>
    <Graphics ZOrder="12372" LineThickness="1.0">
      <Point X="898.6666666666669" Y="926.1021505376352" GraphRef="ddab0" RelX="0.0" RelY="1.0"/>
      <Point X="898.6666666666669" Y="962.7688172043022" GraphRef="aaa9b" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.4" Shape="None" GraphId="afcac"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf010f26c">
    <Graphics ConnectorType="Elbow" ZOrder="12374" LineThickness="1.0">
      <Point X="1086.75" Y="1823.9354838709676" GraphRef="bfc13" RelX="-1.0" RelY="0.0"/>
      <Point X="1085.0000000000005" Y="2018.622983870969" GraphRef="aeb05" RelX="-1.0" RelY="-0.5" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id24e30e9a">
    <Graphics ZOrder="12376" LineThickness="1.0">
      <Point X="2874.376811594201" Y="1151.253125335541" GraphRef="ac8a4" RelX="0.0" RelY="0.0"/>
      <Point X="2845.710144927536" Y="1151.1021505376355" GraphRef="ae4e6" RelX="1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida769adba">
    <Comment>Generation of IP3 from PIP2 via PLC lead to the release of intracellular Ca2+. This leads to the activation CaM (Ca2+-calmodulin) dependant pathways</Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12382" LineThickness="1.0">
      <Point X="2854.376811594201" Y="1040.268817204302" GraphRef="b70e9" RelX="1.0" RelY="0.0"/>
      <Point X="2874.376811594201" Y="1115.1344086021509"/>
      <Point X="2729.449275362317" Y="1190.0"/>
      <Point X="2584.5217391304336" Y="1229.4354838709687" GraphRef="a4e3c" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.2624821683309518" Shape="None" GraphId="ac8a4"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idea98af54">
    <Comment>Activation adn mobilization of endocannabinoids through mGluR activation negatively regulates GABA release from the synapse. </Comment>
    <BiopaxRef>a46</BiopaxRef>
    <Graphics ZOrder="12384" LineThickness="1.0">
      <Point X="377.0" Y="753.435483870968" GraphRef="c324d" RelX="0.0" RelY="1.0"/>
      <Point X="377.0" Y="802.7443074003775" GraphRef="fb109" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ideebe7876">
    <Graphics ZOrder="12386" LineThickness="1.0">
      <Point X="2902.2173913043503" Y="469.2688172043015" GraphRef="f003b" RelX="-1.0" RelY="0.0"/>
      <Point X="2874.595546702739" Y="469.60215053763534" GraphRef="a8166" RelX="1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id593187e">
    <Graphics ConnectorType="Elbow" ZOrder="12388" LineThickness="1.0">
      <Point X="1006.25" Y="1575.8220384928177" GraphRef="b1f46" RelX="0.5" RelY="1.0"/>
      <Point X="1109.25" Y="1811.4354838709676" GraphRef="bfc13" RelX="-0.5" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7cfda92d">
    <Graphics ZOrder="12392" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2255.9711981566866" GraphRef="cb3ca" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2255.3045314900205" GraphRef="ea469" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7278d44d">
    <Comment>Activated TrkB (tyrosine kinase B) recruits and activates PLC, this triggers PLC intracellular cascades</Comment>
    <BiopaxRef>d83</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12394" LineThickness="1.0">
      <Point X="1593.6666666666672" Y="554.602150537634" GraphRef="e58ce" RelX="1.0" RelY="0.0"/>
      <Point X="1853.1304347826072" Y="498.60215053763415"/>
      <Point X="2276.7971014492714" Y="442.6021505376343" GraphRef="cd617" RelX="-1.0" RelY="0.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5ead9312">
    <Comment>4E binding protein (4E-BP) associates with eIF4E, thereby inhibits the assembly of the eIF4F complex and represses translation</Comment>
    <BiopaxRef>eb4</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12396" LineThickness="1.0">
      <Point X="1389.1477591036405" Y="1821.262514683294" GraphRef="eee9f" RelX="1.0" RelY="0.0"/>
      <Point X="1199.0000000000005" Y="2018.622983870969" GraphRef="aeb05" RelX="1.0" RelY="-0.5" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf8140e8c">
    <Comment>AMPAR internaliztion/endocytosis is clathrin mediated and activated through NMDAR stimulation. Local protein synthesis of postsynaptic, dendritic localized mRNAs, regulated through mGluR receptor activation and FMRP regulation, results in internalization of AMPAR, which is a key step in mGluR-mediated long term depression (LTD). </Comment>
    <BiopaxRef>a34</BiopaxRef>
    <Graphics ZOrder="12400" LineStyle="Broken" LineThickness="1.0" Color="ff6600">
      <Point X="4677.472826086952" Y="617.1854838709676" GraphRef="a7c50" RelX="0.0" RelY="1.0"/>
      <Point X="4673.847826086948" Y="2075.01881720431" GraphRef="ff607" RelX="-1.0" RelY="0.0" ArrowHead="Arrow"/>
      <Anchor Position="0.6547609766908219" Shape="None" GraphId="c98be"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ided1b4565">
    <Comment>Activation of PI3K through activated Ras mediated by the TrkB signalling pathway</Comment>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12406" LineThickness="1.0">
      <Point X="1955.8804347826072" Y="939.768817204302" GraphRef="ba06e" RelX="-1.0" RelY="-0.5"/>
      <Point X="1899.5652173913043" Y="808.2177419354844"/>
      <Point X="1303.9076086956522" Y="676.6666666666667"/>
      <Point X="708.2500000000002" Y="856.9354838709687" GraphRef="b3ff7" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ide3680ab5">
    <Comment>Group I mGluR activation stimulates eCB signalling and leads to actovation and mobilization of endocannabinoids which inhibit the release of GABA. </Comment>
    <BiopaxRef>a46</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12408" LineThickness="1.0">
      <Point X="915.5" Y="431.68548387096746" GraphRef="a264b" RelX="-1.0" RelY="0.0"/>
      <Point X="377.0" Y="646.4943074003777" GraphRef="d7fc2" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4cea437a">
    <Comment>Activated PSD-95 directly interacts with synaptic ras GTPase-activating protein (SynGAP)</Comment>
    <BiopaxRef>a19</BiopaxRef>
    <Graphics ZOrder="12410" LineThickness="1.0">
      <Point X="2990.3768115942003" Y="781.1021505376345" GraphRef="b6e01" RelX="0.0" RelY="1.0"/>
      <Point X="2989.3768115941944" Y="853.102150537635" GraphRef="a7faf" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id4ee88c62">
    <Graphics ZOrder="12412" LineThickness="1.0">
      <Point X="2120.963768115943" Y="1328.2017882187947" GraphRef="ffca3" RelX="-1.0" RelY="0.5"/>
      <Point X="1795.7971014492753" Y="1330.535121552128" GraphRef="a6afa" RelX="1.0" RelY="0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.22644232065681727" Shape="None" GraphId="e678d"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id151021ba">
    <Graphics ZOrder="12414" LineThickness="1.0">
      <Point X="1601.333333333334" Y="824.6854838709687" GraphRef="c4403" RelX="1.0" RelY="0.0"/>
      <Point X="1727.5471014492728" Y="826.6854838709687" GraphRef="b6067" RelX="-1.0" RelY="0.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idcc227db8">
    <Comment/>
    <Graphics ConnectorType="Elbow" ZOrder="12418" LineThickness="1.0" Color="ff6633">
      <Point X="4542.097826086949" Y="470.18548387096746" GraphRef="b4869" RelX="0.0" RelY="1.0"/>
      <Point X="4632.347826086952" Y="567.9354838709678" GraphRef="e9e88" RelX="-1.0" RelY="0.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ide820744a">
    <Graphics ConnectorType="Elbow" ZOrder="12420" LineThickness="1.0">
      <Point X="2545.0434782608672" Y="1241.9354838709687" GraphRef="a4e3c" RelX="-1.0" RelY="0.0"/>
      <Point X="2411.9673913043453" Y="1363.1854838709687" GraphRef="fd5c1" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb748332b">
    <Comment>Homer mediates the association between type I mGluR to PIKE-L
</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12424" LineThickness="1.0">
      <Point X="632.163043478261" Y="661.2398316970543" GraphRef="ac4db" RelX="0.0" RelY="1.0"/>
      <Point X="589.5833333333337" Y="748.7688172043015" GraphRef="c9e48" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf2726c27">
    <Graphics ZOrder="12426" LineThickness="1.0">
      <Point X="4734.597826086952" Y="580.3104838709677" GraphRef="a7c50" RelX="1.0" RelY="0.0"/>
      <Point X="5015.014492753616" Y="580.3104838709676" GraphRef="d33a7" RelX="-1.0" RelY="0.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.265464632454911" Shape="None" GraphId="e3910"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6054524f">
    <Comment>PI3K is activated via Gbr2 through Gab1 by a TrkB dependant manner. </Comment>
    <BiopaxRef>a08</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12428" LineThickness="1.0">
      <Point X="1352.3333333333344" Y="705.935483870968" GraphRef="b023c" RelX="-1.0" RelY="0.0"/>
      <Point X="730.7500000000002" Y="856.9354838709687" GraphRef="b3ff7" RelX="0.5" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id1ac8c210">
    <Comment>STEP catalyzes the dephosphorylation of AMPAR subunit GluA2 in order to maintain increased AMPAR endocytosis rate. </Comment>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12434" LineThickness="1.0" Color="ff6600">
      <Point X="4977.1408860663405" Y="451.96559591578693" GraphRef="dd010" RelX="-1.0" RelY="0.0"/>
      <Point X="4890.191670420798" Y="561.8729838709677" GraphRef="abbee" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6f1c4e92">
    <Comment>Group I mGluRs are coupled to PLC (Phospholipase C) through GÎ±q. Activation of mGluR by glutamate leads to activation of PLC which triggers the PLC signalling pathway</Comment>
    <BiopaxRef>c99</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12436" LineThickness="1.0">
      <Point X="1019.5" Y="414.56048387096746" GraphRef="a264b" RelX="1.0" RelY="-0.5"/>
      <Point X="2066.0" Y="412.9146505376339"/>
      <Point X="2276.7971014492714" Y="411.2688172043004" GraphRef="d36bc" RelX="-1.0" RelY="0.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5cbc62a6">
    <Graphics ZOrder="12442" LineThickness="1.0">
      <Point X="1186.333333333333" Y="1406.7688172043013" GraphRef="acdc1" RelX="-1.0" RelY="-0.5"/>
      <Point X="1029.0000000000011" Y="1406.4354838709673" GraphRef="a3823" RelX="1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc250ec00">
    <Graphics ConnectorType="Elbow" ZOrder="12446" LineThickness="1.0">
      <Point X="961.25" Y="1575.8220384928177" GraphRef="b1f46" RelX="-0.5" RelY="1.0"/>
      <Point X="469.33333333333326" Y="1811.4354838709687" GraphRef="b3e88" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd39ac2ad">
    <Comment>PP1 and Calcineurin dephospharylate AMPAR which stimulates AMPAR internalization and thus, LTD.</Comment>
    <BiopaxRef>bfd</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12448" LineThickness="1.0" Color="ff6600">
      <Point X="3925.6811594202854" Y="387.22715053763534" GraphRef="e2fa1" RelX="1.0" RelY="-0.5"/>
      <Point X="4890.191670420798" Y="561.8729838709677" GraphRef="abbee" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb0561b9b">
    <Comment>Activated, GTP bound Ras, recruits RAF1, BRAF and ARAF, the MAP3K (MAP kinase kinase kinase) trier of the cascade, and stimulates their protein kinase activity </Comment>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12450" LineThickness="1.0">
      <Point X="2000.8804347826072" Y="958.518817204302" GraphRef="ba06e" RelX="0.0" RelY="1.0"/>
      <Point X="2225.880434782607" Y="1155.1854838709687" GraphRef="c49ef" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3284bcda">
    <Graphics ConnectorType="Elbow" ZOrder="12452" LineThickness="1.0">
      <Point X="745.3333333333333" Y="356.43548387096746" GraphRef="a2fd0" RelX="0.0" RelY="1.0"/>
      <Point X="915.5" Y="414.56048387096746" GraphRef="a264b" RelX="-1.0" RelY="-0.5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id45320e3c">
    <Comment>Adaptor protein 2 (AP2) interacts with AMPAR and mediates recruitment of clathrin and clathrin-mediated endocytosis of AMPAR. </Comment>
    <BiopaxRef>ece</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12454" LineThickness="1.0" Color="ff6600">
      <Point X="4587.347826086948" Y="991.9354838709687" GraphRef="f466a" RelX="1.0" RelY="0.0"/>
      <Point X="4706.035326086952" Y="617.1854838709676" GraphRef="a7c50" RelX="0.5" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id910897e3">
    <Graphics ZOrder="12460" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2498.8283410138242" GraphRef="f9760" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2499.4950076804917" GraphRef="d8731" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6fbc3f8a">
    <Comment>PKCÎ± is recruited by PICK1 and binds to the PDZ domain of PICK1 and subsequently phosphorylates GluR2 subunit of AMPAR. Phosphorylation of GluR2 by PKCÎ± is necessary for PICK1 binding, since GRIP and PICK1 have the same binding site on the domain and GRIP dissociation is necessary for PICK1 binding and consequent endocytosis of AMPAR</Comment>
    <BiopaxRef>ba9</BiopaxRef>
    <Graphics ZOrder="12462" LineThickness="1.0">
      <Point X="3983.847826086948" Y="791.4354838709675" GraphRef="a5ba0" RelX="0.5" RelY="-1.0"/>
      <Point X="3982.847826086948" Y="701.4354838709678" GraphRef="c3764" RelX="-0.5" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id8937b1dc">
    <Comment>Activation of TrkB and thus autophosphorylation of its Try515 site recruits and phosphorylates Shc. Subsequently, Shc interacts with the adapotor protein Grb2 which recruits and activates SOS (a GEF). </Comment>
    <BiopaxRef>d83</BiopaxRef>
    <Graphics ZOrder="12466" LineThickness="1.0">
      <Point X="1548.6666666666672" Y="567.102150537634" GraphRef="e58ce" RelX="0.0" RelY="1.0"/>
      <Point X="1551.083333333334" Y="780.768817204302" GraphRef="c4403" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idf693d30a">
    <Comment>Calcineurin-dynamin 1 interaction is essential from AMPA clathrin-mediated receptor endocytosis. The formation of the calcineurin-dynamin 1 complex is dependent on Ca2+ influx. </Comment>
    <BiopaxRef>aa6</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12468" LineThickness="1.0">
      <Point X="3919.347826086945" Y="418.6021505376352" GraphRef="b531b" RelX="1.0" RelY="0.0"/>
      <Point X="4316.597826086948" Y="901.1854838709687" GraphRef="c5ce3" RelX="0.5" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ideafcaadd">
    <Comment>Activated cAMP-dependant protein kinase (PKA) phosphorylates and activates the transcription factor cAMP response element-binding
protein (CREB) at Ser133</Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12470" LineThickness="1.0">
      <Point X="2277.0434782608663" Y="1521.4354838709687" GraphRef="b129c" RelX="0.0" RelY="1.0"/>
      <Point X="2339.798721227622" Y="1593.2688172043022"/>
      <Point X="2402.553964194378" Y="1666.7354838709666" GraphRef="c411f" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id425fd6ff">
    <Comment>MAP1b interacts with GRIP and sequesters GRIP and associated AMPAR from the synaptic surface</Comment>
    <BiopaxRef>f94</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12472" LineThickness="1.0" Color="ff6600">
      <Point X="4397.640886066339" Y="666.2842233667607" GraphRef="a0910" RelX="0.0" RelY="-1.0"/>
      <Point X="4397.660326086949" Y="560.8521505376334" GraphRef="d2136" RelX="-0.5" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida85a9a78">
    <Graphics ZOrder="12474" LineThickness="1.0">
      <Point X="2140.1304347826076" Y="860.268817204302" GraphRef="a5d72" RelX="-1.0" RelY="0.0"/>
      <Point X="2022.9830272931324" Y="858.6737400198718" GraphRef="dede9" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idb9fca401">
    <Comment>PICK1 recruits PKCÎ± which phophorylates AMPAR subunit GluA2 at Ser880 and thereby dissociates GRIP from AMPAR allowing PICK1 to bind to the GluA2. PICK1/GluA2 interaction induces AMPAR endocytosis. </Comment>
    <BiopaxRef>f94</BiopaxRef>
    <BiopaxRef>ba9</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12478" LineThickness="1.0" Color="ff6600">
      <Point X="4005.347826086948" Y="701.4354838709678" GraphRef="c3764" RelX="0.0" RelY="1.0"/>
      <Point X="4327.129076086951" Y="734.0"/>
      <Point X="4648.910326086952" Y="617.1854838709676" GraphRef="a7c50" RelX="-0.5" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id85df42f6">
    <Comment>PIKE-L (Phosphatidylinositol 3-kinase enhancer) binds to PI3K and stimulates PI3K's kinase activity</Comment>
    <BiopaxRef>c5c</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12480" LineThickness="1.0">
      <Point X="589.5833333333337" Y="773.7688172043015" GraphRef="c9e48" RelX="0.0" RelY="1.0"/>
      <Point X="685.7500000000002" Y="856.9354838709687" GraphRef="b3ff7" RelX="-0.5" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ide09529b">
    <Comment>CaM phosphorylates CAMIV</Comment>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12482" LineThickness="1.0">
      <Point X="2624.0" Y="1235.6854838709687" GraphRef="a4e3c" RelX="1.0" RelY="-0.5"/>
      <Point X="2707.463768115939" Y="1414.1021505376366" GraphRef="f9f8c" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id823571c1">
    <Graphics ZOrder="12484" LineThickness="1.0">
      <Point X="5072.264492753616" Y="605.1854838709673" GraphRef="c405a" RelX="0.0" RelY="1.0"/>
      <Point X="5073.264492753609" Y="624.143893508168" GraphRef="b5a23" RelX="0.0" RelY="-1.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idfbaa13d2">
    <Graphics ConnectorType="Elbow" ZOrder="12486" LineThickness="1.0">
      <Point X="1437.5098039215682" Y="508.523719165085" GraphRef="cf9d9" RelX="0.0" RelY="1.0"/>
      <Point X="1503.6666666666672" Y="548.352150537634" GraphRef="e58ce" RelX="-1.0" RelY="-0.5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida528e60c">
    <Graphics ZOrder="12488" LineThickness="1.0">
      <Point X="4316.347826086956" Y="292.4354838709676" GraphRef="e665d" RelX="1.0" RelY="0.0"/>
      <Point X="4497.347826086948" Y="293.9354838709676" GraphRef="e9258" RelX="-1.0" RelY="0.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida205d761">
    <Graphics ZOrder="12490" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2480.039825607657" GraphRef="a824e" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2480.0398256076514" GraphRef="eec3b" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ideafed123">
    <Graphics ZOrder="12492" LineThickness="1.0">
      <Point X="1795.7971014492753" Y="1298.285121552128" GraphRef="a6afa" RelX="1.0" RelY="-0.5"/>
      <Point X="2120.963768115943" Y="1295.9517882187947" GraphRef="ffca3" RelX="-1.0" RelY="-0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.638159020006567" Shape="None" GraphId="ffd68"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5e4da64f">
    <Graphics ZOrder="12494" LineThickness="1.0">
      <Point X="1779.1304347826074" Y="1506.602150537635" GraphRef="f401e" RelX="1.0" RelY="0.0"/>
      <Point X="1859.1304347826074" Y="1505.602150537635" GraphRef="df3b8" RelX="-1.0" RelY="0.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="b24ff"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id1da0271">
    <Comment>Clathrin mediates AMPAR endocytosis by binding to AP-2 complex. AP-2 complex is bound to AMPAR and recruits clathrin to the receptor to form a clathrin-coated vesicle containg AMPAR. </Comment>
    <BiopaxRef>c3d</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12496" LineThickness="1.0">
      <Point X="4403.514492753621" Y="1276.1021505376352" GraphRef="e42e2" RelX="-0.5" RelY="-1.0"/>
      <Point X="4466.9311594202845" Y="1136.0"/>
      <Point X="4530.347826086948" Y="1052.4354838709687" GraphRef="f466a" RelX="0.0" RelY="1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id8522480f">
    <Graphics ZOrder="12498" LineThickness="1.0">
      <Point X="1778.4637681159404" Y="1722.268817204302" GraphRef="d478a" RelX="1.0" RelY="0.0"/>
      <Point X="1859.4637681159404" Y="1722.268817204302" GraphRef="e1da2" RelX="-1.0" RelY="0.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="e4cf7"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id85e1f4c6">
    <Comment>SynGAP is a negtaive regulator of ras and thus also a negative regulator of the ERK1/2 cascade, thereby having a role in neuronal development and plasticity</Comment>
    <BiopaxRef>a19</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12500" LineThickness="1.0">
      <Point X="2944.3768115941944" Y="865.602150537635" GraphRef="a7faf" RelX="-1.0" RelY="0.0"/>
      <Point X="2544.3768115942007" Y="872.58120179696"/>
      <Point X="2022.6669404329507" Y="799.1440480189856" GraphRef="b97a2" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id2021030e">
    <Graphics ZOrder="12502" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2396.8675567000996" GraphRef="a8467" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2397.2008900334326" GraphRef="b0e44" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id65826470">
    <Graphics ZOrder="12504" LineThickness="1.0">
      <Point X="2023.3804347826072" Y="933.518817204302" GraphRef="ba06e" RelX="0.5" RelY="-1.0"/>
      <Point X="2022.3804347826072" Y="745.1854838709687" GraphRef="b2983" RelX="0.5" RelY="1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.3974074894748505" Shape="None" GraphId="dede9"/>
      <Anchor Position="0.7134943496565478" Shape="None" GraphId="b97a2"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3c0843cf">
    <Graphics ZOrder="12506" LineThickness="1.0">
      <Point X="1006.5000000000011" Y="1425.1854838709673" GraphRef="a3823" RelX="0.5" RelY="1.0"/>
      <Point X="1006.25" Y="1550.8220384928177" GraphRef="b1f46" RelX="0.5" RelY="-1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="a7568"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida706ee19">
    <Graphics ZOrder="12508" LineThickness="1.0">
      <Point X="2215.797101449276" Y="1297.3267882187947" GraphRef="e9306" RelX="1.0" RelY="0.0"/>
      <Point X="2224.8383958188733" Y="1299.7688172043026" GraphRef="f02b3" RelX="-1.0" RelY="0.0"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id78e0ba47">
    <Comment>Activated mTORC1 phophorylates PP2A, thereby inhibiting PP2A's phopsphatase activity </Comment>
    <BiopaxRef>a34</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12512" LineThickness="1.0">
      <Point X="966.2499999999999" Y="1284.3521505376357" GraphRef="d0da8" RelX="-1.0" RelY="0.0"/>
      <Point X="733.0" Y="1405.7688172043022" GraphRef="c4c61" RelX="0.0" RelY="-1.0" ArrowHead="mim-inhibition"/>
      <Anchor Position="0.7177597641857029" Shape="None" GraphId="b09b1"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idbe4f4f3d">
    <Comment>Ribosomal protein S6 kinase 1 (S6K1) phosphorylates FMRP, allowing phosphorylated FMRP to bind to stalling ribosomes and thereby repress translation</Comment>
    <BiopaxRef>b85</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12514" LineThickness="1.0">
      <Point X="1411.3333333333348" Y="1402.4354838709662" GraphRef="f9577" RelX="0.0" RelY="1.0"/>
      <Point X="1006.4000000000007" Y="1475.4401057197074" GraphRef="a7568" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id7a1b768e">
    <Graphics ZOrder="12516" LineThickness="1.0">
      <Point X="1977.3804347826072" Y="745.1854838709687" GraphRef="b2983" RelX="-0.5" RelY="1.0"/>
      <Point X="1978.3804347826072" Y="933.518817204302" GraphRef="ba06e" RelX="-0.5" RelY="-1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="f5ce1"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id555d5b7c">
    <Comment>FMRP represses the action PI3K and thereby negatively regulates the mTOR pathway</Comment>
    <BiopaxRef>a34</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12522" LineThickness="1.0">
      <Point X="938.75" Y="1557.0720384928177" GraphRef="b1f46" RelX="-1.0" RelY="-0.5"/>
      <Point X="534.0" Y="1213.2537611818932"/>
      <Point X="663.2500000000002" Y="869.4354838709687" GraphRef="b3ff7" RelX="-1.0" RelY="0.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3315d84f">
    <Graphics ZOrder="12524" LineThickness="1.0">
      <Point X="1160.666666666667" Y="1145.8521505376352" GraphRef="d6ade" RelX="-1.0" RelY="0.5"/>
      <Point X="1084.6666666666677" Y="1146.5188172043022" GraphRef="f3077" RelX="1.0" RelY="0.5" ArrowHead="mim-conversion"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id186dec8f">
    <Graphics ZOrder="12528" LineThickness="1.0">
      <Point X="961.25" Y="1550.8220384928177" GraphRef="b1f46" RelX="-0.5" RelY="-1.0"/>
      <Point X="961.5000000000011" Y="1425.1854838709673" GraphRef="a3823" RelX="-0.5" RelY="1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="c6bcb"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idbc5fe0fb">
    <Comment>Protein phasphatase 2 (PP2) dephosphorylates FMRP. Unphosphorylated FMRP is associated with actively translating polyribosomes. </Comment>
    <BiopaxRef>bc3</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12532" LineThickness="1.0">
      <Point X="733.0" Y="1430.7688172043022" GraphRef="c4c61" RelX="0.0" RelY="1.0"/>
      <Point X="961.3500000000005" Y="1500.5674166440776" GraphRef="c6bcb" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id26caf50a">
    <Comment>Activation of MNK1  phosphorylates eIF4E of the eIF4E-CYFIP1-FMRP inhibitory complex. The phosphorylation of eIF4E releases the CYFIP1-FMRP complex from the mRNA and enables translation</Comment>
    <BiopaxRef>c69</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12536" LineThickness="1.0" Color="0033ff">
      <Point X="1904.4637681159404" Y="1734.768817204302" GraphRef="e1da2" RelX="0.0" RelY="1.0"/>
      <Point X="1199.0000000000005" Y="2043.2271505376352" GraphRef="aeb05" RelX="1.0" RelY="0.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.7373178629249862" Shape="None" GraphId="c4ec5"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idca6b4e29">
    <Graphics ZOrder="12538" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2325.867556700096" GraphRef="c2bc4" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2326.5342233667607" GraphRef="b4ed7" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idccbd6f6c">
    <Comment>Phosphorylation of the 4E-BP by mTORC1 leads to inactivation of 4E-BP and thus induces translation of proteins</Comment>
    <BiopaxRef>f3c</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12540" LineThickness="1.0" Color="0033ff">
      <Point X="1113.3749999999995" Y="1333.6021505376357" GraphRef="d0da8" RelX="0.0" RelY="1.0"/>
      <Point X="1140.6874999999998" Y="1353.6021505376357"/>
      <Point X="1168.0" Y="1533.041171909278"/>
      <Point X="1344.8492696420913" Y="1712.4801932809203" GraphRef="fce0a" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ide5f86b84">
    <Comment>TSC2 acts as GAD (GTPase activating protein) towards RHEB, converting it from the active GTP-bound state to the inactive GDP-bound state. This activity is inhibited by phosphorylation of TSC2 through AKT. As a consequence, the conversion of GTP bound RHEB to GDP bound RHEB is inhibited.</Comment>
    <BiopaxRef>c01</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12542" LineThickness="1.0">
      <Point X="1189.6666666666679" Y="976.018817204302" GraphRef="f384c" RelX="1.0" RelY="0.0"/>
      <Point X="1115.0666666666673" Y="1133.7521505376353" GraphRef="cd870" RelX="0.0" RelY="0.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ida0ed1893">
    <Comment>Through inhibition of the TSC complex and thus conversion of RHEB-GTP to RHEB-GDP, there is accumulation of RHEB-GTP which stimulates and activates mTORC1. </Comment>
    <BiopaxRef>c01</BiopaxRef>
    <Graphics ZOrder="12544" LineThickness="1.0">
      <Point X="1039.6666666666677" Y="1152.7688172043022" GraphRef="f3077" RelX="0.0" RelY="1.0"/>
      <Point X="1039.8124999999998" Y="1235.1021505376357" GraphRef="d0da8" RelX="-0.5" RelY="-1.0" ArrowHead="mim-stimulation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id8744aef8">
    <Comment>Activated, GTP bound Ras, recruits RAF1, BRAF and ARAF, the MAP3K (MAP kinase kinase kinase) trier of the cascade, and stimulates their protein kinase activity </Comment>
    <BiopaxRef>a32</BiopaxRef>
    <BiopaxRef>e89</BiopaxRef>
    <Graphics ZOrder="12546" LineThickness="1.0">
      <Point X="2000.8804347826072" Y="958.518817204302" GraphRef="ba06e" RelX="0.0" RelY="1.0"/>
      <Point X="1766.8949275362295" Y="1155.1854838709687" GraphRef="de858" RelX="0.0" RelY="-1.0" ArrowHead="mim-binding"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id22195d3">
    <Comment>FMRP represses the action PIKE and thereby negatively regulates the mTOR pathway</Comment>
    <BiopaxRef>b1b</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12552" LineThickness="1.0">
      <Point X="938.75" Y="1557.0720384928177" GraphRef="b1f46" RelX="-1.0" RelY="-0.5"/>
      <Point X="488.0" Y="1159.1704278485595"/>
      <Point X="544.5833333333337" Y="761.2688172043015" GraphRef="c9e48" RelX="-1.0" RelY="0.0" ArrowHead="mim-inhibition"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id731cd784">
    <Comment>mTORC1 phosphorylates and activates S6K1 which induces its kinase activity</Comment>
    <BiopaxRef>a34</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12554" LineThickness="1.0">
      <Point X="1260.499999999999" Y="1284.3521505376357" GraphRef="d0da8" RelX="1.0" RelY="0.0"/>
      <Point X="1411.3333333333348" Y="1377.4354838709662" GraphRef="f9577" RelX="0.0" RelY="-1.0" ArrowHead="mim-stimulation"/>
      <Anchor Position="0.339077265147308" Shape="None" GraphId="ec363"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id41bbefae">
    <Graphics ZOrder="12560" LineThickness="1.0">
      <Point X="1084.6666666666677" Y="1134.0188172043022" GraphRef="f3077" RelX="1.0" RelY="-0.5"/>
      <Point X="1160.666666666667" Y="1133.3521505376352" GraphRef="d6ade" RelX="-1.0" RelY="-0.5" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="cd870"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idc625a5ad">
    <Comment>mGluR is bound to HOMER which mediates activation of the PI3K-Akt-mTOR pathway</Comment>
    <BiopaxRef>b48</BiopaxRef>
    <Graphics ConnectorType="Elbow" ZOrder="12566" LineThickness="1.0">
      <Point X="967.5" Y="465.93548387096746" GraphRef="a264b" RelX="0.0" RelY="1.0"/>
      <Point X="799.8315217391305" Y="552.6666666666667"/>
      <Point X="632.163043478261" Y="636.2398316970543" GraphRef="ac4db" RelX="0.0" RelY="-1.0" ArrowHead="mim-modification"/>
      <Anchor Position="0.39811172305271547" Shape="None" GraphId="d1a8e"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="idd2e2d64e">
    <Comment>AKT directly phosphorylates TSC2 on Ser939, Ser981 and Thr1462. This leads to inactivation of TSC2, which inhibits its GAP (GTPase-accelerating protein) activity</Comment>
    <BiopaxRef>c01</BiopaxRef>
    <Graphics ZOrder="12570" LineThickness="1.0">
      <Point X="943.6666666666669" Y="975.2688172043022" GraphRef="aaa9b" RelX="1.0" RelY="0.0"/>
      <Point X="1087.6666666666679" Y="976.0188172043021" GraphRef="f7bf9" RelX="-1.0" RelY="0.0" ArrowHead="mim-binding"/>
      <Anchor Position="0.579871979245966" Shape="None" GraphId="ca4d4"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id5abdbf12">
    <Graphics ZOrder="12572" LineThickness="1.0">
      <Point X="921.1666666666667" Y="844.7688172043024" GraphRef="c42c7" RelX="0.5" RelY="-1.0"/>
      <Point X="919.1666666666669" Y="772.102150537635" GraphRef="cd6ac" RelX="0.5" RelY="1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.4" Shape="None" GraphId="fd1c9"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id6be9dd02">
    <Graphics ZOrder="12574" LineThickness="1.0">
      <Point X="874.1666666666669" Y="772.102150537635" GraphRef="cd6ac" RelX="-0.5" RelY="1.0"/>
      <Point X="876.1666666666667" Y="844.7688172043024" GraphRef="c42c7" RelX="-0.5" RelY="-1.0" ArrowHead="mim-conversion"/>
      <Anchor Position="0.43807339449541033" Shape="None" GraphId="ab27c"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="id3bedb29e">
    <Comment>PTEN catalyzes the conversion of PIP3 to PIP2</Comment>
    <BiopaxRef>f3c</BiopaxRef>
    <Graphics ZOrder="12576" LineThickness="1.0">
      <Point X="1062.666666666668" Y="814.9354838709687" GraphRef="b8ad4" RelX="-1.0" RelY="0.0"/>
      <Point X="920.3666666666668" Y="815.7021505376355" GraphRef="fd1c9" RelX="0.0" RelY="0.0" ArrowHead="mim-catalysis"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="afd25">
    <Graphics ZOrder="33066" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2290.4950076804885" GraphRef="a8263" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2290.9116743471545" GraphRef="c167f" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="a003b">
    <Graphics ZOrder="33068" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2361.534223366764" GraphRef="f473b" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2362.2008900334295" GraphRef="ee5c2" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ef326">
    <Graphics ZOrder="33072" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2428.161674347158" GraphRef="fe57b" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2428.161674347157" GraphRef="bb595" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="cc7db">
    <Graphics ZOrder="33074" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2464.161674347159" GraphRef="e5fba" RelX="1.0" RelY="-0.5"/>
      <Point X="2059.1408860663387" Y="2464.8283410138247" GraphRef="ceef6" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="adaa2">
    <Graphics ZOrder="33082" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2328.447388632877" GraphRef="eba48" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2328.4473886328765" GraphRef="f052f" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="eb86f">
    <Graphics ZOrder="33098" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2280.706492274326" GraphRef="a327a" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2280.706492274326" GraphRef="e8fca" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="e34cc">
    <Graphics ZOrder="33100" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2323.3731589409913" GraphRef="fd84a" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2324.706492274324" GraphRef="a14d7" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="f7d8b">
    <Graphics ZOrder="33102" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2364.039825607655" GraphRef="a279d" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2365.3731589409845" GraphRef="d7a44" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ead8e">
    <Graphics ZOrder="33104" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2443.0398256076624" GraphRef="c82be" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2442.7064922743166" GraphRef="e91f9" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="f0e5f">
    <Graphics ZOrder="33106" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2521.373158941005" GraphRef="c8c69" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2522.373158941005" GraphRef="f0e0d" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="ec331">
    <Graphics ZOrder="33108" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2561.373158941005" GraphRef="d08d6" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2564.373158941005" GraphRef="f0c60" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="a315b">
    <Graphics ZOrder="33110" LineThickness="1.0">
      <Point X="1026.0476190476204" Y="2602.373158941006" GraphRef="bc2be" RelX="1.0" RelY="-0.5"/>
      <Point X="1092.1904761904793" Y="2604.123158941006" GraphRef="ccf74" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="bcb11">
    <Graphics ZOrder="33112" LineThickness="1.0">
      <Point X="1986.9999999999966" Y="2250.9655959157867" GraphRef="cd7a0" RelX="1.0" RelY="-0.5"/>
      <Point X="2061.1408860663387" Y="2251.7155959157867" GraphRef="dc475" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="b2605">
    <Graphics ZOrder="33124" LineThickness="1.0">
      <Point X="1987.6666666666665" Y="2669.8759600614467" GraphRef="d055a" RelX="1.0" RelY="-0.5"/>
      <Point X="2056.75" Y="2669.8759600614467" GraphRef="cd09d" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="f224d">
    <Graphics ZOrder="33126" LineThickness="1.0">
      <Point X="1987.6666666666665" Y="2703.8759600614467" GraphRef="d27f0" RelX="1.0" RelY="-0.5"/>
      <Point X="2056.75" Y="2703.8759600614467" GraphRef="a70a9" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="c623c">
    <Graphics ZOrder="33128" LineThickness="1.0">
      <Point X="1987.6666666666665" Y="2737.8759600614467" GraphRef="fc054" RelX="1.0" RelY="-0.5"/>
      <Point X="2056.75" Y="2738.8759600614467" GraphRef="e3430" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="c1c7d">
    <Graphics ZOrder="33130" LineThickness="1.0">
      <Point X="1987.6666666666665" Y="2772.8759600614467" GraphRef="d9f72" RelX="1.0" RelY="-0.5"/>
      <Point X="2056.75" Y="2773.8759600614467" GraphRef="a0794" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="f40bf">
    <Graphics ZOrder="33398" LineThickness="1.0" Color="ff0000">
      <Point X="1005.3333333333278" Y="2680.6021505376357" GraphRef="b7d58" RelX="0.0" RelY="1.0"/>
      <Point X="791.5960144927587" Y="2823.8267882187884" GraphRef="f07bf" RelX="0.5" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="d5364">
    <Graphics ZOrder="33399" LineThickness="1.0" Color="ff0000">
      <Point X="1005.3333333333278" Y="2680.6021505376357" GraphRef="b7d58" RelX="0.0" RelY="1.0"/>
      <Point X="985.9166666666711" Y="2910.660121552119" GraphRef="e2d51" RelX="0.0" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="efc20">
    <Graphics ZOrder="33400" LineThickness="1.0" Color="ff0000">
      <Point X="1005.3333333333278" Y="2680.6021505376357" GraphRef="b7d58" RelX="0.0" RelY="1.0"/>
      <Point X="763.565217391309" Y="2773.199976624585" GraphRef="ceb77" RelX="1.0" RelY="-0.5" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="a2f32">
    <Graphics ZOrder="33401" LineThickness="1.0" Color="ff0000">
      <Point X="1005.3333333333278" Y="2680.6021505376357" GraphRef="b7d58" RelX="0.0" RelY="1.0"/>
      <Point X="867.2210144927581" Y="2874.007947639078" GraphRef="e7bbc" RelX="0.0" RelY="-1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="cdea0">
    <Graphics ZOrder="33402" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="822.0215053763454" Y="252.08064516129008" GraphRef="b1576" RelX="0.0" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="db462">
    <Graphics ZOrder="33403" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="908.0215053763452" Y="198.1639784946222" GraphRef="b5fdb" RelX="0.0" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="b96bb">
    <Graphics ZOrder="33404" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="1021.7715053763459" Y="191.49731182794858" GraphRef="c9c06" RelX="-0.5" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="d56ea">
    <Graphics ZOrder="33405" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="1061.521505376346" Y="224.58064516128917" GraphRef="df32e" RelX="-1.0" RelY="0.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="c1ff4">
    <Graphics ZOrder="33406" LineThickness="1.0" Color="ff3333">
      <Point X="969.7450980392151" Y="365.3080328905759" GraphRef="f20f2" RelX="0.0" RelY="-1.0"/>
      <Point X="1091.9999999999807" Y="269.7056451612875" GraphRef="f31d0" RelX="-1.0" RelY="0.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="f395a">
    <Graphics ZOrder="33417" LineThickness="1.0">
      <Point X="1491.6666666666665" Y="2399.7500000000014" GraphRef="e2467" RelX="1.0" RelY="-0.5"/>
      <Point X="1560.75" Y="2399.5000000000014" GraphRef="c13a6" RelX="-1.0" RelY="-0.5" ArrowHead="mim-transcription-translation"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <Interaction GraphId="c0548">
    <Graphics ZOrder="33453" LineThickness="1.0" Color="ff3300">
      <Point X="4515.681159420346" Y="2118.935483870968" GraphRef="b23f7" RelX="0.0" RelY="-1.0"/>
      <Point X="4435.67391304347" Y="2021.9354838709687" GraphRef="ab818" RelX="0.0" RelY="1.0" ArrowHead="Arrow"/>
    </Graphics>
    <Xref Database="" ID=""/>
  </Interaction>
  <GraphicalLine GraphId="a2e75">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="381.3333333333336" Y="2613.333333333334"/>
      <Point X="381.3333333333336" Y="2588.0000000000005" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a641b">
    <Comment>Loss of FMRP may be linked to impaired NMDAR LTP</Comment>
    <BiopaxRef>b0a</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff0000">
      <Point X="3346.3478260869524" Y="538.6666666666666"/>
      <Point X="3346.3478260869524" Y="568.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ab13b">
    <Comment>FXS: disrupted scaffolding of mGluR with Homer, leads to abnormal mGluR activity</Comment>
    <BiopaxRef>e61</BiopaxRef>
    <Graphics ZOrder="12288" LineStyle="Broken" LineThickness="1.0" Color="ff3333">
      <Point X="890.0" Y="566.0"/>
      <Point X="896.6666666666666" Y="538.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="acbe2">
    <Comment> Hypofunction in the hippocampal dentate gyrus may partly contribute to cognitive impairments in FXS. </Comment>
    <BiopaxRef>b4e</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="3433.33333333333" Y="410.66666666666686"/>
      <Point X="3433.33333333333" Y="441.33333333333354" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b3362">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="2162.0" Y="2345.3333333333276"/>
      <Point X="2162.0" Y="2319.3333333333276" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="be809">
    <Comment>In FMR1 KO, AKT activation is increased</Comment>
    <BiopaxRef>b94</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="844.0" Y="983.0"/>
      <Point X="844.0" Y="959.0" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c83a0">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff0000">
      <Point X="1659.9999389648438" Y="2553.0"/>
      <Point X="1659.9999389648438" Y="2528.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cac17">
    <Comment>Elevated activity of ERK in FMR1 KO mouse model</Comment>
    <BiopaxRef>cd6</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="1872.463768115939" Y="1546.6666666666667"/>
      <Point X="1872.463768115939" Y="1522.6666666666667" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ccb10">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="107.23908918406869" Y="388.5971435098072"/>
      <Point X="107.23908918406869" Y="359.1853788039248" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dac41">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="364.0" Y="702.9354838709677"/>
      <Point X="364.0" Y="676.9354838709675" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e1d58">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff0000">
      <Point X="2167.0" Y="2553.0"/>
      <Point X="2167.0" Y="2525.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e6fbe">
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="1659.9999389648447" Y="2593.333333333328"/>
      <Point X="1659.9999389648447" Y="2569.333333333328" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e7a20">
    <Comment>Reduced insertion of AMPAR into the synaptic membrane leads to impaired synaptic plasticity in FXS and contributes to enhanced mGluR-LTD in FXS</Comment>
    <BiopaxRef>bbc</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff0000">
      <Point X="4942.347826086952" Y="636.0"/>
      <Point X="4942.347826086952" Y="663.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f3426">
    <Comment>Exaggerated mGluR signalling in FXS results in overactivation of TrkB signalling as a compensatory mechanism in order to physically alter the shape of dendrites to prepare in advance for low postsynaptic activity. Activation of  TrkB receptors by  BDNF initiates intracellular cascades that locally initate the ramification of dendrites and formation of spines. </Comment>
    <BiopaxRef>a67</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3300">
      <Point X="1642.0" Y="482.0"/>
      <Point X="1642.0" Y="450.0" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f72ef">
    <Comment>Loss of FMRP: increase in synthesis of CAMKIIÎ± which hyperphosphorylates Homer and thus leads to Homer dissocation from mGluR</Comment>
    <BiopaxRef>e61</BiopaxRef>
    <Graphics ZOrder="12288" LineThickness="1.0" Color="ff3333">
      <Point X="770.9999999999998" Y="677.6666666666669"/>
      <Point X="770.9999999999998" Y="648.6666666666669" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c5d4c">
    <Graphics ZOrder="12398" LineThickness="1.0" Color="ff0000">
      <Point X="2164.8095238095216" Y="2381.0783410138215"/>
      <Point X="2164.8095238095216" Y="2357.0783410138215" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fe217">
    <Graphics ZOrder="12430" LineThickness="1.0" Color="ff0000">
      <Point X="2158.6666870117233" Y="2653.2688172043095"/>
      <Point X="2158.6666870117233" Y="2629.268817204309" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ce2bf">
    <Comment>FMRP loss: enhaced phosphorylation of 4E-BP leading to enhanced inhibition of 4E-BP binding to the eIF4F complex. This leads to elevated levels of eIF4F complex. </Comment>
    <Graphics ZOrder="12456" LineThickness="1.0" Color="ff0000">
      <Point X="2076.0" Y="2109.2688172043017"/>
      <Point X="2076.0" Y="2081.2688172043017" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id73807507">
    <Graphics ZOrder="12510" LineThickness="1.0">
      <Point X="1949.1304347826074" Y="1505.602150537635" GraphRef="df3b8" RelX="1.0" RelY="0.0"/>
      <Point X="1956.2509798701467" Y="1507.1021505376357" GraphRef="d31e3" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id9bb18ccb">
    <Graphics ZOrder="12518" LineThickness="1.0">
      <Point X="2058.247652274651" Y="947.2688172043031" GraphRef="f4e23" RelX="-1.0" RelY="0.0"/>
      <Point X="2045.8804347826072" Y="946.018817204302" GraphRef="ba06e" RelX="1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id77db778b">
    <Graphics ZOrder="12526" LineThickness="1.0">
      <Point X="2044.8804347826072" Y="732.6854838709687" GraphRef="b2983" RelX="1.0" RelY="0.0"/>
      <Point X="2053.414318941319" Y="733.3521505376361" GraphRef="d2fce" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id3d64e7b2">
    <Graphics ZOrder="12530" LineThickness="1.0">
      <Point X="2215.797101449276" Y="1326.3267882187947" GraphRef="e4f56" RelX="1.0" RelY="0.0"/>
      <Point X="2225.27744510069" Y="1325.1021505376366" GraphRef="d060a" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id53fa0c1c">
    <Graphics ZOrder="12534" LineThickness="1.0" Color="0033ff">
      <Point X="1465.3392244362844" Y="2043.2271505376352" GraphRef="c4ec5" RelX="0.0" RelY="0.0"/>
      <Point X="1466.4166666666656" Y="2031.4909856313384" GraphRef="ffaab" RelX="0.0" RelY="1.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="idbe9863cf">
    <Graphics ZOrder="12548" LineThickness="1.0">
      <Point X="1028.75" Y="1563.3220384928177" GraphRef="b1f46" RelX="1.0" RelY="0.0"/>
      <Point X="1047.6361907761793" Y="1563.2225987169077" GraphRef="a50d5" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id13c43af6">
    <Graphics ZOrder="12550" LineThickness="1.0">
      <Point X="1949.4637681159404" Y="1722.268817204302" GraphRef="e1da2" RelX="1.0" RelY="0.0"/>
      <Point X="1967.3410779253936" Y="1723.7688172043029" GraphRef="ffee9" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id88f64253">
    <Graphics ZOrder="12556" LineThickness="1.0">
      <Point X="1027.1682316780866" Y="975.7037211887366" GraphRef="ca4d4" RelX="0.0" RelY="0.0"/>
      <Point X="1027.416666666666" Y="967.1838455699728" GraphRef="f2d94" RelX="0.0" RelY="1.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id811d4502">
    <Graphics ZOrder="12558" LineThickness="1.0">
      <Point X="994.6666666666677" Y="1140.2688172043022" GraphRef="f3077" RelX="-1.0" RelY="0.0"/>
      <Point X="985.3827825079562" Y="1140.102150537636" GraphRef="dd3c9" RelX="1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id4d3db901">
    <Graphics ZOrder="12564" LineThickness="1.0">
      <Point X="1250.666666666667" Y="1139.6021505376352" GraphRef="d6ade" RelX="1.0" RelY="0.0"/>
      <Point X="1257.2838841587113" Y="1139.685483870969" GraphRef="ba8eb" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="id35d504ad">
    <Graphics ZOrder="12568" LineThickness="1.0">
      <Point X="898.6666666666669" Y="940.768817204302" GraphRef="afcac" RelX="0.0" RelY="0.0"/>
      <Point X="919.7096213179007" Y="940.6021505376359" GraphRef="bb672" RelX="-1.0" RelY="0.0"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a58db">
    <Graphics ZOrder="33114" LineThickness="1.0" Color="ff3333">
      <Point X="107.23908918406005" Y="251.50980392156862"/>
      <Point X="107.23908918406005" Y="225.5098039215677" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dfca0">
    <Comment>FMRP negatively regulates the mTOR pathway through inhibition of PIKE and PI3K. In FXS, FMRP is lost, this leads to suppression of the negative feedback given to the mTOR pathway and leads to upregulation of PIKE and PI3K. Altogether, the mTOR signalling pathway is upregulated. </Comment>
    <Graphics ZOrder="33240" LineThickness="1.0" Color="ff3333">
      <Point X="494.1884057971016" Y="594.8485273492282"/>
      <Point X="494.1884057971016" Y="568.8485273492283" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a8078">
    <Comment>Upregulation of PI3K leads to overactivation of mTOR. </Comment>
    <Graphics ZOrder="33242" LineThickness="1.0" Color="ff3333">
      <Point X="590.9999999999998" Y="880.9354838709685"/>
      <Point X="590.9999999999998" Y="854.9354838709687" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d488e">
    <Comment>Increased activation of PIKE (PIKE is being de-repressed) which promotes enhanced activation of PI3K</Comment>
    <Graphics ZOrder="33244" LineThickness="1.0" Color="ff3333">
      <Point X="510.3333333333329" Y="774.9354838709692"/>
      <Point X="510.3333333333329" Y="748.9354838709692" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ccbe9">
    <Comment>Enhanced Group I mGluR activity has been reported in FMR1 KO animal models. Overactivation of GluR1/5 mediate most symptomes of FXS. 
</Comment>
    <Comment>FXS symptoms linked with Group I mGluR overactivation are illustrated in the above red box</Comment>
    <Graphics ZOrder="33260" LineThickness="1.0" Color="ff3333">
      <Point X="923.1075268817209" Y="398.7204301075264"/>
      <Point X="923.1075268817209" Y="372.72043010752657" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ab504">
    <Comment>Enhanced cap-mediated translation initiation in FXS leading to excessive protein synthesis. </Comment>
    <BiopaxRef>ba4</BiopaxRef>
    <Graphics ZOrder="33274" LineThickness="1.0" Color="ff3333">
      <Point X="1530.0" Y="2049.9354838709687"/>
      <Point X="1530.0" Y="2024.9354838709687" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d1727">
    <Comment>Loss of FMRP, leads to exaggerated mGluR-LTD which may lead to slowed net synaptic maturation, thereby contributing to developmental delay, dysmorphogenesis of dendritic spines and loss of motor coordination, which are the main features of FXS.  Increased mGluR-LTD leads to slow synaptic maturation, developmental delay, cognitive impairment, epilepsy, increased density of of long thin dendritic spines and loss of motor coordination. </Comment>
    <BiopaxRef>b17</BiopaxRef>
    <Graphics ZOrder="33276" LineThickness="1.0" Color="ff3333">
      <Point X="4446.014492753615" Y="2143.6021505376393"/>
      <Point X="4446.014492753615" Y="2118.6021505376393" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ca4d5">
    <Graphics ZOrder="33278" LineThickness="1.0" Color="ff3333">
      <Point X="4783.347826086948" Y="1117.9354838709678"/>
      <Point X="4783.347826086948" Y="1092.9354838709678" ArrowHead="mim-conversion"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="af50d">
    <Comment>Loss of FMRP enhances coupling between mGluR and endocannabinoid synthesis and release</Comment>
    <BiopaxRef>fa0</BiopaxRef>
    <Graphics ZOrder="33282" LineThickness="1.0" Color="ff3333">
      <Point X="366.5686274509791" Y="626.5237191650845"/>
      <Point X="366.5686274509791" Y="601.5237191650845" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c64de">
    <Graphics ZOrder="33286" LineThickness="1.0" Color="ff3333">
      <Point X="107.23835676218505" Y="268.1450138466025"/>
      <Point X="107.23835676218505" Y="294.1450138466025" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d90d6">
    <Comment>Loss of FMRP has as a consequence, reduced expression of GABA A receptors. GABA A receptor deficiency leads to the occurence of epileptic seizure in FXS. </Comment>
    <BiopaxRef>a8a</BiopaxRef>
    <Graphics ZOrder="33288" LineThickness="1.0" Color="ff3333">
      <Point X="1306.5938375350197" Y="2551.060133730908"/>
      <Point X="1307.117647058828" Y="2576.2506099213842" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d577d">
    <Graphics ZOrder="33296" LineThickness="1.0" Color="ff3333">
      <Point X="1197.9680084741444" Y="2274.060133730905"/>
      <Point X="1198.4918179979527" Y="2299.250609921381" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b36bd">
    <Graphics ZOrder="33298" LineThickness="1.0" Color="ff3333">
      <Point X="1197.968008474144" Y="2397.3934670642416"/>
      <Point X="1198.4918179979527" Y="2422.5839432547177" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ee42a">
    <Graphics ZOrder="33300" LineThickness="1.0" Color="ff3333">
      <Point X="1664.7981945219524" Y="2310.459293394782"/>
      <Point X="1664.7981945219524" Y="2284.459293394782" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fc5d0">
    <Comment>Loss of FMRP: Increased synthesis of SLC16A1 (a monocarboxylate transporter) may favor hepatic transport  of KB (terminal breakdown product of mitochondrial Î² oxidation). This may contribute to the elevation of the circulating levels of KB acetone and acetoacetate in FMR1 KO mouse. </Comment>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics ZOrder="33302" LineThickness="1.0" Color="ff3333">
      <Point X="2158.666684105289" Y="2686.4592933947806"/>
      <Point X="2158.666684105289" Y="2660.4592933947806" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eaaaa">
    <Comment>Overexpression of the transporters ABCD3 and ALDH3A2 may be responsible for increased peroxisomal Î² oxidation of lipids</Comment>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics ZOrder="33304" LineThickness="1.0" Color="ff3333">
      <Point X="2158.6666841052865" Y="2753.7926267281127"/>
      <Point X="2158.6666841052865" Y="2727.7926267281127" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d20ad">
    <Comment>Overexpression of the transporters ABCD3 and ALDH3A2 may be responsible for increased peroxisomal Î² oxidation of lipids</Comment>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics ZOrder="33306" LineThickness="1.0" Color="ff3333">
      <Point X="2158.6666841052875" Y="2719.792626728113"/>
      <Point X="2158.6666841052875" Y="2693.792626728113" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c9ccb">
    <Graphics ZOrder="33308" LineThickness="1.0" Color="ff3333">
      <Point X="2158.6666841052865" Y="2791.125960061446"/>
      <Point X="2158.6666841052865" Y="2765.125960061446" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bb1eb">
    <Comment>In FMR! KO mouse, PTEN activity is decreased</Comment>
    <BiopaxRef>cd6</BiopaxRef>
    <Graphics ZOrder="33324" LineThickness="1.0" Color="ff3333">
      <Point X="1049.0000000000005" Y="800.2688172043036"/>
      <Point X="1049.333333333334" Y="831.3333333333348" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f5cc8">
    <Comment>Increased activation of mTOR due to upregulation of PIKE and PI3K (negative feedback from experted on PIKE and PI3K by FMRP is abolished)</Comment>
    <Graphics ZOrder="33326" LineThickness="1.0" Color="ff3333">
      <Point X="1159.0" Y="1230.9354838709687"/>
      <Point X="1159.0" Y="1204.9354838709687" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cdb98">
    <Comment>FMRP loss: abnormal increase in microtubule stability leading to impaied synaptic maturation, abnormalities in spine maturation and synapse formation and abnormal mGluR-LTD. </Comment>
    <Graphics ZOrder="33328" LineThickness="1.0" Color="ff3333">
      <Point X="1659.999970935639" Y="2827.102150537644"/>
      <Point X="1659.999970935639" Y="2801.102150537644" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c62aa">
    <Comment>Loss of FMRP: Increased phosphorylation of PP2A</Comment>
    <Graphics ZOrder="33330" LineThickness="1.0" Color="ff3333">
      <Point X="938.9999999999997" Y="1294.9354838709692"/>
      <Point X="938.0" Y="1266.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a3e63">
    <Comment>Loss of FMRP: Invcreased phosphrylation of S6K1</Comment>
    <Graphics ZOrder="33332" LineThickness="1.0" Color="ff3333">
      <Point X="1301.0000000000002" Y="1292.9354838709694"/>
      <Point X="1301.0000000000002" Y="1266.9354838709694" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bfac6">
    <Graphics ZOrder="33352" LineThickness="1.0" Color="ff0000">
      <Point X="2162.142857142854" Y="2412.4116743471636"/>
      <Point X="2162.142857142854" Y="2388.4116743471636" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ef8c3">
    <Graphics ZOrder="33354" LineThickness="1.0" Color="ff0000">
      <Point X="2164.809523809521" Y="2442.4116743471623"/>
      <Point X="2164.809523809521" Y="2418.4116743471623" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cafb1">
    <Comment>FMRP loss and thus upregulation of de novo Shank synthesis leads to enlargment of dendritic spines and contributes to spine dysmorphogenesis observed in FXS.  </Comment>
    <BiopaxRef>f78</BiopaxRef>
    <Graphics ZOrder="33356" LineThickness="1.0" Color="ff0000">
      <Point X="2164.80952380952" Y="2476.4116743471536"/>
      <Point X="2164.80952380952" Y="2452.4116743471536" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f3a8b">
    <Comment>Loss of FMRP leads to upregulation of APP and its metabolites, which is linked to impaired synaptic function, neuronal overgrowth and increase in brain volume (which can be associated with macrocephaly as a symptome of FXS). APP dysregulation is also linked to hyperactivity. </Comment>
    <BiopaxRef>fb0</BiopaxRef>
    <Graphics ZOrder="33358" LineThickness="1.0" Color="ff0000">
      <Point X="2166.142857142851" Y="2509.0783410138347"/>
      <Point X="2166.142857142851" Y="2485.0783410138347" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="dd059">
    <Comment>ARC </Comment>
    <Graphics ZOrder="33360" LineThickness="1.0" Color="ff0000">
      <Point X="2162.1428571428523" Y="2307.0783410138197"/>
      <Point X="2162.1428571428523" Y="2283.0783410138197" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c3c08">
    <Comment>STEP promotes LTD by stimulating synaptic weakening by dephosphorylation of ERK1/2 (inactivation of ERK1/2) and subunits of NDMA and AMPA receptors. Thus, loss of FMRP leads to overactivation of STEP protein synthesis and increase in LTD. </Comment>
    <BiopaxRef>cf2</BiopaxRef>
    <Graphics ZOrder="33362" LineThickness="1.0" Color="ff0000">
      <Point X="2160.8095238095184" Y="2267.578341013828"/>
      <Point X="2160.8095238095184" Y="2243.578341013828" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d4cef">
    <Graphics ZOrder="33364" LineThickness="1.0" Color="ff0000">
      <Point X="1664.7981974283855" Y="2453.93548387097"/>
      <Point X="1664.7981974283855" Y="2429.93548387097" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cfc6d">
    <Graphics ZOrder="33388" LineThickness="1.0" Color="ff3333">
      <Point X="364.0" Y="785.9354838709684"/>
      <Point X="364.0" Y="759.9354838709681" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e68a8">
    <Graphics ZOrder="33391" LineThickness="1.0" Color="ff3333">
      <Point X="1197.9680084741444" Y="2360.060133730905"/>
      <Point X="1198.4918179979527" Y="2385.250609921381" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="abce2">
    <Graphics ZOrder="33392" LineThickness="1.0" Color="ff3333">
      <Point X="1197.9680084741444" Y="2313.060133730905"/>
      <Point X="1198.4918179979527" Y="2338.250609921381" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c3be3">
    <Graphics ZOrder="33393" LineThickness="1.0" Color="ff3333">
      <Point X="1197.968008474144" Y="2435.3934670642416"/>
      <Point X="1198.4918179979527" Y="2460.5839432547177" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="a0dc8">
    <Graphics ZOrder="33409" LineThickness="1.0" Color="ff3333">
      <Point X="720.0000000000018" Y="2592.6666666666665"/>
      <Point X="720.0000000000018" Y="2567.333333333333" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ac5c2">
    <Graphics ZOrder="33410" LineThickness="1.0" Color="ff3333">
      <Point X="720.0000000000019" Y="2624.0000000000005"/>
      <Point X="720.0000000000019" Y="2598.666666666667" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="cf251">
    <Graphics ZOrder="33411" LineThickness="1.0" Color="ff3333">
      <Point X="720.000000000002" Y="2660.666666666668"/>
      <Point X="720.000000000002" Y="2635.3333333333344" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="fd251">
    <Graphics ZOrder="33412" LineThickness="1.0" Color="ff3333">
      <Point X="544.6666666666665" Y="2596.6666666666665"/>
      <Point X="544.6666666666665" Y="2571.333333333333" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b3fb8">
    <Graphics ZOrder="33413" LineThickness="1.0" Color="ff3333">
      <Point X="548.0" Y="2635.9999999999986"/>
      <Point X="548.0" Y="2610.666666666665" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f0137">
    <Graphics ZOrder="33414" LineThickness="1.0" Color="ff3333">
      <Point X="1659.9999389648451" Y="2681.333333333325"/>
      <Point X="1659.9999389648451" Y="2655.999999999992" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="bbbeb">
    <Comment>VHR tempers and shortens ERK activation through its phosphatase activity. Loss of FMRP upregulates phosphatase activity of VHR</Comment>
    <BiopaxRef>f3d</BiopaxRef>
    <Graphics ZOrder="33419" LineThickness="1.0" Color="ff0000">
      <Point X="1851.0" Y="1452.0"/>
      <Point X="1851.0" Y="1427.0" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d74b2">
    <Graphics ZOrder="33422" LineThickness="1.0" Color="ff0000">
      <Point X="1776.904764811198" Y="2375.93548387097"/>
      <Point X="1776.904764811198" Y="2351.93548387097" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="decf4">
    <Comment>Decreased expression of GABA A-Î³ is associated with audiogenic seizures, hyperactivity and prepulse inhibition</Comment>
    <BiopaxRef>cd6</BiopaxRef>
    <Graphics ZOrder="33426" LineThickness="1.0" Color="ff3333">
      <Point X="1197.9679881290924" Y="2600.393467064242"/>
      <Point X="1198.491797652901" Y="2625.583943254718" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f4941">
    <Graphics ZOrder="33428" LineThickness="1.0" Color="ff0000">
      <Point X="1664.904764811198" Y="2271.93548387097"/>
      <Point X="1664.6666666666667" Y="2250.0000000000014" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="b5cde">
    <Graphics ZOrder="33430" LineThickness="1.0" Color="ff3300">
      <Point X="1659.9999389648438" Y="2716.6666666666674"/>
      <Point X="1659.9999389648438" Y="2690.6666666666674" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="da52d">
    <Graphics ZOrder="33432" LineThickness="1.0" Color="ff3300">
      <Point X="1659.9999389648456" Y="2785.333333333339"/>
      <Point X="1659.9999389648456" Y="2759.333333333339" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="f5bbb">
    <Graphics ZOrder="33434" LineThickness="1.0" Color="ff3300">
      <Point X="1659.9999389648428" Y="2751.3333333333344"/>
      <Point X="1659.9999389648428" Y="2725.3333333333344" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c41be">
    <Graphics ZOrder="33436" LineThickness="1.0" Color="ff3300">
      <Point X="1659.9999389648424" Y="2636.000000000002"/>
      <Point X="1659.9999389648424" Y="2610.000000000002" ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="d127d">
    <Graphics ZOrder="33456" LineThickness="1.0" Color="ff3333">
      <Point X="107.0" Y="402.0"/>
      <Point X="108.0" Y="434.0" ArrowHead="mim-stimulation"/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="P" GraphId="c8d84">
    <Graphics CenterX="1332.250000000001" CenterY="619.1021505376355" Width="46.5" Height="21.0" ZOrder="-84" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="Anterior cingulate &#10;cortex" GraphId="a510b">
    <Comment>Loss of FMRP in the anterior cingulate cortex leads to fear memory impairment and synaptic plasticity alterations. This may be responsible for certain types of mental disorders in FXS. </Comment>
    <BiopaxRef>d35</BiopaxRef>
    <Graphics CenterX="1172.4999999999798" CenterY="318.91666666666737" Width="128.99999999999818" Height="39.166666666666664" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff3333"/>
  </Label>
  <Label TextLabel="NMDAR&#10;internalization" GraphId="abbe7">
    <Graphics CenterX="3453.6811594202845" CenterY="894.8521505376355" Width="90.0" Height="28.5" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" Color="336600"/>
  </Label>
  <Label TextLabel="Other targets" GraphId="ad392">
    <Graphics CenterX="1518.6666666666665" CenterY="2511.999999999999" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="FXS:&#10;loss of FMRP&#10;&#10;" GraphId="b31b4">
    <Graphics CenterX="162.84693232131804" CenterY="176.59313725489937" Width="114.00000000000182" Height="54.5" ZOrder="28672" FillColor="ffffff" FontSize="14" Valign="Middle" Color="ff3333"/>
  </Label>
  <Label TextLabel="stalled&#10; polyribosomes" GraphId="b3674">
    <Graphics CenterX="806.0000000000005" CenterY="1828.2500000000002" Width="90.0" Height="44.49999999999997" ZOrder="28672" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="GABA A &#10;Receptor &#10;Subunits" GraphId="bb69e">
    <Graphics CenterX="1254.4166666666674" CenterY="2565.3010752688147" Width="102.5" Height="67.39784946237069" ZOrder="28672" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Defective &#10;cAMP &#10;production" GraphId="bdfcb">
    <Comment>Dysregulation in cAMP is believed to contribute to the neuropathophysiology of FXS</Comment>
    <BiopaxRef>a86</BiopaxRef>
    <Graphics CenterX="2580.0" CenterY="1308.25" Width="90.0" Height="44.5" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff3300"/>
  </Label>
  <Label TextLabel="NMDAR&#10;subunits" GraphId="e8408">
    <Graphics CenterX="1734.166666666666" CenterY="2366.6666666666683" Width="63.66666666666663" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="NMDA Receptor&#10;Pool&#10;" GraphId="f14f5">
    <Graphics CenterX="3408.347826086954" CenterY="1288.9354838709687" Width="90.0" Height="25.0" ZOrder="28672" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Basolateral &#10;Amygdala" GraphId="fc0e9">
    <Comment>Related FXS phenotypes: Anxiety, autism spectrum disorders, seizures</Comment>
    <Graphics CenterX="1129.6557971014474" CenterY="2920.7470780738595" Width="97.5" Height="35.0" ZOrder="28672" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="RISC Complex&#10;&#10;&#10;" GraphId="efb04">
    <Graphics CenterX="500.6666666666668" CenterY="2246.6021505376357" Width="90.0" Height="25.0" ZOrder="28674" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="GABAergic synapse components" GraphId="d00ba">
    <Comment>Target mRNA regulated are involved in GABA metabolism, GABA membrane transportes and GABA scaffolding protein. FMRP regulates the expression of GABA receptor subunits. GABAergic signalling is essential for the regulation of neuronal maturation and migration and for neuronal circuit formation. </Comment>
    <BiopaxRef>a46</BiopaxRef>
    <Graphics CenterX="1056.7142857142812" CenterY="2250.225399837348" Width="182.2156862745096" Height="18.91316526610626" ZOrder="28676" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Dysregulated metabolic &#10;homeostasis" GraphId="a733d">
    <Comment>FXS patients show metabolic anomalies. FXS patients have shown to have significant low levels of plasma cholesterol levels, reduced total choesterol, LDL and HDL. Furthermore, FMR1 Ko models have shown reduced circulating glucose, insulin levels and increased fatty acid levels in the circuitry system. </Comment>
    <BiopaxRef>c27</BiopaxRef>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics CenterX="2269.2463768115954" CenterY="2704.1778868630204" Width="161.83333333333337" Height="29.73118279569713" ZOrder="28678" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="Rectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="TSC complex " GraphId="f6f70">
    <Comment>The TSC1 complex is a negative regulator of mTORC1, when phosphorylated, its inhibitory activity is repressed</Comment>
    <Graphics CenterX="1131.3333333333348" CenterY="909.2688172043015" Width="90.0" Height="25.0" ZOrder="28680" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="PKA" GraphId="cf14b">
    <Graphics CenterX="2325.3768115941984" CenterY="1431.9354838709692" Width="90.0" Height="25.0" ZOrder="28682" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="eIF4F complex" GraphId="f796b">
    <Graphics CenterX="1140.6666666666658" CenterY="1989.9354838709705" Width="90.0" Height="25.0" ZOrder="28684" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="mGluR-LTD&#10;&#10;" GraphId="b23f7">
    <Comment>Upon activation of Group I mGluR, there is rapid translation of proteins which mediate postsynaptic internalization of AMPAR eventually leading to mGluR-dependant LTD. As a consequence, LTD lowers the postsynaptic receptor densisty, thereby allowing the formation of new connection via LTP. LTD mechanisms are essential  for activity-guided synapse elimination. AN important feature of mGluR-LTD is that it is irreversible in contrast to NMDAR-LTD. </Comment>
    <BiopaxRef>f04</BiopaxRef>
    <Graphics CenterX="4515.681159420346" CenterY="2132.6413662239092" Width="102.3333333333344" Height="27.411764705882888" ZOrder="28686" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="14" Valign="Middle" ShapeType="Rectangle" Color="ff6600"/>
  </Label>
  <Label TextLabel="Receptor subunits" GraphId="b58de">
    <Comment/>
    <Graphics CenterX="1518.3809523809539" CenterY="2231.459293394777" Width="150.71428571428578" Height="25.0" ZOrder="28688" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Hippocampus CA1" GraphId="bb8b9">
    <Comment>Exaggerated mGluR-LTD in CA1 neurons leads to cognitive impairment and developmental delay.  </Comment>
    <BiopaxRef>fda</BiopaxRef>
    <Graphics CenterX="4573.67391304347" CenterY="2011.6854838709687" Width="117.0" Height="20.5" ZOrder="28690" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="AMPA Receptor" GraphId="b6391">
    <Graphics CenterX="5067.181159420285" CenterY="528.6021505376343" Width="103.0" Height="25.0" ZOrder="28694" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Enteric innervation &#10;of the ileum" GraphId="b1576">
    <Comment>mGluR is expressed in the enteric innervation of the ileum, overactivation of mGluR may affect intesinal mobility, since fragile x patients often complain about loose bowels. </Comment>
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="822.0215053763453" CenterY="236.74731182794926" Width="128.99999999999827" Height="30.666666666681657" ZOrder="28696" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="upregulation" GraphId="ba056">
    <Graphics CenterX="177.00379506642048" CenterY="238.1450144075866" Width="90.0" Height="25.0" ZOrder="28698" FillColor="ffffff" FontSize="12" Valign="Middle" Color="ff3333"/>
  </Label>
  <Label TextLabel="TrkB Receptor&#10;" GraphId="e8658">
    <Graphics CenterX="1557.3333333333335" CenterY="531.053130929791" Width="90.0" Height="25.0" ZOrder="28702" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="LTD proteins" GraphId="fa316">
    <Comment>LTD proteins refers to proteins in dendrites that induce LTD at locally active synapses</Comment>
    <Graphics CenterX="2013.701680672266" CenterY="2224.2485090810496" Width="109.0" Height="22.5" ZOrder="28704" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="1" GraphId="c1ef2">
    <Comment>Hypothesis 1: Repression of translation via FMRP is mediated through the RNA interference (RNAi) pathway. FMRP associates with Argonaute 2 and Dicer, components of the RNA-induced silencing complex (RISC), and to specific miRNAs. The KH domains of teh FMRP protein help the miRNA associate on their target mRNA, thus miRNA-RISC comple</Comment>
    <BiopaxRef>c6a</BiopaxRef>
    <Graphics CenterX="456.6666666666672" CenterY="1607.9354838709687" Width="90.0" Height="25.0" ZOrder="28708" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="24" Valign="Middle"/>
  </Label>
  <Label TextLabel="Clathrin&#10;" GraphId="ad70c">
    <Graphics CenterX="4505.014492753615" CenterY="1269.268817204302" Width="90.0" Height="25.0" ZOrder="28710" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="NMDA&#10; Receptor&#10;" GraphId="a3594">
    <Graphics CenterX="3395.5144927536257" CenterY="434.6021505376342" Width="107.0" Height="25.0" ZOrder="28712" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="AMPAR &#10;internalization" GraphId="ca6bc">
    <Comment>AMPA internalization is either mediated via te NMDAR pathway or through rapid translation of 'LTD proteins' mediated by mGluR activation. The proteins involved in AMPAR endocytosis and thus LTD, are referred to as 'LTD proteins'. AMPAR endocytosis is triggered by de novo synthesis of LTD proteins. </Comment>
    <Graphics CenterX="4729.622019635333" CenterY="1121.6854838709644" Width="93.66666666666697" Height="34.499999999999886" ZOrder="28714" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" Color="ff6600"/>
  </Label>
  <Label TextLabel="AMPA Receptor &#10;Pool" GraphId="b536f">
    <Graphics CenterX="4762.514492753615" CenterY="2075.01881720431" Width="133.0" Height="100.5" ZOrder="28716" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Dysregulation of GABAergic &#10;synaptic transmission&#10;" GraphId="b7d58">
    <Graphics CenterX="1005.3333333333278" CenterY="2665.6854838709687" Width="161.83333333333337" Height="29.833333333334053" ZOrder="28718" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="Rectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="deletion" GraphId="e68fd">
    <Graphics CenterX="168.66856419987425" CenterY="327.4783477409167" Width="56.003795066420025" Height="21.16666666666667" ZOrder="28720" FillColor="ffffff" FontSize="12" Valign="Middle" Color="ff3333"/>
  </Label>
  <Label TextLabel="release of Ca2+" GraphId="ae4e6">
    <Graphics CenterX="2799.710144927536" CenterY="1151.1021505376355" Width="92.0" Height="27.0" ZOrder="28722" FillColor="ffffff" FontSize="10" Valign="Middle" ShapeType="Rectangle"/>
  </Label>
  <Label TextLabel="Lipid and glucose metabolsim" GraphId="aa058">
    <Comment>FMRP contols hepatic/lipid metabolism of key enzymes and transporters through direct translational regulation or through compensatory/adaptive mechanisms. </Comment>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics CenterX="2019.8809523809534" CenterY="2606.102150537638" Width="158.0" Height="25.0" ZOrder="28724" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="AP-2" GraphId="ce004">
    <Graphics CenterX="4524.347826086948" CenterY="913.9354838709685" Width="90.0" Height="25.0" ZOrder="28726" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Group I mGluR" GraphId="f0c38">
    <Comment>Group I metabotrobic glutamate receptors 1 and 5 are synaptic receptors involved in synaptic plasticity</Comment>
    <BiopaxRef>a34</BiopaxRef>
    <Graphics CenterX="970.6666666666663" CenterY="386.0188172043013" Width="102.66666666666742" Height="32.16666666666657" ZOrder="28728" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="mTORC1" GraphId="fcc4b">
    <Comment>mTORC1 complex directly regulates protein synthesis in mammals</Comment>
    <BiopaxRef>e4b</BiopaxRef>
    <Graphics CenterX="1201.6666666666645" CenterY="1222.0188172043017" Width="90.0" Height="22.500000000000455" ZOrder="28730" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="GDP" GraphId="d48e9">
    <Graphics CenterX="1268.0000000000014" CenterY="1140.9354838709678" Width="31.5" Height="18.5" ZOrder="28732" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="GTP" GraphId="c333a">
    <Graphics CenterX="972.2500000000003" CenterY="1141.7688172043022" Width="31.5" Height="18.5" ZOrder="33028" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P at Ser500&#10;" GraphId="bdbf8">
    <Graphics CenterX="1082.8739495798316" CenterY="1561.6203578205493" Width="55.999999999999986" Height="21.0" ZOrder="33032" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="GDP" GraphId="ce6b0">
    <Graphics CenterX="2065.7971014492737" CenterY="732.9354838709687" Width="31.5" Height="18.5" ZOrder="33040" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="GTP" GraphId="e73cb">
    <Graphics CenterX="2070.380434782607" CenterY="947.1021505376355" Width="31.5" Height="18.5" ZOrder="33042" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="e0f68">
    <Graphics CenterX="1966.047101449273" CenterY="1509.018817204302" Width="46.5" Height="20.833333333334398" ZOrder="33052" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="b2f3f">
    <Graphics CenterX="2230.2137681159393" CenterY="1300.1601215521277" Width="46.5" Height="21.0" ZOrder="33054" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="c84b3">
    <Graphics CenterX="2233.713768115942" CenterY="1329.1633941093983" Width="46.5" Height="21.673211781203463" ZOrder="33056" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="d952f">
    <Graphics CenterX="1342.9166666666683" CenterY="1266.1021505376366" Width="46.5" Height="21.0" ZOrder="33060" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="efd50">
    <Graphics CenterX="1273.4166666666683" CenterY="1616.4354838709748" Width="46.5" Height="21.0" ZOrder="33064" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="dbd58">
    <Graphics CenterX="699.250000000001" CenterY="1307.1021505376361" Width="46.5" Height="21.0" ZOrder="33140" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="fd06d">
    <Graphics CenterX="1973.5471014492773" CenterY="1725.4354838709687" Width="46.5" Height="21.0" ZOrder="33146" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="AMPA Receptor" GraphId="cfe33">
    <Graphics CenterX="4884.396845694789" CenterY="1981.2688172043097" Width="103.0" Height="25.0" ZOrder="33156" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="d610e">
    <Graphics CenterX="1027.916666666667" CenterY="960.4354838709685" Width="46.5" Height="21.0" ZOrder="33158" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="2&#10;" GraphId="d1ec4">
    <Comment>Hypothesis 2: FMRP inhibits translation of target mRNA through binding to the coding sequence that are associated with actively translating ribosomes, thereby acting as a steric block for ribosome elongation and thus, translation. </Comment>
    <BiopaxRef>c6a</BiopaxRef>
    <Graphics CenterX="789.9999999999998" CenterY="1611.9354838709671" Width="90.0" Height="25.0" ZOrder="33180" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="24" Valign="Middle"/>
  </Label>
  <Label TextLabel="3&#10;&#10;" GraphId="cf6dc">
    <Comment>Hypothesis 3: FMRP inhibits cap-dependant translation. Cap-dependent translation requires eIF4F complex (comosed of eIFG-eIF4F-eIF4E) for translational initiation and are inhibited when 4E-binding proteins (4E-BP) interfer with the complex.  FMRP inhibits this type of translation by recruiting and binding cytoplasmic FMRP-interacting protein (CYFIP1) to target mRNAs and subsequently associates with eIF4E, thereby forming a FMRP/CYFIP1/eIF4E complex, blocking the recruitment of the translation initation machinery.</Comment>
    <BiopaxRef>c6a</BiopaxRef>
    <Graphics CenterX="1089.2222222222233" CenterY="1613.2132616487486" Width="61.55555555555473" Height="27.888888888889603" ZOrder="33182" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="24" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="b7b7b">
    <Graphics CenterX="1465.3333333333344" CenterY="2022.6021505376375" Width="20.666666666666956" Height="22.66666666666967" ZOrder="33184" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P at Thr308" GraphId="e211e">
    <Graphics CenterX="950.4999999999995" CenterY="941.102150537636" Width="53.0" Height="21.0" ZOrder="33186" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="a4e55">
    <Graphics CenterX="2251.3804347826085" CenterY="1629.7688172043024" Width="32.83333333333442" Height="21.0" ZOrder="33238" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="mGluR-LTP&#10;" GraphId="d0e6c">
    <Comment/>
    <Graphics CenterX="4997.014492753618" CenterY="647.8521505376348" Width="89.3333333333303" Height="31.16666666666697" ZOrder="33250" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="14" Valign="Middle" ShapeType="Rectangle" Color="ffcc66"/>
  </Label>
  <Label TextLabel="AMPA Receptor" GraphId="e5965">
    <Graphics CenterX="4667.181159420285" CenterY="520.6021505376343" Width="103.0" Height="25.0" ZOrder="33252" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="AMPAR &#10;exocytosis" GraphId="c8e17">
    <Comment>AMPAR exosytosis mediates the increase in synaptic strength during LTP. </Comment>
    <BiopaxRef>b64</BiopaxRef>
    <Graphics CenterX="5147.347826086948" CenterY="1123.2688172043008" Width="108.0" Height="25.0" ZOrder="33258" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" Color="ffcc66"/>
  </Label>
  <Label TextLabel="downregulation" GraphId="c0712">
    <Graphics CenterX="187.67046173308836" CenterY="282.84313725490165" Width="90.0" Height="25.0" ZOrder="33290" FillColor="ffffff" FontSize="12" Valign="Middle" Color="ff3333"/>
  </Label>
  <Label TextLabel="NMDAR&#10;LTD&#10;&#10;" GraphId="f4a71">
    <Comment>NMDA-LTD is revesible and induced upon the activation of NMDA receptors. NMDAR-LTD is essential for working and space memory. </Comment>
    <BiopaxRef>d25</BiopaxRef>
    <Graphics CenterX="3468.014492753627" CenterY="1202.6666666666665" Width="115.33333333334963" Height="29.333333333333016" ZOrder="33310" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="14" Valign="Middle" Color="336600"/>
  </Label>
  <Label TextLabel="PKA" GraphId="e6721">
    <Graphics CenterX="4151.347826086945" CenterY="235.93548387096803" Width="90.0" Height="25.0" ZOrder="33312" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Cerebellar cortex" GraphId="ab818">
    <Comment>Exaggerated LTD in the cerebellar cortex leads to loss of motor coordination. </Comment>
    <BiopaxRef>f14</BiopaxRef>
    <Graphics CenterX="4435.67391304347" CenterY="2011.6854838709687" Width="117.0" Height="20.5" ZOrder="33334" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Amygdala" GraphId="b5f0c">
    <Comment>Fear memory formation and LTP are dependant on mGluR5. FMR1 KO mouse show abnormal contextual and conditional fear responses. mGluR-LTP and NMDA-LTP have been correlated with anxiety-like behaviors in FXS. </Comment>
    <BiopaxRef>fa6</BiopaxRef>
    <BiopaxRef>f83</BiopaxRef>
    <BiopaxRef>de2</BiopaxRef>
    <Graphics CenterX="4996.8478260869515" CenterY="751.6854838709714" Width="117.0" Height="20.5" ZOrder="33338" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Corticostriatal &#10;synapse" GraphId="df32e">
    <Comment>mGluR-dependant LTP in the corticostriatal synapse is linked to obsessive-compulsive behaviours in FXS. </Comment>
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="1126.0215053763452" CenterY="224.58064516128917" Width="128.99999999999827" Height="34.833333333333115" ZOrder="33340" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Neocortical layer&#10;5 neurons" GraphId="b5fdb">
    <Comment>Heightened behavioral responses to sensory stimuli</Comment>
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="908.0215053763452" CenterY="179.08064516128962" Width="128.99999999999827" Height="38.16666666666517" ZOrder="33342" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Audiogenic seizures" GraphId="aab06">
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="751.2473118279572" CenterY="290.85483870967715" Width="128.99999999999827" Height="28.999999999998934" ZOrder="33344" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="C-fiber innervation" GraphId="f31d0">
    <Comment>mGluR overactivation in c-fiber innervation of the skin leads to heightened sensitivity to tactile irritation. </Comment>
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="1156.4999999999798" CenterY="269.7056451612875" Width="128.99999999999827" Height="28.750000000007333" ZOrder="33346" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Suprachiasmatic &#10;nucleus" GraphId="c9c06">
    <Comment>mGluR overactivation in the suprachiasmatic nucleus has shown to disrupt circadian rythm in Drosophila. </Comment>
    <BiopaxRef>f83</BiopaxRef>
    <Graphics CenterX="1054.0215053763454" CenterY="175.7473118279495" Width="128.99999999999824" Height="31.49999999999819" ZOrder="33348" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="P &#10;at Y1472" GraphId="aadef">
    <Graphics CenterX="2866.7934782608572" CenterY="476.26881720430197" Width="46.5" Height="21.0" ZOrder="33373" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="b9ab3">
    <Graphics CenterX="5075.097826086943" CenterY="630.935483870968" Width="46.5" Height="21.0" ZOrder="33374" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="AP-2" GraphId="b1364">
    <Graphics CenterX="3592.3478260869456" CenterY="675.9354838709673" Width="90.0" Height="25.0" ZOrder="33376" FillColor="ffffff" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="Clathrin&#10;" GraphId="bee6e">
    <Graphics CenterX="3652.3478260869433" CenterY="997.935483870968" Width="90.0" Height="25.0" ZOrder="33382" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle"/>
  </Label>
  <Label TextLabel="overactivation" GraphId="ce168">
    <Graphics CenterX="186.33712839975442" CenterY="372.17647058823366" Width="90.0" Height="21.16666666666667" ZOrder="33389" FillColor="ffffff" FontSize="12" Valign="Middle" Color="ff3333"/>
  </Label>
  <Label TextLabel="Somatosensory&#10;Cortex" GraphId="f07bf">
    <Comment>Related FXS phenotype: Seizures, cognitive dysfunction, sensory hypersensitivity</Comment>
    <Graphics CenterX="767.2210144927587" CenterY="2840.0767882187884" Width="97.5" Height="32.5" ZOrder="33394" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Striatum" GraphId="e2d51">
    <Comment>Relatred FXS phenotypes: Frontostriatal dysfunction, involved in hyperactivity disorder and repetitive behaviour observed in FXS phenotype </Comment>
    <Graphics CenterX="985.9166666666711" CenterY="2923.160121552119" Width="97.5" Height="25.0" ZOrder="33395" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Subiculum " GraphId="ceb77">
    <Comment>Related FXS phenotypes: Seizures, cogniitve impairment</Comment>
    <Graphics CenterX="714.815217391309" CenterY="2779.449976624585" Width="97.5" Height="25.0" ZOrder="33396" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="Hippocampus &#10;CA1" GraphId="e7bbc">
    <Comment>Related FXS phenotypes: Seizures, cognitive impairment, circuit hyperplasticity</Comment>
    <Graphics CenterX="867.2210144927581" CenterY="2890.257947639078" Width="97.5" Height="32.5" ZOrder="33397" FillColor="ffffff" FontStyle="Italic" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ff0000"/>
  </Label>
  <Label TextLabel="NMDAR&#10;LTP&#10;&#10;" GraphId="c0b9d">
    <Comment>NMDA-LTD is revesible and induced upon the activation of NMDA receptors. NMDAR-LTD is essential for working and space memory. mGluR facilitates NMDAR-LTP. </Comment>
    <Graphics CenterX="3306.9654731457695" CenterY="557.7128399747008" Width="94.23529411763319" Height="43.907653383929755" ZOrder="33420" FillColor="ffffff" FontWeight="Bold" FontStyle="Italic" FontSize="14" Valign="Middle" Color="669900"/>
  </Label>
  <Label TextLabel="NMDAR&#10;intsertion" GraphId="a938f">
    <Graphics CenterX="3355.01449275362" CenterY="899.5188172043017" Width="90.0" Height="28.5" ZOrder="33421" FillColor="ffffff" FontSize="12" Valign="Middle" Color="669900"/>
  </Label>
  <Label TextLabel="P" GraphId="df0f7">
    <Graphics CenterX="1536.9166666666665" CenterY="1124.1021505376361" Width="46.5" Height="21.0" ZOrder="33441" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="ae97f">
    <Graphics CenterX="1857.3804347826108" CenterY="987.4354838709661" Width="46.5" Height="21.0" ZOrder="33442" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="b2591">
    <Graphics CenterX="2391.96014492754" CenterY="1019.102150537638" Width="32.83333333333442" Height="21.0" ZOrder="33447" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="P" GraphId="e8fb6">
    <Graphics CenterX="2409.6702898550748" CenterY="1164.6963534361878" Width="32.83333333333442" Height="21.0" ZOrder="33449" FillColor="ffffff" FontSize="10" Valign="Middle"/>
  </Label>
  <Label TextLabel="hypofunction" GraphId="cf939">
    <Graphics CenterX="186.33712839975442" CenterY="411.67647058823366" Width="90.0" Height="21.16666666666667" ZOrder="33457" FillColor="ffffff" FontSize="12" Valign="Middle" Color="ff3333"/>
  </Label>
  <Shape GraphId="fc9aa">
    <Graphics CenterX="4676.507246376809" CenterY="572.0" Width="182.98550724638153" Height="176.0" ZOrder="-92" FillColor="cccccc" FontSize="12" Valign="Middle" ShapeType="Oval" Color="cccccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="ea186">
    <Graphics CenterX="1063.9999999999986" CenterY="2433.3333333333317" Width="314.6666666666699" Height="415.9999999999965" ZOrder="-90" FillColor="ffcccc" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ffcccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="c7dbe">
    <Graphics CenterX="1781.0833333333323" CenterY="2519.0833333333335" Width="816.5000000000005" Height="655.1666666666658" ZOrder="-88" FillColor="ffcccc" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ffcccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="d8a83">
    <Graphics CenterX="1332.4166666666663" CenterY="616.7688172043022" Width="13.5" Height="14.0" ZOrder="-86" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.768856498101333"/>
  </Shape>
  <Shape GraphId="fe2fa">
    <Graphics CenterX="1548.5294117647045" CenterY="553.4648956356732" Width="128.82352941176202" Height="94.11764705882354" ZOrder="-74" FillColor="cccccc" FontSize="12" Valign="Middle" ShapeType="Oval" Color="cccccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="fccef">
    <Graphics CenterX="3392.151747655582" CenterY="465.9873497786198" Width="130.27450980392564" Height="109.30803289057292" ZOrder="-72" FillColor="cccccc" FontSize="12" Valign="Middle" ShapeType="Oval" Color="cccccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="f20f2">
    <Graphics CenterX="969.7450980392152" CenterY="431.4845034788111" Width="155.88235294117646" Height="132.35294117647055" ZOrder="-70" FillColor="cccccc" FontSize="12" Valign="Middle" ShapeType="Oval" Color="cccccc" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="e2fa1">
    <Graphics CenterX="3874.764492753619" CenterY="404.35215053763534" Width="101.83333333333303" Height="68.50000000000006" ZOrder="-50" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="b805b">
    <Graphics CenterX="332.6666666666648" CenterY="2597.93548387097" Width="118.66666666667041" Height="52.00000000000091" ZOrder="-40" FillColor="ccccff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ccccff" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="af92b">
    <Graphics CenterX="672.0833333333328" CenterY="2610.6854838709696" Width="111.83333333333496" Height="113.16666666666697" ZOrder="-38" FillColor="ccccff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ccccff" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="d7fe4">
    <Graphics CenterX="700.583333333333" CenterY="1305.6021505376357" Width="13.5" Height="14.0" ZOrder="-14" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.941101569565699"/>
  </Shape>
  <Shape GraphId="e358b">
    <Graphics CenterX="1342.75" CenterY="1266.7225987169077" Width="13.5" Height="14.0" ZOrder="-10" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="3.641873081814645"/>
  </Shape>
  <Shape GraphId="ba8eb">
    <Graphics CenterX="1269.2500000000002" CenterY="1139.685483870969" Width="33.16666666666664" Height="23.83333333333257" ZOrder="12562" FillColor="ffcc99" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="4.709403914624118"/>
  </Shape>
  <Shape GraphId="a8122">
    <Graphics CenterX="3406.3478260869542" CenterY="1278.6854838709687" Width="172.0" Height="66.5" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Oval" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="b107c">
    <Graphics CenterX="1214.280356654231" CenterY="2566.2217726673634" Width="112.44517916899443" Height="14.732871221901792" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Brace" Rotation="1.557493342189519"/>
  </Shape>
  <Shape GraphId="b921f">
    <Graphics CenterX="1059.750000000007" CenterY="2568.4166666666733" Width="261.83333333333314" Height="120.50000000000091" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="c44df">
    <Graphics CenterX="167.0" CenterY="302.08333333333326" Width="191.1666666666674" Height="327.8333333333335" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" LineStyle="Broken" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="da0ab">
    <Graphics CenterX="1676.8744991376711" CenterY="2366.7596533470733" Width="98.49433359426777" Height="24.49918115526316" ZOrder="16384" FontSize="12" Valign="Middle" ShapeType="Brace" Rotation="1.5676810720750818"/>
  </Shape>
  <Shape GraphId="a264b">
    <Comment/>
    <Graphics CenterX="967.5" CenterY="431.68548387096746" Width="104.0" Height="68.5" ZOrder="16386" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="b2f66">
    <Graphics CenterX="3702.34782608695" CenterY="1633.9354838709676" Width="112.0" Height="105.33333333333337" ZOrder="16388" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="a15ec">
    <Graphics CenterX="495.08333333333184" CenterY="2597.6854838709687" Width="112.49999999999999" Height="75.16666666666697" ZOrder="16390" FillColor="ccccff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Color="ccccff" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="a6afa">
    <Graphics CenterX="1746.5471014492753" CenterY="1314.410121552128" Width="98.5" Height="64.5" ZOrder="16392" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="c6afc">
    <Graphics CenterX="2320.46376811594" CenterY="425.6854838709676" Width="112.0" Height="72.5" ZOrder="16394" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="bdf59" GroupRef="bb884">
    <Graphics CenterX="493.083333333333" CenterY="2363.2688172042976" Width="103.16666666666674" Height="86.66666666666694" ZOrder="16398" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="ff607">
    <Graphics CenterX="4896.097826086948" CenterY="2075.01881720431" Width="444.5" Height="108.5" ZOrder="16400" FontSize="12" Valign="Middle" ShapeType="Oval" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="c4403">
    <Graphics CenterX="1551.083333333334" CenterY="824.6854838709687" Width="100.5" Height="87.83333333333339" ZOrder="16402" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="ce1d8">
    <Graphics CenterX="107.3671028696831" CenterY="328.8567712660545" Width="25.666666666666913" Height="25.66666666666667" ZOrder="16404" FontSize="12" Valign="Middle" ShapeType="mim-degradation" Color="ff0000" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="f2d94">
    <Graphics CenterX="1027.4166666666663" CenterY="957.7688172043022" Width="13.5" Height="14.0" ZOrder="33020" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.768856498101333"/>
  </Shape>
  <Shape GraphId="bb672">
    <Graphics CenterX="928.4166666666667" CenterY="940.6021505376358" Width="13.5" Height="14.0" ZOrder="33022" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.941101569565699"/>
  </Shape>
  <Shape GraphId="dd3c9">
    <Graphics CenterX="973.4166666666669" CenterY="1140.102150537636" Width="33.16666666666664" Height="23.83333333333257" ZOrder="33026" FillColor="ffcc00" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="4.709403914624118"/>
  </Shape>
  <Shape GraphId="a50d5">
    <Graphics CenterX="1056.9166666666656" CenterY="1563.2225987169077" Width="13.5" Height="14.0" ZOrder="33030" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="3.641873081814645"/>
  </Shape>
  <Shape GraphId="d2fce">
    <Graphics CenterX="2065.3804347826076" CenterY="733.3521505376358" Width="33.16666666666664" Height="23.83333333333257" ZOrder="33036" FillColor="ffcc99" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="4.709403914624118"/>
  </Shape>
  <Shape GraphId="f4e23">
    <Graphics CenterX="2070.2137681159406" CenterY="947.2688172043025" Width="33.16666666666664" Height="23.83333333333257" ZOrder="33038" FillColor="ffcc00" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="4.709403914624118"/>
  </Shape>
  <Shape GraphId="f02b3">
    <Graphics CenterX="2232.8804347826085" CenterY="1299.7688172043026" Width="13.5" Height="14.0" ZOrder="33044" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.20653607310564231"/>
  </Shape>
  <Shape GraphId="d060a">
    <Graphics CenterX="2234.880434782608" CenterY="1325.1021505376366" Width="13.5" Height="14.0" ZOrder="33046" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.6454415979488468"/>
  </Shape>
  <Shape GraphId="d31e3">
    <Graphics CenterX="1965.547101449275" CenterY="1507.1021505376357" Width="13.5" Height="14.0" ZOrder="33048" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.5057146137729001"/>
  </Shape>
  <Shape GraphId="ffee9">
    <Graphics CenterX="1976.547101449274" CenterY="1723.7688172043026" Width="13.5" Height="14.0" ZOrder="33050" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.4756151227398147"/>
  </Shape>
  <Shape GraphId="ffaab">
    <Graphics CenterX="1466.4166666666658" CenterY="2021.7688172043013" Width="13.5" Height="14.0" ZOrder="33058" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.7882799997999591"/>
  </Shape>
  <Shape GraphId="ab17f">
    <Graphics CenterX="1276.25" CenterY="1614.2688172043065" Width="13.5" Height="14.0" ZOrder="33062" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="4.426861556086591"/>
  </Shape>
  <Shape TextLabel="Influx Ca2+" GraphId="a88d2">
    <Graphics CenterX="3828.4311594202845" CenterY="979.1854838709692" Width="84.5" Height="22.166666666666515" ZOrder="33150" FillColor="ffffff" FontSize="12" Valign="Middle" ShapeType="RoundedRectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="b5a23">
    <Graphics CenterX="5073.26449275361" CenterY="631.2688172043011" Width="13.5" Height="14.0" ZOrder="33164" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.018689412446905664"/>
  </Shape>
  <Shape GraphId="ffca3">
    <Graphics CenterX="2170.213768115943" CenterY="1312.0767882187947" Width="98.5" Height="64.5" ZOrder="33226" FontSize="12" Valign="Middle" ShapeType="Rectangle" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="f3f22">
    <Graphics CenterX="2251.547101449273" CenterY="1625.7688172043013" Width="13.5" Height="14.0" ZOrder="33236" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.7882799997999591"/>
  </Shape>
  <Shape GraphId="bca46">
    <Comment>FMRP gene product is lost</Comment>
    <Graphics CenterX="1107.4999999999952" CenterY="1404.102150537634" Width="25.666666666666913" Height="25.66666666666667" ZOrder="33262" FontSize="12" Valign="Middle" ShapeType="mim-degradation" Color="ff0000" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="fe3f9">
    <Comment>With FMRP loss, there is loss of the translational repression activity of FMRP. This leads to overexpression of target mRNAs.</Comment>
    <Graphics CenterX="467.49999999999534" CenterY="1714.102150537634" Width="25.666666666666913" Height="25.66666666666667" ZOrder="33264" FontSize="12" Valign="Middle" ShapeType="mim-degradation" Color="ff0000" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="bd92a">
    <Comment>With FMRP loss, there is loss of the translational repression activity of FMRP. This leads to overexpression of target mRNAs.</Comment>
    <Graphics CenterX="1109.4999999999952" CenterY="1704.102150537634" Width="25.666666666666913" Height="25.66666666666667" ZOrder="33268" FontSize="12" Valign="Middle" ShapeType="mim-degradation" Color="ff0000" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="a8166">
    <Graphics CenterX="2865.71376811593" CenterY="469.60215053763534" Width="13.5" Height="14.0" ZOrder="33372" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.898949923113344"/>
  </Shape>
  <Shape GraphId="a4a58">
    <Comment>With FMRP loss, there is loss of the enhances protein expression by FMRP to GABAergic system components</Comment>
    <Graphics CenterX="806.205882352935" CenterY="1708.337444655281" Width="25.666666666666913" Height="25.66666666666667" ZOrder="33390" FontSize="12" Valign="Middle" ShapeType="mim-degradation" Color="ff0000" Rotation="0.0"/>
  </Shape>
  <Shape GraphId="f4d08">
    <Graphics CenterX="1534.9876585671711" CenterY="1122.8297612036642" Width="13.5" Height="9.545590334587839" ZOrder="33437" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.768856498101333"/>
  </Shape>
  <Shape GraphId="f5e1e">
    <Graphics CenterX="1855.8804347826144" CenterY="988.1021505376387" Width="13.5" Height="14.0" ZOrder="33440" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="5.768856498101333"/>
  </Shape>
  <Shape GraphId="b768c">
    <Graphics CenterX="2390.7934782608672" CenterY="1019.7688172043013" Width="13.5" Height="14.0" ZOrder="33443" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.7721177700472522"/>
  </Shape>
  <Shape GraphId="ff791">
    <Graphics CenterX="2408.155797101445" CenterY="1164.6963534361857" Width="13.5" Height="14.0" ZOrder="33446" FillColor="ffff00" FontSize="12" Valign="Middle" ShapeType="Oval" Color="ffff00" Rotation="0.7882799997999591"/>
  </Shape>
  <Group GroupId="abd19" GraphId="a7c50" Style="Complex"/>
  <Group GroupId="a4311" GraphId="ae386" Style="Complex"/>
  <Group GroupId="acd3f" GraphId="aeb05" Style="Complex"/>
  <Group GroupId="fbce9" GraphId="af3f1" Style="Complex"/>
  <Group GroupId="ceedf" GraphId="b129c" Style="Complex"/>
  <Group GroupId="eeb7e" GraphId="b7b69" Style="Complex"/>
  <Group GroupId="bb884" GraphId="b8279" Style="Complex"/>
  <Group GroupId="cf30a" GraphId="bf43f" Style="Complex"/>
  <Group GroupId="f9883" GraphId="c7984" Style="Complex">
    <Comment>Exact subunits which form</Comment>
  </Group>
  <Group GroupId="adc57" GraphId="cb9d3" Style="Complex"/>
  <Group GroupId="caa4b" GraphId="cd97a" Style="Complex"/>
  <Group GroupId="a806b" GraphId="d0da8" Style="Complex"/>
  <Group GroupId="f8b08" GraphId="d2136" Style="Complex"/>
  <Group GroupId="b28cc" GraphId="d33a7" Style="Complex"/>
  <Group GroupId="ee19f" GraphId="d8174" Style="Complex"/>
  <Group GroupId="e4320" GraphId="e42e2" Style="Complex">
    <Comment>Exact subunits which form </Comment>
  </Group>
  <Group GroupId="a4a6b" GraphId="e665d" Style="Complex"/>
  <Group GroupId="bc2f4" GraphId="f384c" Style="Complex"/>
  <Group GroupId="e75aa" GraphId="f466a" Style="Complex"/>
  <InfoBox CenterX="0.0" CenterY="0.0"/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a10">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">P54764 (EPHA4_HUMAN)</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProt</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">autism spectrum disorder</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:0060041</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23641197</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">FMRP: a triple threat to PSD-95.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Cell Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Westmark CJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f94">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20188650</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">LÃ¼scher C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a79">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9839441</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fyn, a Src family tyrosine kinase.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int J Biochem Cell Biol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1998</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Resh MD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24044036</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of GABAA receptors by fragile X mental retardation protein.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int J Physiol Pathophysiol Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wan Q</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28473628</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular mechanisms of Dicer: endonuclease and enzymatic activity.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochem J</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Song MS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rossi JJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26468183</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klann E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Costa-Mattioli M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zukin RS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e61">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">26670047</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Elevated CaMKIIÎ± and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Rep</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guo W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ceolin L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Collins KA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Perroy J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c69">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28859574</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Genomics Hum Genet</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Borrie SC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Brems H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Legius E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bagni C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e12">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProtKB - A7KAX9 (RHG32_HUMAN)</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProt</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="def">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ALDH5A1 aldehyde dehydrogenase 5 family member A1 [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sabiha Abekhoukh</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">H. Bahar Sahin</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mauro Grossi</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Samantha Zongaro</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thomas Maurin</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Irene Madrigal</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Daniele Kazue-Sugioka</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annick Raas-Rothschild</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mohamed Doulazmi</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pilar Carrera</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Andrea Stachon</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Steven Scherer</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maria Rita Drula Do Nascimento</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alain Trembleau</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ignacio Arroyo</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Peter Szatmari</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Isabel M. Smith</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Montserrat MilÃ </bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Adam C. Smith</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Angela Giangrande</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Isabelle CaillÃ©</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Barbara Bardoni</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17084704</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of ras signaling dynamics by Sos-mediated positive feedback.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Curr Biol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Boykevisch S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhao C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sondermann H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Philippidou P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Halegoua S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kuriyan J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bar-Sagi D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dc9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GAD1 glutamate decarboxylase 1 [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db1">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25781681</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ras activation revisited: role of GEF and GAP systems.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biol Chem</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hennig A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Markwart R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Esparza-Franco MA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ladds G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rubio I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f91">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18215622</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SchlÃ¼ter OM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Steiner P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Czervionke BL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sabatini B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malenka RC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b65">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17088211</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chowdhury S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shepherd JD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Okuno H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lyford G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Petralia RS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Plath N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kuhl D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huganir RL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Worley PF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d20">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ERK/MAPK signaling and</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ScienceDirect</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph Vithayathil</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joanna Pucilowska</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gary E. Landreth</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22483044</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The pathophysiology of fragile X (and what it teaches us about synapses).</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bhakar AL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DÃ¶len G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bear MF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b94">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Autism</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kong, Sek Won</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mustafa Sahin</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Christin D. Collins, Mary H. Wertz</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malcolm G. Campbell</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jarrett D. Leech</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dilja Krueger</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F. Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Louis M. Kunkel</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Isaac S. Kohane.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27573877</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Novel roles of amyloid-beta precursor protein metabolites in fragile X syndrome and autism.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Psychiatry</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Westmark CJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sokol DK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maloney B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lahiri DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e42">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17644144</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of NMDA receptors by phosphorylation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuropharmacology</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen BS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Roche KW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27239350</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Synaptic Plasticity, a Prominent Contributor to the Anxiety in Fragile X Syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neural Plast</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yang T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhao H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lu C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li X</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xie Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d83">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20186705</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dev Neurobiol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yoshii A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Constantine-Paton M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">neuron</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CL:0000540</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c01">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Neurobiology of mTOR</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Katarzyna Switona</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Katarzyna Kotulskab</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aleksandra Janusz-Kaminskaa</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Justyna Zmorzynskaa</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jacek Jaworski</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d35">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19436069</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ca2+/calmodulin-dependent protein kinase IV links group I metabotropic glutamate receptors to fragile X mental retardation protein in cingulate cortex.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2009</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fukushima H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kida S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhuo M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a67">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25113167</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activity-dependent alterations in the sensitivity to BDNF-TrkB signaling may promote excessive dendritic arborization and spinogenesis in fragile X syndrome in order to compensate for compromised postsynaptic activity.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Med Hypotheses</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim SW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cho KJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="df5">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">25913861</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huang J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ikeuchi Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malumbres M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bonni A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d51">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Modeling Fragile X Syndrome</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Books</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Robert B. Denman</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b17">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The mGluR theory of fragile X mental retardation</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F. Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kimberly M. Huber</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stephen T. Warren</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c0d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24533017</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Curr Neuropharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Uzunova G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hollander E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Shepherd J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a1e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27847432</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Metabotropic glutamate receptor dependent long-term depression in the cortex.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Korean J Physiol Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kang SJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kaang BK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22405502</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genes Brain Behav</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Goebel-Goody SM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wilson-Wallis ED</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Royston S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tagliatela SM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Naegele JR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lombroso PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24346713</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">From FMRP function to potential therapies for fragile X syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neurochem Res</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sethna F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moon C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f04">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The mGluR theory of fragile X mental retardation</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F. Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">M. Huber</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stephen T. Warren</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c5c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14676271</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PIKE GTPase: a novel mediator of phosphoinositide signaling.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Cell Sci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ye K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Snyder SH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f78">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19345194.</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The postsynaptic density proteins Homer and Shank form a polymericnetwork structure.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2009</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayashi MK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tang C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verpelli C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Narayanan R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stearns MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu RM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sala C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayashi Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa0">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20410124</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Alger BE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a61">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19345194</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The postsynaptic density proteins Homer and Shank form a polymeric network structure.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2009</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayashi MK</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tang C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Verpelli C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Narayanan R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stearns MH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu RM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sala C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayashi Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a08">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neurotrophin-regulated signalling pathways</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">LF Reichard</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14585353</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Targeting the PI3K-Akt pathway in human cancer: rationale and promise.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cancer Cell</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Luo J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Manning BD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cantley LC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f83">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15219735</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The mGluR theory of fragile X mental retardation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Trends Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bear MF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Warren ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f14">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The mGluR theory of fragile x mental retardation</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kimberly M Huber</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stephen T Warren</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a20">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24727796</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">FMRP regulates miR196a-mediated repression of HOXB8 via interaction with the AGO2 MID domain.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Biosyst</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tang W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang LR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang CY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d7c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17298186</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">FMRP mediates mGluR5-dependent translation of amyloid precursor protein.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PLoS Biol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Westmark CJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malter JS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b64">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23576886</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dialogues Clin Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Henley JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wilkinson KA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a34">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22017584</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular mechanisms of fragile X syndrome: a twenty-year perspective.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Annu Rev Pathol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Santoro MR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bray SM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Warren ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile X Mental Retardation Protein: Regulator of Specific mRNAs or Master Regulator of Global Translation?</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Denise Cook</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Scott A. Cameron</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Emma V. Jones</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22267161</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nat Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ronesi JA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Collins KA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hays SA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tsai NP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guo W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Birnbaum SG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hu JH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Worley PF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gibson JR</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b48">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18184796</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ronesi JA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Huber KM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d04">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Analysis of the Structure and Function of Protein Phosphatase 2A </bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Institutional Repository of the University of Basel</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Karsten Schmidt</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dfe">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27257628</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Activity-Regulated Cytoskeleton-Associated Protein Controls AMPAR Endocytosis through a Direct Interaction with Clathrin-Adaptor Protein 2.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">eNeuro</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DaSilva LL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wall MJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">P de Almeida L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wauters SC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">JanuÃ¡rio YC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MÃ¼ller J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CorrÃªa SA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f34">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">30686771</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The translational regulator FMRP controls lipid and glucose metabolism in mice and humans.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mol Metab</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Leboucher A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pisani DF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Martinez-Gili L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chilloux J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bermudez-Martin P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Van Dijck A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ganief T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Macek B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Becker JAJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Le Merrer J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kooy RF</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Amri EZ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Khandjian EW</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dumas ME</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Davidovic L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb4">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">9472019</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genes Dev</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1998</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gingras AC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kennedy SG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Leary MA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Sonenberg N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hay N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ALDH3A2 aldehyde dehydrogenase 3 family member A2 [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c99">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> Intercellular Communication in the Nervous System</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Books</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Robert Malenka</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e3a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">SLC6A1 solute carrier family 6 member 1 [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aa6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10473536</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1999</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lai MM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hong JJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ruggiero AM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Burnett PE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Slepnev VI</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">De Camilli P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Snyder SH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a46">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">30402088</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Impaired GABA Neural Circuits Are Critical for Fragile X Syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neural Plast</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gao F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Qi L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yang Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yang T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang Y</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhao H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Mechanisms of Fragile X Syndrome: A Twenty-Year Perspective</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Michael R. Santoro</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Steven M. Bray</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stephen T. Warren</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d25">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NMDA Receptor-Dependent LTD Is Required for Consolidation But Not Acquisition of Fear Memory</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Journal of Neurosicence</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xing Liu</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Qin-Hua Gu</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kaizheng Duan</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zheng Li</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee2">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProtKB - Q9Y566 (SHAN1_HUMAN)</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProt</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b0a">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21162125</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Neurosci Res</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yun SH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Trommer BL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dda">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string"> ABAT 4-aminobutyrate aminotransferase [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a32">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11237210</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Recent Prog Horm Res</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2001</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Avruch J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Khokhlatchev A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kyriakis JM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Luo Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tzivion G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vavvas D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhang XF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">27766264</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biomed Res Int</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2016</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kawaguchi K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Morita M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b22">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">CPT1A gene </bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NIH - Genetics Home Refrence</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d7d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">24044036</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Regulation of GABAA receptors by fragile X mental retardation protein.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int J Physiol Pathophysiol Pharmacol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2013</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Liu B</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chen J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Li Z</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wan Q</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mechanisms of clathrin-mediated endocytosis</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nature</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Marko Kaksonen</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">AurÃ©lien Roux</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12563289</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tor signalling in bugs, brain and brawn.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nat Rev Mol Cell Biol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jacinto E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hall MN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b75">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">19602257</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Src kinase up-regulates the ERK cascade through inactivation of protein phosphatase 2A following cerebral ischemia.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">BMC Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2009</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hu X</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wu X</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Xu J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhou J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Han X</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Guo J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="afd">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16908410</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2006</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hou L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Antion MD</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hu D</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Spencer CM</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Paylor R</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Klann E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8c">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">11837891</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GABA and GABA receptors in the central nervous system and other organs.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Int Rev Cytol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2002</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Watanabe M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Maemura K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kanbara K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tamayama T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hayasaki H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d33">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">MECP2 Gene</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gene Cards</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a86">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">17895972</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The cyclic AMP cascade is altered in the fragile X nervous system.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PLoS One</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kelley DJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Davidson RJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Elliott JL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lahvis GP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yin JC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bhattacharyya A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfd">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">22510460</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD).</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cold Spring Harb Perspect Biol</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">LÃ¼scher C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malenka RC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e30">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GPHN gephyrin [ Homo sapiens (human) ]</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">NCBI Gene</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2019</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbc">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">23202739</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Clin Invest</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2012</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bagni C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Tassone F</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neri G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hagerman R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e89">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">21167873</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2011</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Plotnikov A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zehorai E</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Procaccia S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Seger R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc3">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">14570712</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phosphorylation influences the translation state of FMRP-associated polyribosomes.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hum Mol Genet</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2003</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ceman S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">O'Donnell WT</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Reed M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Patton S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pohl J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Warren ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3b">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16125054</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The cAMP signalling pathway activates CREB through PKA, p38 and MSK1 in NIH 3T3 cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Cell Signal</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2005</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Delghandi MP</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Johannessen M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Moens U</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b4e">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">30705620</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile-X Syndrome Is Associated With NMDA Receptor Hypofunction and Reduced Dendritic Complexity in Mature Dentate Granule Cells.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Mol Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Yau SY</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bettio L</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chiu J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chiu C</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Christie BR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b23">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">12368261</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Genes Dev</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2002</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ishizuka A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Siomi MC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Siomi H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aae">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">G Protein regulation of MAPK networks</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nature</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2007</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Review | Published: 14 May 2007

G Protein regulation of MAPK networks
Z G Goldsmith</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">D N Dhanasekaran</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a26">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Molecular Autism</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2014</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kong, Sek Won</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mustafa Sahin</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Christin D. Collins</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mary H. Wertz</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Malcolm G. Campbell</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Jarrett D. Leech</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Dilja Krueger</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F. Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Louis M. Kunkel</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Isaac S. Kohane.</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3d">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18332424</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim SH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Markham JA</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Weiler IJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Greenough WT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c33">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile X mental retardation protein: from autism to neurodegenerative disease</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Frontiersin</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2015</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hansen Wang</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ece">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">30364226</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The Regulation of AMPA Receptor Endocytosis by Dynamic Protein-Protein Interactions.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Front Cell Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Hanley JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">brain disease pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PW:0001414</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d39">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">20457613</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2010</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Wang H</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kim SS</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zhuo M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">fragile X syndrome</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DOID:14261</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Disease</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fda">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">The mGluR theory of fragile X mental retardation</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Google Scholar</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2004</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Mark F Bear</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kimberly M Huber</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Stephen T Warren</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba9">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">16055064</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuron</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2005</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lu W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ziff EB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a19">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">15673435</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Differential expression of two NMDA receptor interacting proteins, PSD-95 and SynGAP during mouse development.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Eur J Neurosci</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2005</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Porter K</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Komiyama NH</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Vitalis T</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kind PC</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Grant SG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b85">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">18474609</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">J Biol Chem</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2008</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Narayanan U</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nalavadi V</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Nakamoto M</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Thomas G</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ceman S</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Bassell GJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Warren ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa6">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">10613508</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Neuroscience</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">1999</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Paradee W</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Melikian HE</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Rasmussen DL</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Kenneson A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Conn PJ</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Warren ST</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e46">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ERK/MAPK signaling and autism spectrum disorders</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">ScienceDirect</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2018</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joseph Vithayathil</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Joanna Pucilowska</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Gary E.Landreth</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edd">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">TECR_HUMAN</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">UniProt</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string"/>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c27">
      <bp:ID rdf:datatype="http://www.w3.org/2001/XMLSchema#string">28334053</bp:ID>
      <bp:DB rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PubMed</bp:DB>
      <bp:TITLE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">New insights of altered lipid profile in Fragile X Syndrome.</bp:TITLE>
      <bp:SOURCE rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PLoS One</bp:SOURCE>
      <bp:YEAR rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2017</bp:YEAR>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Ãaku A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Seidah NG</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Lortie A</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">GagnÃ© N</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Perron P</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">DubÃ© J</bp:AUTHORS>
      <bp:AUTHORS rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Corbin F</bp:AUTHORS>
    </bp:PublicationXref>
  <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#"><bp:TERM>disease pathway</bp:TERM><bp:ID>PW:0000013</bp:ID><bp:Ontology>Pathway Ontology</bp:Ontology></bp:openControlledVocabulary></Biopax>
</Pathway>